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Preface to ”Early Life Nutrition and Future Health”
Inequity starts before birth and is programmed in part by nutritional exposures. If these
exposures occur around the time of conception, during pregnancy, and/or in infancy or childhood
(all critical periods of development) they may alter a child’s health trajectory and impact
risk for chronic diseases and disorders across the child’s lifespan. Adverse health outcomes
associated with suboptimal nutrition in early life include poor growth, impaired cognition and
learning, cardiometabolic diseases, immune and inflammatory-mediated diseases and disorders, and
neuropsychiatric illnesses. This Special Issue on “Early Life Nutrition and Future Health” has the
following aims: 1) understand the origins of offspring health inequities from an early nutritional
perspective; 2) uncover new insights into the environmental, biological, and social mechanisms
that underpin these health outcomes in offspring; and 3) present novel targets and approaches
to optimise health trajectories and prevent chronic diseases and disorders in later life and across
generations. The research projects included herein highlight novel mechanistic, epidemiologic, and
intervention studies that target key windows where nutrition has greatest influence on future health
(preconception, prenatal, and postnatal periods) and that explore vulnerable populations and animal
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Abstract: Human milk oligosaccharides (HMOs), phospholipids (PLs), and gangliosides (GAs) are
components of human breast milk that play important roles in the development of the rapidly growing
infant. The differences in these components in human milk from the United Arab Emirates (UAE)
were studied in a cross-sectional trial. High-performance liquid chromatography-mass spectrometry
was used to determine HMO, PL, and GA concentrations in transitional (5–15 days) and mature (at 6
months post-partum) breast milk of mothers of the United Arab Emirates (UAE). The results showed
that the average HMO (12 species), PL (7 species), and GA (2 species) concentrations quantified in
the UAE mothers’ transitional milk samples were (in mg/L) 8204 ± 2389, 269 ± 89, and 21.18 ± 11.46,
respectively, while in mature milk, the respective concentrations were (in mg/L) 3905 ± 1466, 220 ± 85,
and 20.18 ± 9.75. The individual HMO concentrations measured in this study were all significantly
higher in transitional milk than in mature milk, except for 3 fucosyllactose, which was higher in
mature milk. In this study, secretor and non-secretor phenotype mothers showed no significant
difference in the total HMO concentration. For the PL and GA components, changes in the individual
PL and GA species distribution was observed between transitional milk and mature milk. However,
the changes were within the ranges found in human milk from other regions.
Keywords: human milk; human milk oligosaccharides; phospholipids; sphingomyelin; gangliosides;
LC–MS
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1. Introduction
Human milk (HM) is the complete food source for infants, providing all the nutrients required
for growth in the early stages of life. There has been long interest in the composition of human milk
and its changes with lactation and differences between mothers and between populations in different
geographical locations or with different diets. Changes in the macronutrient composition of HM
with respect to fat, protein, and lactose in different population cohorts have been investigated for
many years [1].
As a group, human milk oligosaccharides (HMOs) are a major component of HM, forming the third
most dominant component (12–18.6 g/L) after lactose (55–70 g/L) and fat 20–60 g/L) [2,3], and on average
having a higher concentration than protein. However, whether they are a macronutrient in sensu
stricto is open to interpretation [4]. Phospholipids (PLs) and gangliosides (GAs), which are constituents
of the milkfat globule membrane (MFGM) that surrounds the lipid droplet, are minor components.
Increasing evidence indicates that HMOs, PLs, and GAs play critical roles in the development of the
growing infants and have been of increasing interest in recent years as infant formula manufacturers
look to humanise their formulations.
HMOs are shown to play significant biological roles as prebiotics, antimicrobials, and immune
modulators [5–16] for the growing infant. To date, there are over 200 oligosaccharides [17] reported
in HM. One impact on the HMO profile from an individual mother is the absence (non-secretor) or
presence (secretor) of a fully functional α-(1,2)-fucosyltransferase 2, which is coded by the FUT2 gene;
milk produced by non-secretor mothers contains low concentrations of 2’-fucosyllactose (2’FL) as well
as lacto-N-fucopentaose I (LNFP I) [5,18].
In addition to their essential roles in cell membrane structural integrity, PLs play critical roles
in lung and brain development in the growing infant [19–23]. The PLs in HM are mainly found
in the tri-layer of the MFGM and consist of sphingomyelins (SMs) and the glycerophospholipids
phosphatidyl choline (PC) and its lyso species (L-PC), phosphatidyl ethanolamine (PE) and its lyso
species (L-PE), phosphatidyl inositol (PI), and phosphatidyl serine (PS).
GAs are also important in neurological development, memory formation, and synaptic signal
transduction, and are implicated in regulating the immune system and supporting gut maturation in
the new born [24–26].
There are recent studies that report the changes in HMOs [27–30], PLs [31–33], and GAs [32–35]
across lactation for various population cohorts; however, to our knowledge, there is no specific study
reported for the UAE or other Middle Eastern populations. In this study, the HMO, PL, and GA
concentrations in transitional (5–15 days) and mature milk (at 6 months post-partum) were measured in
a cross section of UAE mothers’ breast milk samples, collected from a wider mother–infant study cohort
(MISC) [36]. The information obtained from this study allows comparison with other similar studies
on HMO, PL, and GA levels in HM from other population cohorts to better address the hypothesis that
geography and ethnicity impact the levels of these HM bioactives [28].
2. Materials and Methods
2.1. Study Setting and Population
A randomly selected subsample of breast milk samples (transitional milk period, days 5 to 15
post-partum, n = 41, and mature milk at 6 months post-partum, n = 40) were made from a large
cohort collected as part of the MISC in the UAE to comprehensively investigate maternal and infant
factors in relation to child health outcomes, as well as early-life determinants of non-communicable
diseases, through integration of sociodemographic, dietary, lifestyle, anthropometric, and biological
and cognitive data [36].
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Arab participants were recruited from antenatal clinics in three main public governmental
hospitals, and seven primary health care clinics and mother and child centres in the Emirates of
Sharjah, Dubai, and Ajman. The inclusion criteria were pregnant women who were Emirati or Arab
expatriate; aged 19–40 years; singleton pregnancy; within the third trimester of pregnancy (27–42 weeks
of gestation); free of chronic diseases (including diabetes, hypertension, kidney disease, cancer,
and others), autoimmune disorders, infections with the human immunodeficiency virus, or hepatitis
in preconception; receiving antenatal care in any of the above-mentioned clinics; and expected to give
birth in a participating public hospital and remaining in the UAE during the timeline of the study.
The exclusion criteria were as follows: multiple pregnancy, high risk pregnancy or pre-eclampsia,
and history of chronic diseases [36].
The study was approved by the Research and Ethics Committee, University of Sharjah
(REC/14/01/1505) and by Al Qassimi Clinical Research Centre Ethical Research Committee (REC
Reference Number: 215 12015-03), by the Ministry of Health Ethical Research Committee (R02), and by
Dubai Health Authority (DSREC-0/2016).
2.2. Phospholipid, Ganglioside, and Oligosaccharide Analysis
Extraction of HM samples and analysis using HPLC-MS was as described previously for PLs [31]
and GAs [34]. Briefly, 0.25 mL of HM samples was extracted using the modified Svennerholm and
Fredman [37] method described by Fong et al. [38]. The non-polar (lower) phase was diluted to 5 mL
with choroform/methanol (1:2) and an aliquot was used for quantification of PC, PS, PI, PE, SM, L-PC,
and L-PE. Separation and quantification were as described previously [38] with individual PL species
separated using an ACQUITY UPLC system (Waters, Milford, MA, USA) equipped with an APS-2
Hypersil column (150 mm × 2.1 mm, 3 Um, Thermo Electron Corporation, Waltham, MA, USA).
The eluate from the HPLC was directed into a TSQ Quantum mass spectrometry (Thermo Electron
Corporation, Waltham, MA, USA) with individual PL species detected either by precursor ion or
neutral loss experiments [38]. The polar (upper) phase from the extraction was diluted to 10 mL with
methanol/water (1:1), and then GA classes (disialoganglioisde 3 (GD3) and monosialoganglioside 3
(GM3)) were separated on an Agilent 1100 series HPLC system (Santa Clara, CA, USA) equipped
with an APS-2 Hypersil column (150 mm × 2.1 mm, 3 mm), interfaced to a SCIEX 6500 QTrap mass
spectrometer (AB SCIEX, Framingham, MA, USA) and quantified as described by Ma et al. [26] using
multiple reaction monitoring in negative mode.
HMOs (3’-sialyllactose (3’SL), 6’-sialyllactose (6’SL), 6’-sialyllactosamine (6’SLN), disialyllactose
(DSL), 3’-sialyl-3-fucosyllactose (3’S3FL), LS-tetrasaccharide a/b (LSTa/b), LS-tetrasaccharide (LSTc),
lacto-N-neotetraose (LNnT), lacto-N-tetraose (LNT), Lacto-N-fucopentaose (LNFP total against LNFP
I as standard), 2’-fucosyllactose (2’FL), and 3-fucosyllactose (3FL)); were analysed for, and in all
cases, the sialic acid is N-acetyl neuraminic acid. HMOs were separated using a Luna hydrophilic
interaction liquid chromatography column (150 mm × 2.1 mm, 3 um, Phenomenex, Torrence, CA,
USA) on an Agilent 1100 series HPLC [30]. The HPLC system was coupled to a SCIEX 6500 QTrap
mass spectrometer, operated in negative ion mode, and HMOs were quantified as described [30] using
3’-sialyllactosamine as an internal standard.
2.3. Statistical Analysis
Statistical analysis was conducted using one-way analysis of variance (ANOVA), where difference
among the means is significant when p < 0.05 (MiniTab Release 17.2.1 2016, MiniTab Inc., State College,
PA, USA).
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3. Results
3.1. HMO
Seven acidic (3’SL, 6’SL, 6’SLN, 3’S3FL, DSL, LSTa/b, and LSTc) and five neutral (LNnT, LNT,
LNFP (total), 2’FL, and 3FL) oligosaccharides were measured.
The average HMO concentration in transitional milk (8204 ± 2389 mg/L; Table 1) was significantly
higher than that measured in mature milk (3905 ± 1466 mg/L; Table 1). This trend was also reflected at
the individual HMO level (Table 1). When secretor and non-secretor milk samples were considered
separately (based on a non-secretor milk having a 2’FL concentration <50 mg/L), the total HMO
concentrations for both groups were not significantly different for either transitional or mature milk
(Table 1).
The proportion of the acidic HMOs in transitional milk (18%) was higher than that measured
in mature milk (7%); concomitantly, the neutral HMOs in transitional milk were 82% of total HMOs
measured, compared with 93% in mature milk. When considered separately, secretors and non-secretors
were not significantly different in this aspect. The HMO species for which there was a significant
difference in concentration between secretor and non-secretor milk samples were 2’FL, 3FL, and 3’S3FL
(Table 1). The secretor milk samples were higher in 2’FL and lower in 3FL and 3’S3FL compared with
non-secretor milk samples.
3.2. Phospholipids
The average total PL concentration (± SD) measured in the transitional milk (269.0 ± 89.2 mg/L)
was significantly (p < 0.05) higher than that measured for mature milk (219.6 ± 85.0 mg/L, Table 2).
The concentration of PE, SM, and L-PE did not change significantly (p > 0.05) between transitional and
mature milk, but PI, PC, PS, and L-PC decreased significantly in concentration in mature milk (Table 2).
The relative distribution of the five different PL classes (PI, PC, PE, PS, and SM) and L-PC and
L-PE is presented in Table 2. Because of the changes in individual PL species concentration, significant
changes in the relative distribution of PL classes were observed, with PE increasing from 25% in
transitional milk to 36% in mature milk (6 months post-partum), while PC and PS decreased from 25%
to 14% and 11% to 7%, respectively. SM remained the dominant PL class during both lactation milk
time points, and only increased slightly (Table 1). Little change in the PI distribution was observed
over the two-time points, decreasing from 4% to 3%.
3.3. Gangliosides
The average total GA (TGA) concentration measured in the UAE mothers’ transitional milk
(21.2 ± 11.46 mg/L) and mature milk (20.2 ± 9.8 mg/L) was not significantly different (p > 0.05)
across the two-time points. However, the relative distribution of ganglioside classes, GD3 and GM3,
changed across the two-time points from 56% and 44%, respectively, for transition milk, to 9% and
91% respectively, for mature milk (Table 2), with both GM3 and GD3 showing significant changes
in concentration.
4
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4. Discussion
HM is considered the “gold standard” for an infant’s nutrition, to which infant formula
manufacturers strive to emulate in both nutrient composition and performance. HM composition
varies considerably between individual mothers and over lactation, and so could be considered to
be personalised to each infant that is breastfed. Various factors such as diet, geography, ethnicity,
milk collection time, and genetics have been implicated to have a significant influence on the HMO, PL,
and GA composition in HM, but most of the data obtained to date indicate that the stage of lactation is
perhaps the primary factor that has the greatest influence on HM composition [27–29,39]. There are
several recent studies reporting the composition of HM, trying to gain a better understanding of the
changes in the HMOs and complex lipids (PLs and GAs) through lactation of different geographical
population cohorts [28,31,32,34,35,39,40]. However, this is the first study that looks at the transitional
and mature milk from UAE mothers, helping to address geographical variation in HMOs, PLs, and GAs.
4.1. Human Milk Oligosaccharides
The UAE mothers’ transitional breast milk samples had significantly higher average total HMO
concentrations (8204 ± 2389 mg/L) compared with the mature milk samples (3876 ± 1403 mg/L).
The largest decrease in the HMOs over these two lactation timepoints was observed with the acidic
oligosaccharide, LSTc, which decreased by 98% from 488 ± 224 mg/mL in transitional milk to 11 mg/L
in the six months post-partum mature milk (Table 1). The only HMO to increase across this period
was 3FL (Table 1). This trend is in line with lactational trend data reported in the literature [27,29,30]
(Figure 1). While only five neutral oligosaccharides (2’FL, 3FL, LNT, LNnT, and total LNFP) were
measured in this study, they made up a significant proportion (82% and 93% for transitional and
mature milk, respectively) of the total HMOs measured in this study, with the acidic HMOs making
up 18% and 7% for transitional and mature milk, respectively. This finding is consistent with those
reported by Ma et al. [30] for their Malaysian and Chinese cohort of 89%–91% and 8.5%–11% of neutral
and acidic HMOs, respectively, and other similar studies [27–29], despite differences in the range of
HMOs and respective concentrations being different.
The individual HMO levels measured in this study for the UAE breast milk samples were also
in a range similar to that reported by Ma et al. [30] for Chinese and Malaysian mothers (Table 3 and
Figure 1); and Larsson et al. [41], Coppa et al. [42], Bao et al. [43], and Austin et al. [29] for the common
HMOs measured for the corresponding time points, except for 3’SL, LNT, and LNnT where Austin
et al. [29] reported lower HMO lactational results (Table 3 and Figure 1).
HMOs have been implicated not just to provide anti-infective protection for the infant, but also
as being involved as immune modulators, and may play a key role in gut maturation of the rapidly
growing infant. Higher HMO concentrations in colostrum and transitional milk may be the consequence
of increased protection required for the vulnerable infant during the early few days of life. The changes
in HMO levels over the course of lactation [29,30] may reflect changes in the development stages of the
growing infant, and a requirement for specific compositions of these HMOs.
On the basis of the 2’FL concentrations, 26% of the UAE mothers in this cohort expressed a
non-secretor phenotype, having a 2’FL concentration <50 mg/L in their breast milk samples [29,44].
2’FL (and LNFP I) are products of α-(1,2)-fucosyltransferase 2, which is coded by the FUT2 gene that
is supposedly non-functional in non-secretor mothers. However, in the study of Austin et al. [20],
2’FL was found to be not completely absent in the non-secretor mothers, as was the case in this
study. The secretor/non-secretor frequency is known to vary with geography and racial difference,
with 22.5% non-secretor phenotype reported for the Han Chinese population, Eastern China region [29];
37% reported for the Chinese cohort (Guangzhou); and 17% reported for Malay mothers [30]. The typical
frequency of non-secretor phenotype reported by Azad et al. [39] was 28% for Caucasian mothers,
while Asian mothers had higher non-secretor frequency at 40%; however, the Asian mothers’ sub-ethnic
groups were not defined. There is no current information as to the non-secretor frequency for the UAE
population. Azad et al. [30] also reported that the non-secretor group had significantly less HMOs
6
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than the secretor group. For the HMOs measured in this study, however, there was no significant
difference (p > 0.05) in the average total HMOs between secretor and non-secretor mothers for either
their transitional milk (8292 ± 2516 mg/L versus 6994 ± 1905 mg/L, respectively) or their mature milk
(4289 ± 1791 mg/L versus 4317 ± 1857 mg/L, respectively) (Table 1).
Figure 1. Human milk oligosaccharide (HMO) concentrations in the United Arab Emirates (UAE)
mothers’ milk () across the transitional milk and mature milk periods, plotted against the lactational
trend reported by Ma et al. [30] for a Chinese cohort () and Malaysian cohort (), and by Austin
et al. [29] for a Chinese cohort (). 3’SL, 3’-sialyllactose; 6’SL, 6’-sialyllactose; 6’SLN, 6’-sialyllactosamine;
DSL, disialyllactose; 3’S3FL, 3’-sialyl-3-fucosyllactose; LSTa/b, LS-tetrasaccharide a/b; LSTc, LS-
tetrasaccharide; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetraose LNFP, lacto-N-fucopentaose I;
2’FL, 2’-fucosyllactose; 3FL, 3-fucosyllactose.
One important consideration in assessing crude population figures for HMO species is the impact
that the percentage of non-secretors in each study population has on the average or mean 2’FL and 3FL
concentrations that would be reported for the full cohort; the higher the percentage of non-secretors in
a population, the lower the average 2’FL and higher the average 3FL concentrations for the cohort as a
whole. Furthermore, it is not only the crude 2’FL and 3FL figures that are impacted, but also the figures
for other oligosaccharides such as LNFP I and 3’S3FL. For example, in this study, the mature milk results
for the full cohort showed that 2’FL and 3FL concentrations are relatively similar, which was also shown
by Ma et al. [30] and Austin et al. [29], but if the non-secretor percentage was lower, then 3FL would
be lower than 2’FL at later points in lactation, as evidenced in the limited data of Larsson et al. [41],
which is the analysis of secretors alone, and the results of this study. Figure 1 also emphasises the
impact of lactation on interpreting which oligosaccharides are in highest concentration, because, at six
months in all four cohorts (two Chinese, one Malaysian, and one UAE), the concentrations of 3FL and
2’FL are very similar.
7
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4.2. Phospholipids
The average total PL concentrations observed with HM samples of UAE mothers were within the
typical ranges reported for human breast milk for other geographical population cohorts (Table 4).
In this study, the UAE transitional milk had an average total PL concentration that was significantly
higher (p < 0.05) than that measured for the six-month mature milk. While this trend is consistent with
the majority of the published data [31,33,45–48], the trend reported from some studies showed the
total PL concentration in colostrum and transitional milk was either much lower than [49–51] or the
same as [52] that in mature milk (Table 4).
At the individual PL class level, changes in the relative distribution of the individual PL classes
were observed over the transitional milk and mature milk periods (Figure 1). There was a significant
increase in the relative amount of PE from 25% in transitional milk to 36% in the UAE mature milk
samples, while PC and PS both decreased, the former from 25% to 14% and the latter from 11% to 7%.
SM increased only slightly, while PI decreased slightly. Similarly, changes in the relative distribution
between transition milk and mature milk was observed for a Malaysian HM cohort [31] (Figure 2).
In contrast, however, the PL distribution was relatively constant for Spanish [34] and Chinese [24]
breast milk cohorts (Figure 2).
Table 4. Human milk phospholipid concentration reported in the literature for both transitional and
mature milk (modified from Ma et al. [31]) a.
Total PL Ranges (mg/L)
Country Reference
Transitional Milk Mature Milk
390 ± 50-440 ± 73 (8-15, 20) 370 ± 106-405 ± 80 (22–36, 40) Germany Harzer et al. [52]
310 ± 30 (11, 5) 270 ± 30 (23, 5 pooled) USA Bitman et al. [47]
158 (11, 17) 114 (23, 19) Spain Sala-Vila et al. [48]
148 (7, 6) 133–227 (20–84, 6) USA Bitman et al. [49]
973 (14, 10) 1023-1298 (42-112, 10) USA Clark et al. [50]
185 (6-15, 45) 182 (>16, 45) Denmark Zou et al. [51]
550 ± 260 (6–10, 7) 450 ± 260 (30, 16) France Gracia et al. [45]
230 ± 49–242 ± 82 (30–120, 50) Singapore Thakkar et al. [32]
437 ± 23–535 ± 26 (6–15, 44) 260 ± 3–422 ± 13 (16–360, 44) Spain Claumarchirant et al. [46]
266 ± 57 (6-14, 12) 170 ± 80-219 ± 92 (60–365, 132) Malaysia Ma et al. [31]
285 ± 144 (6–15, 81) 242 ± 114 (16–240, 345) China Guiffrida et al. [33]
269 ± 89 (6–14, 41) 220 ± 85 (180, 40) UAE This study
a Lactational period, in days, and number of samples are given in parentheses. Data from Sala-Vila et al. [48]
recalculated from total phospholipid data provided using average molecular masses of 758.4, 864.4, 787.1, 737.6,
and 754.4 for PC, PI, PS, PE, and SM, respectively; data from Bitman et al. [49] recalculated from graph using termed
mothers only.
However, across the mature milk period, three recent studies [31,32,46] and two earlier
studies [49,52] showed that the individual PL class distribution remained relatively constant through
the mature milk period, despite changes in their absolute concentrations.
Variation in absolute PL concentrations may be attributable to a variety of factors, such as time of
sampling protocols (full breast expression, time of sampling, and breast variation [53]), diet, geographic,
and even metabolic stage and gestational age at birth, in addition to different analytical methods
used [54–56]. However, the fact that the relative distribution of the individual PL class remains
constant through the mature milk period indicates that some metabolic controls are maintained over
the biosynthesis of these PL classes, perhaps to maintain the integrity of the MFGM structure.
Changes in the individual PL distribution observed between early milk and mature milk may be
the consequence of the changing structure. It is reported that colostrum and transitional milk has much
larger fat droplet size than that of mature milk [57]. In fact, Cohen et al. [58] reported the phospholipid
composition of the mammary epithelial cell regulated the lipid droplet size, rather than the cellular
triglyceride content; this phospholipid composition is critical in maintaining membrane structure
integrity as the lipid droplet size changes.
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Figure 2. Distribution of phospholipid classes in transitional milk (TM) and mature milk (MM;
six months post-partum) in UAE mothers’ milk, and from other geographic cohorts. SM, sphingomyelins;
PC, phosphatidyl choline (PC); L-PC, PC lyso species; PE, phosphatidyl ethanolamine; L-PE, PE lyso
species; PI, phosphatidyl inositol; PS, phosphatidyl serine.
4.3. Gangliosides
In HM, GAs are present predominantly as the GM3 and GD3 classes (which have the same polar
head group, but different sphingosine and fatty acid). Typically, GD3 is present at relatively high
concentrations in colostrum and transitional HM, making up approximately 30%–80% of the TGAs,
but decreasing to 8%–25% by four to six months post-partum. Conversely, the relative proportion of
GM3 is higher in mature milk [33,35,59–61].
However, there is no clear consistent lactational trend observed for TGA concentration. While a
few studies show colostrum and transitional milk to contain the highest TGA concentration [34,59],
other studies show the opposite [60,62]. Similarly, the TGA lactation trend over the mature milk period
is also not clear. While the studies of Thakkar et al. [32] and Ma et al. [34] showed a gradual increase in
the TGA level over the mature milk period (of four months and eight months duration, respectively),
from the data published for the Malaysian cohort [34], this gradual increase did not appear to be
sustained: the average TGA levels dropped from ~25.3 ± 15.7 mg/L at 6 months to 16.6 ± 8.5 mg/L at
around 12 months post-partum.
In this study, there was no significant difference between the average TGA results measured
between the transitional milk (21.18 ± 11.46) and the mature milk period (20.18 ± 9.75), with GD3
making up 55% of the TGAs in transition milk, decreasing to 8% at six months post-partum. The change
in the GA class distribution is consistent across other published cohort studies [34,35] (Table 5),
suggesting that the biosynthesis of GAs is under metabolic control, and different classes may be
required for different stages of the development and growth for the breast fed infant. Interestingly,
Thakkar et al. [32] reported that HM from mothers with male infants had higher energy content and
lipids compared with that mothers of female infants; these differences may be because of differences
in nutritional requirements to support specific growth and development patterns between the two
sexes [23]. However, in the current study, there were no significant differences in the GA concentrations
of either the transitional milk or mature milk breast milk from mothers who had male or female infants.
The average TGA levels observed with the UAE cohort were similar to those reported for the Malaysian
and Chinese cohorts (25.3 ± 15.7 mg/L and 22.9 ± 9.9 mg/L, respectively [34,35]), but higher than those
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reported by Thakkar et al. [32] for their Singapore cohort (4.6–5.6 mg/L) and Giuffrida et al. [33] for
their Chinese cohort (11.0 ± 5.0 mg/L).
Table 5. Human milk mean GM3, GD3, and total ganglioside concentrations reported in the literature
for both transitional and mature milk (mg/L ± standard deviation) a.
Reference Milk n GM3 GD3 Total GA
Giuffrida et al. [40] China Colostrum/Transition (0–11 days) 450 3.8 ± 0.4 (47) 4.3 ± 0.9 (53) 8.1
Ma et al. [34] Malaysia Transition 12 8.3 ± 4.8 (44) 10.6 ± 4.3 (56) 18.9 ± 6.6
This Study UAE Transition (5–15 days) 41 9.5 ± 8.4 (45) 11.7 ± 9.5 (55) 21.2 ± 11.5
Ma et al. [34] Malaysia Mature (6 months) 42 21.4 ± 13 (85) 4.3 ± 5.5 (15) 25.3 ± 15.7
Ma et al. [35] China Mature (6 months) 20 21.4 ± 9.5 (93) 1.5 ± 1.4 (7) 22.9 ± 9.9
This Study UAE Mature (6 Months) 40 18.6 ± 9.7 (92) 1.6 ± 2.2 (8) 20.2 ± 9.8
a % of total GA is given in parenthesis.
5. Conclusions
This study provides new information about the HMO, PL, and GA concentrations in breast
milk specific to UAE mothers. Despite reports indicating that human milk composition varies across
different geographies and ethnicities, the average HMO, PL, and GA concentrations measured in the
MISC study from UAE were within the typical ranges reported for other ethnic cohorts, especially data
obtained by the same methodologies. There appear to be more similarities than differences for HMOs,
PLs, and GAs in HM from different geographical locations and ethnicities. The similarity in the range
of concentrations of HMO, PL, and GA between different cohorts suggests they each have specific
biological and functional roles linked to timing of lactation.
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Abstract: Sugar-containing beverages (SCBs) are a major source of sugar intake in children. Early life
intake of SCBs may be a strong predictor of SCB intake later in life. The primary objective of this
study was to evaluate if SCB intake (defined as 100% fruit juice, soda, and sweetened drinks) in early
childhood (≤2.5 years of age) was associated with SCB intake in later childhood (5–9 years of age).
A prospective cohort study was conducted using data from the TARGet Kids! primary care practice
network (n = 999). Typical daily SCB intake was measured by parent-completed questionnaires.
Odds ratios (OR) and 95% confidence intervals (CI) were estimated using logistic regression. A total
of 43% of children consumed ≥0.5 cups/day of SCBs at ≤2.5 years and this increased to 64% by
5–9 years. Daily SCB intake, compared to no daily intake, at ≤2.5 years was significantly associated
with SCB intake at 5–9 years (adjusted OR: 4.03; 95% CI: 2.92–5.55) and this association was much
stronger for soda/sweetened drinks (adjusted OR: 12.83; 95% CI: 4.98, 33.0) than 100% fruit juice
(OR: 3.61; 95% CI: 2.63–4.95). Other early life risk factors for SCB intake at 5–9 years were presence
of older siblings, low household income, and shorter breastfeeding duration. Daily intake of SCBs
in early childhood was strongly associated with greater SCB intake in later childhood. Early life may
be an important period to target for population prevention strategies.
Keywords: sugars; fruit juices; life-course epidemiology; infant; child
1. Introduction
Sugar intake in children has been associated with increased cardiometabolic risk factors, including
obesity [1,2], high blood pressure, and dyslipidemia [3–8] and dental caries [9,10]. These adverse
conditions in childhood are associated with disease outcomes in later adulthood, such as type 2
Nutrients 2019, 11, 2338; doi:10.3390/nu11102338 www.mdpi.com/journal/nutrients15
Nutrients 2019, 11, 2338
diabetes and cardiovascular disease [11–13]. Further, sugar intake across the life-course is associated
with similar adult disease outcomes [2,14]. In 2015, fruit juice and sweetened fruit drinks were among
the top ten most common sources of sugar intake for children ages two to eight in Canada, amounting
to approximately 11.6% and 3.5% of their total sugar intake, respectively [15]. In the US, it was found
that children and adolescents derive 10%–15% of total calories from sugar-containing beverages [16].
Recent estimates suggest that the percentage of U.S. children 19–23 months of age consuming any 100%
fruit juice is about 50%, and 38% consumed any sugar-sweetened beverages [17].
Sugar-sweetened beverages are frequently defined as liquids that are sweetened with various
forms of added sugars (e.g., sodas, fruit drinks) [18]. Fruit juices which contain 100% juice are
often excluded from the definition of sugar-sweetened beverages, as they are sometimes perceived
as a healthier beverage option. However, 100% fruit juice also contains a high sugar content and
lacks dietary fibre. The World Health Organization defines free sugars as “all monosaccharides and
disaccharides added to foods and beverages by the manufacturer, cook or consumer, as well as sugars
that are naturally present in honey, syrups, fruit juices and fruit juice concentrates”, and recommends
that both adults and children reduce their intake of free sugars to less than 10% of total energy
intake [19]. The American Academy of Pediatrics recommends limiting children’s fruit juice intake [20],
which is consistent with the newly released 2019 Canada Food Guide, which also suggests limiting,
if not replacing sugar-containing drinks with water [21]. The term sugar-containing beverages (SCBs)
is used here to include the following beverages containing free sugars: Soda or pop, sweetened drinks,
and 100% fruit juice.
Dietary patterns in childhood have been shown to track into adulthood [22,23], thus the
early introduction of sugar-sweetened beverages may increase intake across the life-course [24–26].
Studies conducted in the United States [26] and Norway [25] reported that intake of soda and sweetened
beverages before two years of age is strongly associated with increased intake in later childhood at age
six and seven, respectively. However, neither study included 100% fruit juice, and only one study
controlled for potential confounders [26]. Further, a recent systematic review of risk factors associated
with sugar beverage intake in children <6 years of age also did not include 100% fruit juice intake
in its definition of SCB [27]. This systematic review identified 17 determinants of sugar beverages that
support an association with intake of SCB in early childhood, including child age, parental knowledge,
household rules, screen time, snack consumption, formula fed, lower parental socioeconomic status,
and early introduction of solids [10,27]. Few studies have prospectively evaluated SCB intake during
infancy and risk factors in early life that may predict SCB intake in later childhood.
The primary objective of this study was to evaluate if SCB intake in early childhood (≤2.5 years
of age) was associated with increased SCB intake in later childhood (5–9 years of age). The secondary
objective was to evaluate if the association between early life SCB intake and later childhood intake
was independent of other established SCB risk factors.
2. Materials and Methods
2.1. Study Design
A prospective cohort study was conducted among children in The Applied Research Group for
Kids (TARGet Kids!) primary care practice-based research network. The TARGet Kids! network
recruits children <6 years of age at scheduled well-child visits and follows them prospectively through
childhood [28]. Children were recruited between 2008 and 2017 from primary care pediatricians or
family practice clinics in the Greater Toronto Area, Canada. Children were excluded at enrollment
if they had associated health conditions affecting growth (i.e., failure to thrive, cystic fibrosis),
severe developmental delay, or other chronic conditions except for asthma or if the families were not
English speaking. Informed written consent was obtained from parents and TARGet Kids! is approved
by the research ethics boards at the Hospital for Sick Children (#1000012436) and St. Michael’s Hospital,
Toronto, Canada.
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2.2. Study Population and Sample Size
For this study, children were included if they had at least one visit before or at 2.5 years of age
(defined as early childhood) and a follow-up at 5–9 years of age (defined as later childhood) from
2008 to 2017. A total of 5478 children were identified in the TARGet Kids! database who had a visit
at ≤2.5 years of age, 3574 children were excluded because they were recruited recently and would not
have a minimum of 2.5 year follow-up time (i.e., these children had not yet reached 5 years of age).
Of the remaining 1904 children who had a visit at ≤2.5 years of age there were 1267 with a follow-up
visit between 5 and 9 years of age. However, 268 children were missing data on SCB intake at both
time points (≤2.5 years of age, and 5–9 years of age) and therefore were removed, resulting in a total
sample size of 999 children (Figure 1).
Figure 1. Participant flow diagram.
2.3. Measurement of Sugar-Containing Beverage Intake
At each TARGet Kids! visit, parents completed an age-specific nutrition and health questionnaire [28].
To determine a child’s sugar beverage intake, parents were asked to “circle how many cups of each drink
your child has currently in a typical day, if none then circle 0 (1 cup = 8 ounces = 250 mL)” and the response
options were: 0, 1/2, 1, 2, 3, 4, and 5+. The list of beverages included “100% juice (apple, orange etc.)”,
“sweetened drinks (Kool Aid, Sunny D, etc.)” and “soda or pop”. In this analysis, three primary exposure
variables were investigated: (1) 100% fruit juice, (2) soda and sweetened drinks (combined sweetened
drinks with soda/pop), and (3) total sugar-containing beverages (SCBs), which includes all three beverages
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(100% fruit juice, soda, and sweetened drinks). Similar to previous studies in this age group [26] all
variables were dichotomized into 0 cups/day and ≥0.5 cups/day since a high proportion of respondents
indicated no intake.
2.4. Other Variables
Based on a recent systematic review of risk factors for sugar beverage intake in children <6 years
of age [27], we identified variables of interest associated with SCB consumption, including age, sex,
mother’s education, mother’s ethnicity, family income, number of siblings, zBMI, weekday free time
play, parental BMI, and length of breastfeeding. Child and parent BMI were measured through
the measurement of height and weight by trained research assistants using standard methods [29].
Child overweight and obesity categories were defined using BMI z-scores calculated using the WHO
growth reference standard which is recommended for child growth monitoring in Canada [30]. All other
variables were captured through questionnaires completed by parents.
2.5. Statistical Analysis
All statistical analyses were conducted using SAS software 9.4 (Raleigh, NC, USA). Descriptive
analyses for all variables were conducted, including the frequency and percent, and when applicable,
the mean and standard deviation. To assess whether the intake of SCBs in early childhood (ages ≤2.5)
was associated with intake in later childhood (ages 5–9), multivariable logistic regression was used
to estimate odds ratios (OR) and corresponding 95% confidence intervals (CI). Multivariable models
included all potential risk factors identified a priori based on a previous systematic review. Results
are presented for three dependent variables at 5–9 years of age: (1) total SCB intake; (2) sugar and
sweetened drink; and (3) 100% fruit juice. All variables were adjusted for as presented in Table 1.
Multicollinearity was assessed by inspection of the variance of inflation factors (VIFs). None of the
VIFs were greater than 2.5, suggesting no concerns with multicollinearity. To account for missing data
in the covariates, multiple imputation was performed using PROC MI and PROC MIANALYZE on
SAS. Participants who were missing data on both the primary exposures and outcome variables were
excluded from the study thus these variables were not imputed, only data on covariates was imputed.
A minimum of 20 datasets were imputed for each analysis. All variables listed in Table 2 were included
in the imputation model, including the exposure (≤2.5 years of age) and outcome (5–9 years of age).
All statistical tests were 2-sided and a significance level of less than 0.05 was specified.
Table 1. Baseline characteristics of children from the TARGet Kids cohort with a visit at both ≤2.5 years

























Normal and underweight (zBMI ≤ 1.0) 790 79.1
Risk of overweight (1 > zBMI ≤ 2.0) 141 14.1








Age (months) 18.1 4.8
Parent BMI (kg/m2) 3 24.6 4.6
Typical Weekday Free Play (minutes) 58.7 56.5
Child zBMI 0.09 1.07
Breastfeeding duration (months) 11.3 5.7
1 Canadian dollars. 2 Based on WHO Growth Standards. 3 Responses were from either mothers (84%) or fathers (16%).
Table 2. Distribution of sugar-containing beverage consumption in children at ≤2.5 years of age and
5–9 years of age among children in TARGet Kids! in Ontario, Canada (n = 999).
Sugar-Containing Beverages
≤2.5 Years of Age
N (%)
5–9 Years of Age
N (%)
100% Fruit Juice 1
0 cups/day 564 (57.1) 368 (37.1)
≥0.5 cups/day 424 (42.9) 623 (62.9)
Soda and Sweetened Drinks 2
0 cups/day 934 (96.8) 829 (93.9)
≥0.5 cups/day 31 (3.2) 54 (6.1)
Total SCB consumption
0 cups/day 570 (57.1) 361 (36.1)
≥0.5 cups/day 429 (42.9) 638 (63.9)
1 11 missing 100% fruit juice intake at ≤2.5 years of age and 8 missing 100% fruit juice intake at 5–9 years of age;
2 34 missing soda and sweetened drink intake at ≤2.5 years of age and 116 missing soda and sweetened drink intake
at 5–9 years of age.
3. Results
A total of 999 children had measures of sugar-containing beverage intake between 0 and 2.5 years
of age and 5 and 9 years of age (Figure 1). Baseline demographic characteristics are described in Table 1.
Approximately 46.7% of children were female, 73.0% were of European ethnicity, and the mean age
at the first visit was 18.1 months. There were 141 children (14.1%) who met the WHO defined cut-points
for ‘risk of overweight’ and 34 (3.4%) who were ‘overweight or obese’ based on their zBMI at ≤2.5 years
of age.
3.1. Description of SCB Consumption at ≤2.5 Years and 5–9 Years
The proportion of children that typically drank ≥0.5 cups/day of 100% fruit juice was 42.9%
at ≤2.5 years of age, which increased to 62.9% at ages 5–9 (Table 2). At ≤2.5 years of age, only 3.2%
of children typically consumed ≥0.5 cups/day of soda and sweetened drinks, which increased to 6.1%
of children at 5–9 years of age. At ≤2.5 years, 57.1% of children consumed 0 cups/day of SCB,
which decreased to 36.1% at ages 5–9. This represents a 21% decrease in those who consumed
0 cups/day of SCB. At ≤2.5 years of age, the majority of children (51.6%) who consumed soda and
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sweetened drinks, drank 0 to 1 cups (Figure 2a), whereas at 5–9 years of age, almost half of children
(48.1%) drank 1 to 2 cups of soda and sweetened drinks (Figure 2b). Among children who consumed
any SCB, 49.2% consumed 0 to 1 cups at ≤2.5 years of age (Figure 2a), and 42.5% consumed this amount
at 5–9 years of age (Figure 2b).
Figure 2. Distribution of sugar-containing beverage (SCB) intake among children in the TARGet Kids!
Research Network among children who “ever consumed” SCBs.
3.2. SCB Intake at ≤2.5 Years Association with SCB Intake at 5–9 Years
A strong and significant association was observed between SCB intake at ≤2.5 years of age and
later in childhood (5–9 years) and this persisted in the fully adjusted model after controlling for
potential SCB risk factors (Table 3). For total SCB intake, children who consumed ≥0.5 cups/day of SCBs
at ≤2.5 years old had 4.03 times greater odds of consuming SCBs in later childhood (fully adjusted
OR: 4.03; 95% CI: 2.92–5.55) (Table 3). Children who had consumed soda and sweetened drinks at
≤2.5 years of age had 16.91 times greater odds of consuming soda and sweetened drinks at ages
5–9 (fully adjusted OR:16.91; 95% CI: 3.68, 77,69) (Table 3). Those who consumed ≥0.5 cups/day
of 100% fruit juice at ≤2.5 years of age had 3.6 times greater odds of consuming fruit juice at ages
5–9 (fully adjusted OR: 3.61; 95% CI: 2.63–4.95) (Table 3). The associations for 100% fruit juice and
total SCB changed minimally in the models adjusted only for age and sex versus the fully adjusted
models (Table 3). However, the association for soda and sweetened drinks changed substantially with
an OR of 23.48 (95% CI: 9.55, 57.76) for the model adjusted only for age and sex, and this decreased
to 16.91 (95% CI: 3.68, 77.69) for the fully adjusted model (Table 3).
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3.3. Other Early Childhood Risk Factors
Other possible risk factors for SCB consumption in later childhood (5–9 years of age) are
also presented in Table 3. For total SCB intake, breastfeeding decreased odds of consuming SCBs
in later childhood (fully adjusted OR: 0.94; 95% CI: 0.89, 0.99 per two months longer breast feeding)
(Table 3). Having a household income of <$49,999 (fully adjusted OR: 1.64; 95% CI: 0.79, 3.39),
in comparison to a household income ≥$150,000, was suggestive of increased odds of consuming
SCBs at 5–9 years, although not statistically significant. Significant risk factors for increased odds
of soda and sweetened drink intake included children with one sibling in comparison to having
no siblings (fully adjusted OR: 3.72; 95% CI, 1.20, 11.47); a mother of East, South, or South-East
Asian ethnicity in comparison to European (fully adjusted OR: 7.39; 95% CI: 2.47, 22.11); a household
income of <$49,999 (fully adjusted OR: 11.96; 95% CI: 2.86, 50.09) in comparison to a household
income ≥$150,000; parental BMI (per 5 kg/m2) increase (OR: 1.09; 95% CI: 1.01, 1.18). For every
two-month increase of breastfeeding duration there was a 0.89 reduction of odds of consuming soda
and sweetened drink consumption when adjusting for all potential risk factors (95% CI: 0.82, 0.97)
(Table 3). No variables were statistically significant risk factors for the consumption of 100% fruit juice
at 5–9 years of age (Table 3), but, consistent with total SCB consumption, the fully adjusted ORs were
greater than 1.0 for household income <$49,999 (fully adjusted OR: 1.67; 95% CI: 0.82, 3.40), and having
a mother of East, South, or South-East Asian ethnicity (fully adjusted OR: 1.37; 95% CI: 0.88, 2.12).
4. Discussion
In this study 100% fruit juice, soda, and sweetened drinks, and total SCB intake at ≤2.5 years
of age, were each strongly associated with higher SCB intake at 5 –9 years of age. These associations
were observed after adjustment for other potential early life risk factors of SCB intake. The findings
from this study contribute evidence to the current literature supporting the association of SCB intake
in later childhood when SCBs are introduced in early childhood. These results are consistent with
two previous longitudinal cohort studies from the United States [26] and Norway [25]. The U.S. study
included 1333 children with data at <1 and at 6 years of age. They found that children with intake
of sugar-sweetened beverages at any time during infancy, compared to no intake during infancy,
had 2.22 times higher odds for consuming sugar-sweetened beverages at least once per day at 6 years
of age (OR: 2.22; 95% CI: 1.59-3.10) [26]. The Norwegian study included 9025 children participating
at three time points (18 months, 36 months, and 7 years). They observed that children with low,
medium, and high frequency of sugar-sweetened beverage intake at 18 months continued to drink
sugar-sweetened beverage just as often at 36 months and 7 years of age [25]. However, these studies
only examined the intake of soda and sweetened drinks and excluded 100% fruit juice. To the best of our
knowledge, no previous studies have investigated 100% fruit juice in early childhood as a risk factor for
later childhood SCB consumption. Understanding the impact of early childhood consumption of SCBs
is imperative, as dietary patterns and behaviors have been found to influence behaviors throughout
the life-course [31–33].
Following a recent systematic review that identified risk factors for SCB intake in children [27],
we prospectively evaluated the associations between potential risk factors during early childhood
(≤2.5 years of age) and later childhood (5–9 years of age) SCB intake, including 100% fruit juice, soda,
and sweetened drinks, and total SCB intake (which included all three beverages). No statistically
significant risk factors were identified for fruit juice intake and all associations evaluated were close
to null, except for early life fruit juice intake. However, children were at greater odds of consuming soda
and sweetened drinks if they had one sibling (compared to none), if maternal ethnicity was East, South,
or South-East Asian (compared to European), if the household income was <$49,999 (compared to
≥$150, 000), and increasing parental BMI, with ORs suggesting 1.09- to 11.96-fold increased odds for
each of these previously identified risk factors. Child BMI was not associated with any SCB intake,
which may reflect the young age of our study population. However, parent BMI was significantly
associated with increased odds of soda and sweetened drink intake among children, and although not
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statistically significant, the ORs were in the same direction for total SCB and fruit juice intake. Results of
the analyses for total SCBs (combining fruit juice, soda, and sweetened drinks) only identified one
significant risk factor, breastfeeding duration, and this is likely explained by the fact that 100% fruit
juice was the major contributor to total SCBs.
The proportion of children who consumed SCBs in this study population may appear low, but is
somewhat comparable to national data from the 2015 Canadian Community Health Survey (CCHS).
In the 2015 CCHS for children 1–8 years of age [34], 46.1% consumed fruit juice, 6.3% of children
consumed regular soft drinks, and 14.4% consumed fruit drinks. The 2017 American Academy
of Pediatric recommendations for children’s juice intake indicate that infants <12 months of age should
not be introduced to juice, children aged 1–3 should be limited to 4 oz. (0.5 cup) daily, children aged
4–6 should only consume 4–6 oz. daily, and children aged 7–18 should be limited to 8 oz. daily [20].
At ≤2.5 years of age, 21.9% of children from this sample were drinking more than the recommended
limit of 4 oz. daily, and at 5–9 years of age 35.3% were drinking more than the recommended 4–6 oz.
per day. The new 2019 Canada Food Guide suggests limiting, if not replacing sugar-containing drinks
(e.g., fruit juice, soft drinks, sports drinks, fruit flavored drinks, and punches) with water, as there
are many benefits to this practice [21]. These guidelines are general and not specific to age groups,
perhaps to encourage the same healthy lifestyles throughout the life-course.
A potential limitation of this study is measurement error because of parent-reported questionnaires
used to measure child SCB intake. However, studies have found that parent reported SCB is a valid
measure of true SCB intake in children [35,36]. It is possible that parents misclassified 100% fruit juices
as sweetened drinks or vice versa, however, regulations state that juices that are not 100% fruit juice
must be identified as a juice “drink”, “beverage”, or “cocktail”, and thus should have been classified
as a sweetened drink, not as 100% fruit juice [37,38]. Further, we did not collect data on all possible
SCBs. For example, data were not available on sweetened milks or energy drinks. Infant formula was
also not included within the analysis. Since a high proportion of respondents indicated no intake,
all SCB variables were dichotomized into 0 cups/day and ≥0.5 cups/day for all analyses, which may
contribute to a loss of power. Another potential limitation of this study is the missing data for
SCB intake at ≤2.5 years and 5–9 years, and all covariates. To address this limitation, we applied
a multiple imputation approach to account for the missing data and limit potential biases associated
with missing data. In addition, the study had a follow-up response rate of 52%. The low follow-up
rates contributed to a reduction in the sample size leading to lower certainty in the ability to make
strong conclusions. Lastly, the sample of the current study may not be representative of all Canadian
children, since TARGet Kids! is an urban primary care network with relatively high family income
and education levels. Although it may be assumed that SCB consumption during early childhood is
mainly influenced by parents, it is possible that other factors, such as school environment, may also
play a role in consumption patterns, especially in older children. We were unable to evaluate these
factors, but future studies may be able to further understand the role these factors play in defining
the consumption patterns of SCBs in children. Strengths of this study include the prospective nature
of the study design with comprehensive measurements of potential SCB risk factors in early life,
including 100% fruit juice. Few studies have investigated SCB intake and risk factors in early childhood.
However, this may be a sensitive period in development from both a biologic sugar exposure and
behavioural development point of view. Literature shows that taste preferences are developed in the
prenatal, neonatal, infancy, and early childhood stages of life [39,40]. Early introduction to sugary
beverages is only one of the many biological, social, and environmental factors that continue to be
influence taste preferences throughout the lifespan.
5. Conclusions
The results of this study suggest that SCB intake in early childhood is strongly associated with
SCB intake in later childhood and this association persists even after adjustment for many other
possible predictors of SCB intake. Future studies are needed to understand longer-term associations
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and to evaluate if interventions targeting SCB reduction in early life reduce both SCB intake and
adverse health outcomes in later childhood, adolescence and adulthood.
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Abstract: The present study aimed to characterize dietary intake and diet quality from late pregnancy
to six months postpartum. Participants (n = 28) completed 2–3 Web-based 24 h recalls at three distinct
periods: (1) during the third trimester of pregnancy; (2) three months and (3) six months after delivery.
Energy, macro-and micronutrient intakes (from foods and supplements), as well as the Canadian
healthy eating index (C-HEI) were derived from the dietary recalls. No significant variation in energy
and macronutrient intakes was observed between time points. The proportion of women taking at
least one supplement decreased over time (p = 0.003). The total intake of several micronutrients
(vitamins A, C, D, group B vitamins, iron, magnesium, zinc, calcium, phosphorus, manganese, and
copper) decreased significantly over time (p < 0.05 for all micronutrients). The total C-HEI score and
its components did not change, except for the total vegetables and fruit subscore, which decreased
over time (8.2 ± 2.0 in the 3rd trimester, 7.1 ± 2.2 at three months postpartum, 6.9 ± 2.4 at 6 months
postpartum, p = 0.04). In conclusion, we observed a general stability in diet quality, energy, and
macronutrient intakes from the third trimester of pregnancy to six months postpartum. However,
several micronutrient intakes decreased over time, mostly due to changes in supplement use.
Keywords: pregnancy; postpartum; dietary intake; energy intake; supplements; dietary reference
intakes (DRIs); diet quality; Healthy Eating Index
1. Introduction
Adopting healthy eating behaviors is crucial during pregnancy in order to positively influence
both the mother’s and the child’s health [1–3]. Maintaining a balanced diet after childbirth is also
important to ensure optimal maternal health, both in the short and long term [4–7]. In the short
term, a woman’s diet after delivery can influence weight retention since it is associated with the total
energy intake [4]. In the long term, postpartum weight retention has been identified as a contributor to
obesity, the latter being associated with an increase in morbidity and mortality risk [5,6]. Furthermore,
adequate diet quality and dietary intake are essential to support the energy demand associated with
lactation and ensure optimal early life nutrition for the newborn. In fact, greater maternal diet quality
during pregnancy and lactation has been inversely associated with infant weight and adiposity in
the early postpartum period, which could prevent obesity later in life [7]. Hence, it is important to
maintain healthy eating behaviors both during and after pregnancy.
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However, few studies have investigated this continuum and the changes that can occur from
pregnancy to the postpartum period. One study showed that Swedish women’s diet quality tended to
decrease after delivery, mostly due to an increased intake of discretionary food (e.g., sweets, cakes,
cookies, crisps, and ice cream), and a decreased intake of vegetables and fruit [8]. Although a different
study found a significant increase in the proportion of women engaging in more positive behaviors
(drinking two or more cups of milk per day, consuming three or more servings of vegetables and fruit
per day, and eating breakfast every day) from pre-pregnancy to pregnancy, that proportion decreased
dramatically at six months postpartum [9]. It was also reported, in a cohort of low-income women with
diverse ethnicity, that following childbirth, mean daily servings of grains, vegetables and fruit declined,
while the percentage of energy from fat and added sugar increased in comparison with pregnancy [10].
Overall, although an improvement in diet quality has been reported during pregnancy [9,11], healthy
eating habits adopted in the prenatal period are not often maintained after childbirth [8–12].
Nevertheless, studies examining maternal diet from late pregnancy to the postpartum period
rarely detail women’s adherence to dietary recommendations [8–12], despite the significant impact of
nutrition on maternal and child health. Thus, it appears relevant to examine women’s diet during their
transition to maternity as well as look at their adherence to nutritional recommendations. The aims of
this study are to characterize dietary intake and diet quality from late pregnancy to the postpartum
period and to investigate women’s adherence to current Canadian nutritional recommendations at each
time point. Firstly, we hypothesize that diet quality decreases from the third trimester to six months
postpartum. Secondly, we hypothesize that adherence to micronutrient intake recommendations
will be low in the postpartum period, especially for lactating women in whom nutritional needs
are increased.
2. Materials and Methods
2.1. Study Population
The ANGE (Apports Nutritionnels durant la GrossessE) project included eighty-six (86) pregnant
women recruited in Quebec City, QC, Canada. At the recruitment of the initial cohort, the exclusion
criteria were to be under 18 years of age or to present a severe medical condition (i.e., type 1 or 2
diabetes, renal disease, inflammatory and autoimmune disorders). Previously published analyses
included 79 women with complete nutritional data at each trimester of pregnancy [13,14]. In the
present paper, the final sample includes 28 women for whom we have complete nutritional information
for the 3rd trimester of pregnancy, as well as for the 3- and 6-months postpartum time points (see
Figure 1). The Institutional Ethics Committee approved the project (Reference number: 2016–2866)
and participants gave their informed written consent.
2.2. The Automated Web-Based 24 h Recall (R24W)
In the 3rd trimester of pregnancy (range: 31.9–36.1 gestational weeks, gestational age confirmed
by ultrasound in the 1st trimester), at 3 months postpartum (range: 9.4–13.7 weeks after delivery) and
6 months postpartum (range: 23.0–26.4 weeks after delivery), participants used the R24W (Rappel de
24 h Web) platform. They completed, at each period, 2–3 Web-based 24 h dietary recalls. The average
time between recalls was 1.0 ± 0.5, 1.4 ± 0.9 and 1.3 ± 0.7 weeks in the 3rd trimester, at 3 months
postpartum, and at 6 months postpartum, respectively. The R24W has been previously described and
was validated in pregnant women as well as in the general adult population [15–17]. Data regarding
intake of total energy and 22 nutrients were analyzed.
2.3. Healthy Eating Index
The R24W platform automatically calculates the 2007 version of the Canadian Healthy Eating
Index (C-HEI), an adaptation of the HEI developed by Kennedy et al. [18,19] that was used to assess
diet quality at each time point (3rd trimester, 3rd and 6th month of postpartum). The HEI has been
28
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validated in the general population and used by various authors to assess diet quality among pregnant
women [18,20–22]. The assessment of the C-HEI relies on the number of servings reported by an
individual, according to age and sex, as specified in the 2007 version of Canada’s Food Guide [18,23].
In brief, the C-HEI is divided into eight adequacy components and three moderation components [18].
Based on the scoring criteria, participants were allocated a score between 0 and the potential maximum
(5, 10, or 20). In accordance with the method described earlier [18,23], scores are then added up for a
maximum of 100 points, representing a perfect adherence to the 2007 version of Canada’s Food Guide
(see detailed method in Supplementary Table S1).
Participants recruited 
(n=86) 
Initial ANGE cohort         
(n=79) 
Dietary intake and diet quality 
analysis (complete nutritional, 
supplements and breastfeeding data)      
(n=28) 
Complete body weight values           
Pre-pregnancy (n=28) 
3rd trimester of pregnancy (n=26) 
3 months postpartum (n=23) 
6 months postpartum (n=21) 
Complete physical activity data 
3rd trimester of pregnancy (n=28) 
3 months postpartum (n=26) 
6 months postpartum (n=26) 
Miscarriage (n=4) 
Lack of time (n=2) 
Other (n=1) 
Completed less than 2 R24W 
at one or several time points 
(n=51) 
Estimated body weight values 
3 months postpartum (n=5) 
6 months postpartum (n=7) 
Figure 1. Flowchart of the study sample.
2.4. Supplement Use
All participants completed, at each time point, a Web questionnaire collecting information on
supplement use. This questionnaire was previously described elsewhere [14]. In brief, for each
supplement they reported taking, participants had to provide its name, its drug identification number,
its measurement unit (e.g., tablet, drop, gram, milliliter, etc.) and its dose, as well as the frequency
at which the reported dose was taken (e.g., once a day, twice a week, etc.). Nutritional data for all
supplements were obtained by using the Health Canada Licensed Natural Health Product Database
or the companies’ product labels [24]. A research assistant reached out to participants when any
supplement’s characteristic was missing or incomplete. The use of supplements was compiled
according to the supplement’s type (multivitamin or one-nutrient supplement) and the number of
women that reported taking each supplement.
2.5. Other Web Questionnaires
Women completed questionnaires on socioeconomic status and general health early in pregnancy
to obtain data on sample descriptive characteristics. A Web-based self-administered questionnaire was
completed by 27 women at 3 and 6 months postpartum to report the infant feeding methods and a
research assistant contacted women with missing information.
2.6. Estimated Energy and Protein Requirements
Pre-pregnancy BMI was calculated using self-reported pre-pregnancy weight and measured
height. The validated version of the pregnancy physical activity questionnaire (PPAQ) was completed
by women as well as the International physical activity questionnaire (IPAQ) at 3 and 6 months
postpartum [25–27]. Physical activity levels (PALs) were calculated with the total number of minutes
per day participants engaged in moderate and high-intensity activities. Based on the dietary reference
29
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intakes (DRIs), we characterized participants as either sedentary, low-active, active or very active [28].
Estimated energy requirements (EERs) in the 3rd trimester were calculated with the participant’s age,
height, pre-pregnancy weight, physical activity level, to which 452 kcal was added [28]. The weight of
26 women was measured during an on-site visit at the 3rd trimester of pregnancy. In the postpartum
periods, a Web-based self-administered questionnaire regarding maternal weight was completed by
23 women at 3 months and by 21 women at 6 months. Mean weight difference between each period
and pre-pregnancy was calculated (see Table 1). The difference between postpartum periods and
pre-pregnancy weights can then be defined as weight retention. Since body weight values were missing
for 5 women at 3 months postpartum and for 7 women at 6 months postpartum (see Figure 1), an
estimation of their weight difference (in kg) was made at those time points, in order to calculate their
estimated energy and protein requirements. The estimated weight difference was calculated by using
the mean weight difference (vs. pre-pregnancy weight) for the 23 women at 3 months (4.3 kg) and the
mean weight difference for the 21 women at 6 months (2.8 kg). We were therefore able to calculate
EERs at each postpartum period by using age, height, weight, physical activity levels and by adding
500 kcal only for women who were breastfeeding at the time they completed the questionnaires [28].
In the 3rd trimester, daily estimated protein requirements (EPRs) were determined with the following
calculation: 1.1 g/kg of pre-pregnancy weight + 25 g of protein [28]. For postpartum periods, daily
EPRs were estimated as 1.3 g/kg of reported or estimated weight in breastfeeding mothers and 0.8 g/kg
for others [28].
Table 1. Participants’ characteristics (n = 28).
Variables Mean ± SD or n (%)
Age at study enrollment (years) 32.7 ± 3.6
Primiparous 12 (43)
Pre-pregnancy BMI (kg/m2) 24.9 ± 5.1




Pre-pregnancy 69.3 ± 16.6
3rd trimester of pregnancy (difference with pre-pregnancy) a 12.8 ± 4.5
3 months postpartum (difference with pre-pregnancy) b 4.3 ± 6.3










Breastfeeding (exclusively or not)
At 3 months postpartum 27 (96)
At 6 months postpartum 25 (89)
Duration of exclusive breastfeeding postpartum (months) c 5.2 ± 1.0
a n = 26; b n = 23; c n = 21.
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2.7. Statistical Analyses
Based on the automatically generated data from the completed dietary recalls, means and
standard deviations were determined for energy, macro- and micronutrient intakes at each time
point. Micronutrient intake from supplements and from food sources were compiled to estimate the
total micronutrient intake. The intake of energy and nutrients were compared to their respective
dietary reference intakes (DRIs). We then obtained a number of women that had intakes below
the estimated average intakes (EARs) or above the upper intake limit (UL), when relevant [29].
A comparison was made between folate intake expressed as dietary folate equivalents (DFE) and the
folate EAR. Comparison with the folic acid UL was only made with fortified foods and supplements
because this limit is only applicable to synthetic forms of folic acid [28]. Similarly, only intake from
supplements were compared to the UL for niacin and magnesium intakes [28]. The average energy
intake (EI) and percentages of energy provided by each macronutrient (protein, carbohydrate, fats) were
compared respectively with EERs and the acceptable ranges for each macronutrient [28]. The acceptable
macronutrient distribution ranges (AMDR) are recommended intervals for energy proportion provided
from each macronutrient, in order to ensure an adequate intake of essential nutrients [28]. Percentages
of women with data below or above their EERs or AMDR were determined. Comparison of protein
intake (g/day) with the EPRs was performed [28]. To assess changes in energy, macro- and micronutrient
intakes and HEI scores from the 3rd trimester of pregnancy to 6 months postpartum, repeated measure
analyses of variance (ANOVA) were computed. Tukey’s honest significant difference post-hoc tests
were then performed to identify specific differences between time points. Chi-square tests were
conducted to compare supplement use (categorical variables) over time. All statistical analyses were
performed with JMP version 14 (SAS Institute Inc., Cary, NC, USA).
3. Results
Participants’ characteristics are presented in Table 1. All 28 included women were Caucasians
and on average in their early thirties. The sample covered a wide range of pre-pregnancy BMI, but
most of the participants had a normal weight. The majority was also multiparous and had a high level
of education as well as a substantial household income. Most women breastfed, exclusively or not, up
to six months after delivery. This sample’s characteristics (n = 28) do not differ significantly from the
ANGE project’s original sample (n = 79) [13].
3.1. Energy and Macronutrients
Table 2 shows that no significant variation was observed for energy and macronutrient intakes
across time points. Energy intake was below EER for 61%, 78% and 74% of the participants in the
3rd trimester of pregnancy, at three months and at six months postpartum, respectively. When
macronutrient intake was examined in grams (Supplementary Table S2), protein intake of at least
64% of the participants exceeded the EPR at each period. However, at each time points, all women
had protein intake as a percentage of energy within the AMDR. At each time point, more than 57%
of women reported fat intake as percentages of energy intake that was above the AMDR. Inversely,
carbohydrate intake as percentages of energy was below the AMDR range for up to 50% of participants.
Dietary fiber intake decreased over time (p = 0.01) and more than 89% of participants had intake below
the DRI at each period (Supplementary Table S2). No significant difference in energy and nutrient
intakes was observed between normal weight, overweight or obese participants (data not shown).
Secondary analyses were conducted to test associations between energy intake and weight retention
(data not shown). No significant difference in weight retention was observed between participants
who were below or over their EERs. However, Spearman’s correlation showed that energy intake at six
months after delivery was positively associated with postpartum weight retention at the same period
(r = 0.52, p = 0.02).
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3.2. Vitamins and Minerals
Micronutrient intake derived from the R24W (food sources only) and proportions of women that
reported intake above or below the corresponding DRIs are presented in Table 3. Micronutrient intake
from food alone decreased from late pregnancy to six months postpartum for vitamins A and C as well
as thiamin, riboflavin, calcium, and phosphorus (p ≤ 0.03 for all micronutrients). A downward trend
was observed for vitamin D, vitamin B12, and iron intakes. As presented in Table 4, fewer women
reported the use of supplements after delivery (89%, 68% and 46% at the 3rd trimester of pregnancy,
at three and six months postpartum, respectively, p = 0.003), and multivitamins remained the most
commonly used supplement. A secondary analysis showed that 67% and 52% of participants who
breastfed were taking at least one supplement at three and six months after delivery, respectively.
As shown in Table 5, when food sources and dietary supplements were combined, total micronutrient
intake decreased from late pregnancy to the postpartum period for vitamins A, B6, B12, C and D as
well as for thiamin, riboflavin, niacin, pantothenic acid, iron, magnesium, zinc, calcium, phosphorus,
manganese and copper (p ≤ 0.03 for all micronutrients). At each period, a higher proportion of women
had a total micronutrient intake below the EAR, particularly for vitamins A (4%, 54%, 54%) and D
(11%, 36%, 57%). Total intake of sodium was above the UL for more than 79% of women at each time
point. Similar results regarding the total micronutrient intake as well as EAR and UL adherence were
observed, both at three and six months postpartum, when looking only at lactating women, which
represents 89%–96% of our sample.
3.3. Diet Quality
Mean HEI scores are presented in Table 6. Total and sub-scores did not significantly vary from
late pregnancy to six months postpartum, except for the total vegetables and fruit sub-score, which
decreased over time (p = 0.04) and more specifically between the third trimester of pregnancy and six
months postpartum (p = 0.03).
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Total 0–100 64.1 ± 12.2 61.2 ± 11.4 60.5 ± 8.3 0.13
Adequacy 0–60 46.4 ± 7.6 44.5 ± 8.3 43.3 ± 7.5 0.08
Total vegetables and fruit 0–10 8.2 ± 2.0 7.1 ± 2.2 6.9 ± 2.4 0.04
Whole fruit 0–5 4.4 ± 1.5 3.6 ± 1.9 3.4 ± 1.7 0.09
Dark green and orange
vegetables 0–5 3.3 ± 1.6 3.4 ± 1.5 2.9 ± 1.6 0.25
Total grains products 0–5 4.4 ± 0.7 4.5 ± 0.8 4.2 ± 1.0 0.29
Whole grains 0–5 2.6 ± 1.8 2.7 ± 1.7 2.3 ± 1.9 0.62
Milk and alternatives 0–10 9.5 ± 1.4 8.8 ± 1.9 8.8 ± 2.4 0.08
Meat and alternatives 0–10 8.9 ± 1.6 8.6 ± 2.0 8.5 ± 1.9 0.16
Unsaturated fat 0–10 5.2 ± 3.7 5.8 ± 3.7 6.4 ± 3.3 0.29
Moderation 0–40 17.7 ± 7.2 16.7 ± 6.7 17.2 ± 7.6 0.65
Saturated fats 0–10 2.8 ± 2.6 3.5 ± 2.4 3.7 ± 3.1 0.33
Sodium 0–10 4.6 ± 2.8 4.8 ± 2.9 4.8 ± 3.2 0.93
Other foods 0–20 10.3 ± 5.1 8.4 ± 5.2 8.7 ± 4.8 0.16
a p-value for repeated measures ANOVA performed to assess variations in HEI-scores across periods.
4. Discussion
Our prospective evaluation of women’s dietary intake revealed stability in energy and
macronutrient intakes from late pregnancy to six months postpartum. Most women were below their
energy estimated requirements and above their protein estimated requirements. Total micronutrient
intake decreased from late pregnancy to six months after delivery for many vitamins and minerals.
We also observed a decrease in diet quality regarding the total consumption of vegetables and fruit.
Stability in energy intake was found from late pregnancy to six months after delivery. Likewise,
Talai Rad et al., as well as Moran et al. found no significant variation in women’s energy intake from
pregnancy to the postpartum period [20,30]. In contrast, George et al. found that the transition from
pregnancy to the postpartum period was associated with a decrease in the mean energy intake in
the overall sample, and in both lactating and nonlactating low-income women [10]. However, our
small study sample consisted mostly of lactating women, for whom the energy estimated requirements
were similar from late pregnancy to the postpartum period, which may explain the stability in energy
intake. We also found that most women were under their respective EERs in the third trimester of
pregnancy as well as in the postpartum period. In contrast, Moran et al. found that most of 301
overweight or obese women met the Australian Nutrient Reference Values in energy from pregnancy
to four months postpartum [20]. In comparison with our participants, women in this study were
all overweight or obese and came from an area of greater social deprivation [20]. Also, at four
months after delivery, 57% of Australian women were breastfeeding versus 96% of our participants at
three months postpartum [20]. Considering that breastfeeding requires additional energy intake, we
suggest that lactating mothers encounter more difficulties in meeting these caloric recommendations.
The underreporting of energy intake may also have influenced mean caloric intake of our study
sample considering that other studies have reported divergent percentages (between 13% and 49%) of
under-reporters during pregnancy [31–34]. However, there is a lack of consistency in the methods
and thresholds used to evaluate the misreporting of energy intake in pregnancy, indicating a need to
further investigate which method would be the most appropriate to use.
Regarding macronutrient intake, most of our participants had protein intake (as percentages of
energy intake) within their respective acceptable distribution ranges, at all time points. However, the
majority of our participants had protein intake that exceeded their EPRs at all periods, similarly to
Moran et al. [20]. Further, up to 50% of women had carbohydrate consumption (as a percentage of
energy intake) below the AMDR, with a higher proportion in the postpartum period compared to
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what has been observed in overall pregnancy [14]. Furthermore, many participants had fat intake as a
percentage of energy intake that was above the acceptable distribution range from late pregnancy to
six months after delivery. Similarly, Talai Rad et al. found that in 32 healthy women, the proportion
of fat intake within the total caloric intake (36%) slightly exceeded the German Nutrition Society
recommendation from early pregnancy to six weeks after delivery [30]. Additionally, a previous
analysis in this cohort found that macronutrient intake, as percentages of energy intake, was stable
throughout pregnancy [14]. Hence, the mean intake of macronutrients, in comparison with acceptable
distribution ranges, does not seem to change from early pregnancy to six months after delivery in our
cohort of high-income women. Finally, we observed that almost all women did not meet the adequate
intake recommended for dietary fiber, at each period, similarly to the results obtained during pregnancy
in the initial ANGE cohort [14] and in the general population [35]. Also, fiber intake decreased from
late pregnancy to six months after delivery, in contrast to Moran et al. who found a stability from
pregnancy to four months postpartum [20].
Despite our small sample size, we found that total intake of 16 of the 20 vitamins and minerals
had significantly decreased from the third trimester of pregnancy to six months postpartum, which is
concordant with the decrease in vegetables and fruit intakes observed with the HEI-score. In addition,
most participants did not meet the recommendation for vitamin A in the postpartum period since the
EAR for this vitamin almost doubles in the context of lactation compared to pregnancy [29]. Also,
a significant proportion of women failed to meet the recommendation for vitamin D after delivery.
A decreasing trend observed for the milk and alternatives HEI subscore may partially explain the
observed decrease in vitamin D since most of these foods are fortified with vitamin D. Nevertheless,
and more importantly, the decrease in micronutrient intake might be explained by the decline in
supplement use following the delivery, despite the Society of Obstetricians and Gynaecologists of
Canada’s recommendation for women to keep taking a prenatal multivitamin as long as breastfeeding
continues [36]. Similar results regarding total micronutrient intake and adherence to recommendations
were observed in the postpartum period when looking only at lactating women, which represent most
of our sample. A decrease in total micronutrient intake of breastfeeding participants persisted even if
more than half of them continued taking at least one supplement after delivery. Moran et al. also found
lower total intake of iron, zinc and calcium as well as vitamins A, B6 and C from the third trimester to
four months postpartum, with a significant decrease in supplement use over this period [20]. It would
therefore appear that women reduced their supplement use after childbirth, which may put lactating
women at risk of non-adherence to micronutrient recommendations, since their nutritional needs are
increased compared to non-lactating women.
Diet quality remained stable from late pregnancy to the postpartum period in this limited sample
size, except for the total vegetables and fruit sub-score. Total C-HEI score and its components are
based on the number of servings consumed, therefore participants seemed to decrease their vegetable
and fruit intakes after delivery in comparison to late pregnancy. This might have had an impact on
the observed decrease in dietary intake of fiber, vitamin A, and vitamin C. As previously published
by our research team (initial ANGE cohort), total C-HEI scores did not significantly vary throughout
pregnancy [13]. However, the adequacy sub-score decreased significantly from early to late pregnancy,
mostly due to a decreased intake in vegetables and fruit [13]. We can hypothesize that vegetables and
fruit intakes decrease throughout pregnancy, which continues in the postpartum period, as reported in
other studies [8–10]. This is concordant with the supposition that motivation for healthy eating might
decrease as pregnancy progresses and after delivery. Interestingly, a study found that multiparous
women, who make up the majority of this sample, have lower intentions to eat in a healthier manner
compared to new and non-parents [37]. The same authors hypothesized that mothers may find it
difficult to put time and energy in preparing healthy meals for multiple children, thus leading to the
subsequent decrease in motivation for their own dietary behaviors [37]. As a possible strategy to
counter the decrease in micronutrient intake and diet quality, healthcare providers should reinforce
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recommendations regarding multivitamin supplementation and address the importance of vegetables
and fruit consumption during postpartum follow-ups.
To our knowledge, this is the first study to prospectively assess whether women adhere or not to
current Canadian nutritional recommendations up to six months after delivery. A major strength of
this study is the use of detailed information collected on dietary intake with the completion of 2–3
validated Web-based 24 h recalls at each period combined with a Web questionnaire on supplements
use. However, some limitations need to be acknowledged, mainly regarding the small sample size and
lack of representativeness of our sample. The small sample size could have attenuated the statistical
significance, however, the results we observed were similar to those from other studies in larger cohorts.
Our sample can also include a potential proportion of under-reporters and a possible overestimation of
the energy requirement of overweight or obese breastfeeding women [38], which would have inflated
the proportion of women not meeting their EERs. Since all women were Caucasian and most of them
were of higher socioeconomic status, our results may not be representative of mothers from a more
ethnically and socioeconomically diverse population. Diet quality and dietary intake should be further
investigated in a larger and more representative cohort, from pregnancy to the postpartum period.
5. Conclusions
In summary, we observed relative stability in diet quality, energy and macronutrient intakes
from late pregnancy to the postpartum period, but intake of several micronutrients decreased from
the third trimester of pregnancy to six months after delivery. Decreased use of supplements, energy
intake below the estimated requirements, lower intake of vegetables and fruit as well as increased
micronutrient needs may put lactating women at risk of nutritional deficiencies. However, further
research is needed, first, to confirm in a larger and more diverse cohort the decrease we observed in
micronutrient intake, as well as in vegetables and fruit consumption from pregnancy to the postpartum
period, and second, to identify women at a higher risk of inadequate postpartum diet that could be
targeted in future interventions.
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Abstract: Oligosaccharides (OS) are commonly added to infant formulas, however, their physiological
impact, particularly on adult health programming, is poorly described. In adult animals, OS modify
microbiota and stimulate colonic fermentation and enteroendocrine cell (EEC) activity. Since neonatal
changes in microbiota and/or EEC density could be long-lasting and EEC-derived peptides do
regulate short-term food intake, we hypothesized that neonatal OS consumption could modulate
early EECs, with possible consequences for adult eating behavior. Suckling rats were supplemented
with fructo-oligosaccharides (FOS), beta-galacto-oligosaccharides/inulin (GOS/In) mix, alpha-galacto-
oligosaccharides (αGOS) at 3.2 g/kg, or a control solution (CTL) between postnatal day (PND) 5 and
14/15. Pups were either sacrificed at PND14/15 or weaned at PND21 onto standard chow. The effects
on both microbiota and EEC were characterized at PND14/15, and eating behavior at adulthood.
Very early OS supplementation drastically impacted the intestinal environment, endocrine lineage
proliferation/differentiation particularly in the ileum, and the density of GLP-1 cells and production
of satiety-related peptides (GLP-1 and PYY) in the neonatal period. However, it failed to induce
any significant lasting changes on intestinal microbiota, enteropeptide secretion or eating behavior
later in life. Overall, the results did not demonstrate any OS programming effect on satiety peptides
secreted by L-cells or on food consumption, an observation which is a reassuring outlook from a
human perspective.
Keywords: prebiotic; gut-brain; programming; microbiota; L-cell; eating behavior
1. Introduction
Preventing unhealthy feeding behavior is highly desirable since deleterious eating habits are
associated with health problems, including a higher risk of overweight and obesity [1]. Since eating
behavior is the result of integrated central and peripheral biological systems that are influenced by
genetic, psychological, and environmental factors [2], its optimization is highly complex and requires
the full elucidation of the mechanisms that control eating behavior. Central regulation of appetite
is mediated by peripheral inputs generated by stomach distension, through signals from the gut
epithelium when it senses the availability of nutrients, such as satiety-regulating peptides synthetized
and released by enteroendocrine cells (EECs), as well as by long-term energy signals released by
adipose tissue and cerebral inputs generated by hedonics and rewards circuits [2,3].
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In addition to the evident progress in understanding these interconnections, recent advances
include two major findings: first, eating behavior may be programmed very early in life, and second,
it could be regulated by intestinal microbiota.
According to the developmental origin of health and disease (DOHaD) theory, adverse early-life
conditions may predispose a person to disordered eating [4]. Among the environmental stressors that
may have an effect, it is suggested in both animal and human studies that perinatal nutrition could
program the appetite (see [5,6] for reviews). In rodents, experiments based on restricting maternal
nutrition and/or manipulating litter size have demonstrated that both pre- and post-natal nutrition
may alter food intake [7–9] and/or food preference [10] in offspring, with subsequent repercussions in
adulthood. In humans, although controversial results have been observed concerning the influence of
prenatal nutrition on later eating behavior (see [11] for review), some observational evidence suggests
that early nutrition/growth affects appetite regulation [12–14] and food preference programming,
as demonstrated after repeated exposure to new flavors [15].
With regard to the involvement of intestinal microbiota in feeding behavior, although it has been
known for several years that fermentation catalyzed by intestinal microbiota stimulates the expression
of satiety peptides by EECs [16,17], it is only recently, in connection with the growing appreciation
of the role that intestinal microbiota play in regulating host physiology, that this topic has generated
renewed interest [18,19]. As pointed out in these reviews, some observations objectively support
the involvement of intestinal microbiota in the regulation of feeding behavior. Thus, in ascending
order of convincing power, we can quote: (i) the differences observed in microbiota composition
or diversity in patients with anorexia nervosa (see [18] for review, [20]); (ii) the fact that feeding
behavior differs between germ-free and conventional animals (see [21] for an example), (iii) the ability
of certain microbiota modulating agents—e.g., certain prebiotic oligosaccharides [22,23]—to affect
feeding behavior, and (iv) the delineation of mechanistic pathways that link microbiota with central
and peripheral neuroendocrine systems responsible for feeding behavior, a finding which supports
the existence of a causative link. For example, EECs that secrete appetite-regulating peptides can be
mentioned since they have a large diversity of receptors enabling them to sense microbial inputs such
as fermentation-derived short chain fatty acids (SCFA), secondary biliary salts or pathogen-associated
molecular patterns [see 18 for review].
Reconciliating these two emerging issues related to the regulation of feeding behavior, i.e.,
its possible programming in early life and its control by intestinal microbiota, we hypothesized that
early modifications to microbiota may program adult feeding behavior. This programming could stem
from either the programming of intestinal microbiota (e.g., [24]) or the early impacts of microbiotal
changes with long-lasting consequences for the peripheral neuroendocrine systems that control adult
feeding behavior and/or the central sensing of it. In this respect, it is worth mentioning the ability
of microbiota-modulating agents to affect the hypothalamic expression of neurogenic factor (BDNF)
during the neonatal stage [25], and the potential programmable character of both the EECs [26] and
the vagal sensitivity [9]. In addition, the putative ability of the gut microbiota to act through epigenetic
mechanisms (see [27] for review) as well as the ability of the microbiota presence [28] and certain
microbiota modulating agents [e.g., in the case of prebiotics [29,30]) to modulate some behaviors in
adults mice can be cited, assuming that they are transposable in the neonatal period.
Using the rat as a model, we therefore evaluated whether neonatal modulation of the microbiota
induced by prebiotics could program eating behavior and the secretion of gastrointestinal peptides
in adulthood. We first verified that the presuppositions underlying our hypothesis were present in
our case, by investigating the immediate impact of the neonatal prebiotic supplementation on both
the intestinal microbiota and the maturation and functioning of EEC in suckled rats. We decided to
use indigestible oligosaccharides (OS) to modify the intestinal microbiota of the neonatal rats for two
reasons: first, OS are recognized as intensively-fermented prebiotics [31], which are also operant in
neonatal rats [24] and infants (see [32] for review) and have been shown to stimulate EEC proliferation
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and activity in adult animals [33,34]; second, they represent relevant nutrients in neonatal nutrition
since they are commonly added to infant formula to better mimic maternal milk [35].
2. Materials and Methods
2.1. Ethics Statement
All experiments were conducted in accordance with the European Union Directive on the
protection of animals used for scientific purposes (2010/63/EU). The protocols were approved by the
Ethics Committee for Animal Experiments for the Pays de la Loire region (France) and the French
Ministry of Research (APAFIS#3652-20 160 1 1910192893 v3). The animal facility is registered by the
French Veterinary Department as A44276.
2.2. Animal Experiment
Primiparous female Sprague-Dawley rats (n = 16) were obtained on day one of gestation (G1)
from Janvier-labs (le Genest Saint Isle, France) and housed individually (22 ± 2 ◦C, 12:12-h light/dark
cycle) with free access to water and chow (A03, Safe Diet, Augy, France). At birth, 8 litters were culled
to 8 male pups per mother with systematic cross fostering as previously described [24]. From day 5 to
day 14/15 of life (PND5 to PND14/15), the pups were given various solutions of FOS, GOS/In mix (9:1),
αGOS or a mix of the monomers present in the OS solutions (Table 1) by oral gavage. These OS were
selected either because they are already used in infant formula (GOS/In, FOS [35]) or because they
constitute a new source of OS, the physiological properties of which are to be characterized (αGOS).
Two pups from each litter were given one of the 4 solutions daily.
Table 1. Composition of solutions administered by gavage to pups from PND5 to PND14/15 (g·mL−1).
CTL FOS GOS/In αGOS
GOS syrup (VivinalGOS, FrieslandCampina Domo, LE Amersfoort,
The Netherlands) 0.65
Inulin powder (Raftiline HP, BENEO-Orafti S.A., Tienen, Belgium) 0.03
FOS powder (Beneo P95, BENEO-Orafti S.A., Tienen, Belgium) 0.34
αGOS powder (Olygose, Venette, France) 0.32
α-Lactose monohydrate (L3625, Sigma-Aldrich, St. Quentin Fallavier, France) 0.096 0.096 0.096
D(+)-glucose monohydrate (108342, Merck Santé SAS, Fontenay sous Bois, France) 0.087 0.082 0.087
D(+)-galactose monohydrate (104058, Merck Santé SAS, Fontenay sous Bois, France) 0.005 0.005 0.004
D(−)-fructose (F0127, Sigma-Aldrich, St. Quentin Fallavier, France) 0.015 0.015 0.015
Saccharose (S9378, Sigma-Aldrich, St. Quentin Fallavier, France) 0.002 0.002 0.002
Total oligosaccharides § 0.30 0.30 0.30
Total digestible sugars § !! 0.20 0.20 0.20 0.20
CTL, control; FOS, fructo-oligosaccharides; 93.2% dry matter composed of 90.4% oligomers and 6.6% monomers,
providing 0.015 g·mL−1 of fructose, 0.005 g·mL−1 of glucose and 0.002 g·mL−1 of saccharose; GOS/In, mix (9:1) of
galacto-oligosaccharides and long chain fructo-oligosaccharides (In, inuline). For GOS: 75% dry matter composed of
59% oligomers and 41% monomers; for inulin: 97% dry matter composed of 99.5% oligomers, the mix was providing
0.095 g·mL−1 of lactose, 0.086 g·mL−1 of glucose and 0.005 g·mL−1 of galactose; αGOS: alpha galacto-oligosaccharides
(95.9% dry matter composed of 99.4% oligomers, providing 0.001 g·mL−1 of galactose. !!, § These calculations take
into account the dry matter of the components, their purity, and the amount of digestible sugars they contain.
The pups were weighed daily and the administered volume was adapted to body weight to reach
3.2 g/kg in order to approximate the dosage actually consumed by babies fed with prebiotic enriched
formula, taking into account both the difference in metabolic rate between rats and humans and the
true prebiotic content of infant formula [35].
Four of the 8 litters were used for our main objective, i.e., to assess eating behavior programming:
rats from these 4 litters (n = 8 per group) were weaned at PND21 onto standard chow (A03, Safe Diet,
Augy, France) in individual cages until PND124/126, when they were sacrificed by decapitation after
induction of deep anesthesia (isoflurane/O2, 5 L·min−1). During the follow-up, food consumption was
measured 3 times a week. Rats from the 4 remaining litters (n = 8 per group except for FOS where
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n = 7 as explained below) were sacrificed at PND14/15 by the method described above to investigate
the immediate impact of the neonatal prebiotic supplementation on both intestinal microbiota and the
maturation and functioning of EECs.
This experimental set-up was designed to form 8 supplemented males, originating from 4 different
litters, per group at each studied age. Due to the death of one of the pups during the supplementation
period (this pup was then replaced by an untreated one to equilibrate the litter size), the number of
pups in the FOS group at PND14/15 was reduced to 7. These values are maximum numbers that
are not always found in each of the analyses (see the illustration legends). This stemed from either
physiological reasons (e.g., 2 animals did not eat at all during the fasting-refeeding test), or because of
quality requirements (e.g., reliable data from in physiological cages could only be obtained for n = 7 in
CTL and GOS/In groups; n = 6 in FOS group and n = 5 in αGOS group), or statistical inconsistency (e.g.,
outliers identified by the Dixon’s Q test were excluded in RT-qPCR analysis as well as food/beverage
consumption follow-ups), or technical problems (e.g., accidental spillage of supernatant before analysis
of bacterial end-products or sequencing failure during 16S rDNA analysis or poor quality of some
tissue sections in the case of immunochemical analysis). Nevertheless, in all analyses, the 4 different
litters were always represented.
2.3. Tissue Collection
Under anesthesia, intracardiac blood was collected in a tube containing EDTA (Microtubes 1.3 mL
K3E, Sarstedt MG & Co, Marnay, France) and plasma collected after centrifugation 2000× g, 15 min,
4 ◦C) was frozen at −20 ◦C for further analysis. The contents of the most distal 15 cm of the ileum were
harvested by flushing, using 1 mL of Hanks’ Balanced Salt Solution (HBSS, Thermo Fisher Scientific,
St-Herblain, France), and the cecocolonic (PND14/15) or cecal (PND124/126) content was collected,
weighed, mixed with 5-fold or 2-fold their volume of sterile water (PND14/15 and PND124/126,
respectively). After complete homogenization, these cecocolonic/cecal suspensions were centrifuged
7800× g, 20 min, 4 ◦C) then both supernatants and pellets were frozen at −20 ◦C for analysis of the
fermentation end-products (SCFA and lactate) and microbiota, respectively. Intestinal tissues (ileum
and proximal colon) were rapidly collected and frozen in liquid nitrogen for RNA analysis. Additional
tissue samples were fixed in 4% paraformaldehyde for immunofluorescence analysis.
2.4. Eating Behavior
2.4.1. Meal Pattern
Between PND74 and PND99, eating behavior was analyzed in physiological cages (Phecomb
cages, Bioseb, Vitrol, France) as previously described [8]. Briefly, the rats were housed individually
and following 24 h of acclimatization to the cage and refilling with fresh food between 9.00 a.m. and
11.00 a.m., data were recorded every 5 s over a 20-h period. Due to the intervention during the diurnal
phase, the analysis was reduced to 8 h whereas the nocturnal phase was 12 h. The exact feeding pattern
was defined with a minimal size of 0.1 g, a minimum duration of 10 s and a minimum inter-meal
interval of 10 min. Events such as large vibrations (contact with the feed tray without eating) were
filtered by the Phecomb system monitoring software (Compulse v1.1.01). The reliability percentage of
the quality signal was calculated by the software and only experiments with a percentage >80% were
used. Meal parameters extracted from Compulse software included number of meals, meal size and
duration, inter-meal intervals and satiety ratio.
2.4.2. Taste Preference
Preference for sweet taste was measured at PND110 using the bottle test experiment [36]. After a
two-day habituation to the presence of two bottles in their own cages, the animals had the choice of
the two bottles, one containing tap water and the other 0.05% saccharin (Sigma-Aldrich, St. Quentin
Fallavier, France). Drink intake was measured daily for three days. The position of the two bottles was
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reversed each day to prevent position preference bias. The sweet preference score was calculated as
the ratio between the volume of saccharin solution consumed and the total drink intake in 24 h, then
multiplied by 100. Preference was defined as a percentage greater than 50.
2.5. Fasting-Refeeding Test, Kinetics of GLP-1 and PPY Release and Response to Glucose
At PND105, a 4 h kinetic of GLP-1 and PYY release in plasma was carried out. Rats were not fed
for 16 h to induce hunger and then fed for 20 min with a calibrated quantity of chow (A03, safe Diet).
Food intake was weighed at the end of the 20 min period. Any crumbs that fell in the cage were
weighed and deducted from the food intake. Blood samples were collected from the tail vein in tubes
containing EDTA (Microvette CB300 EDTA 3K, Sarstedt, Marnay, France) at 0 (15 min before refeeding),
30, 60, 120, and 180 min after the beginning of the meal.
At PND124/126, the rats were not fed for 16 h, and 2 h before being sacrificed they were given an
oral bolus of glucose (2 kg/kg BW) in order to challenge glucose sensing in GLP-1/PYY-producing EECs.
2.6. Plasma Gastrointestinal Peptides
The plasma concentration of total GLP-1 and total PYY was assayed by the ELISA technique using
kits from Millipore (Merck- Millipore, Molsheim, France) and Phoenix Pharmaceutical (Phoenix France
S.A.S, Strasbourg, France), respectively.
2.7. Fermentation End-Products
Ileal and cecal supernatants were centrifuged 8000× g, 20 min, 4 ◦C, diluted (1/10) with 0.5 M oxalic
acid and SCFA (acetate, propionate, butyrate, isobutyrate, valerate and isovalerate) were analyzed
by gas chromatography as previously described [37]. The D-and L-lactates were measured in the
supernatants after heating to 80 ◦C for 20 min with a D/L-lactic acid enzymatic kit following the
manufacturer’s instructions (Biosentec, Toulouse, France).
2.8. Immunochemistry
Tissue sections (4–5 μm) of fixed ileum and proximal colon were double-stained with a goat
polyclonal antibody raised against GLP-1 diluted at 1/200 (Santa Cruz Biotechnology Inc, Santa Cruz,
USA) and a rabbit anti-chromograninA (chrgA, diluted at 1/1000 (ImmunoStar Inc, Hudson, USA),
followed by incubation with anti-goat and anti-rabbit fluorescent secondary antibodies (1/1000). Nuclei
were counterstained with 4′,6-Diamidine-2′-phenylindole dihydrochloride (DAPI, Sigma-Aldrich,
St. Quentin Fallavier, France). Tissues sections were mounted in Prolong Gold anti-fading medium
(Molecular Probes, Thermo Scientific, Courtaboeuf, France). Three sections per sample were analyzed
with a Nanozoomer (×20) (Hamamatsu Photonics France, Massy, France). The number of fluorescent
cells along the crypt-villus axis unit was counted twice by a blind operator, using the NDP view
software (Hamamatsu, Photonics France, Massy, France). A total of 40 to 60 crypt-villus units per
section were counted.
2.9. Quantitative Real-Time PCR
Total RNA extraction from the ileum and colon was carried out using a QIAamp RNA Blood
Mini kit (Qiagen, Courtaboeuf, France) following the manufacturer’s instructions. Two micrograms of
RNA were reverse-transcribed using M-MLV reverse transcriptase (Promega, Charbonnières-les-Bains,
France). Five microliters of 1/40 dilution of cDNA solution were subjected to RT-qPCR in a Bio-Rad
iCycler iQ system (Biorad, Marnes-la-Coquette, France) using a qPCR SYBR Green Eurobiogreen®Mix
(Eurobio, Les Ulis, France). The quantitative PCR consisted of 40 cycles, 15 s at 95 ◦C, 15 s at
60 ◦C and 15 s at 72 ◦C each. Primers sequences are shown in Table S1 of the Supplementary
Material. For quantification of Neurog3, rat PrimePCRTM SYBR®GreenAssay Neurog3 (Biorad,
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Marnes-la-Coquette, France) was used. Relative mRNA quantification was expressed using the 2−ΔΔCq
method with actin gene as a reference.
2.10. Bacterial 16S rDNA Sequencing of Cecal Contents
DNA was extracted from pellets of ceco-colonic content (max 250 mg) using the QIAamp Fast DNA
Stool Mini kit (Qiagen, Courtaboeuf, France) after enzymatic and mechanical disruptions as described
previously [37] except that homogenization was carried out at 7800 rpm for 3 × 20 s intervals with 20 s
rest between each interval in a Precellys® “evolution” bead-beater (Bertin, Montigny-le-Bretonneux
France). The V4 hyper-variable region of the 16S rDNA gene was amplified from the DNA extracts
during the first PCR step using composite primers (5’-CTTTCCCTACACGACGCTCTTCCGATCTGTGY
CAGCMGCCGCGGTAA-3′ and 5’-GGAGTTCAGACGTGTGCTCTTCCGATCTGGACTACHVGGG
TWTCTAAT-3′) based on the primers adapted from Caporaso et al. (i.e., 515F and 806R) [38]. Amplicons
were purified using a PP201 PCR Purification Kit (Jena Bioscience, Jena, Germany). Paired-end
sequencing was performed on a HiSeq 2500 System (Illumina, San Diego, CA, USA) with v3 reagents,
producing 250 bp reads per end, following the manufacturer’s instructions by the GeT+-PlaGe platform
(INRA, Toulouse, France). The 16S rDNA raw sequences were analyzed with FROGS v2 pipeline
(http://frogs.toulouse.inra.fr/) [39]. After de-multiplexing, quality filtering and chimera removing, the
taxonomic assignments were conducted for OTUs with abundance >0.005% with Blast using Silva
128 database containing sequences with a pintail score at 80 to determine the bacterial compositions.
FROGSSTAT Phyloseq tools were used to normalize raw abundances by rarefaction and to calculate
alpha and beta diversity indices.
2.11. Statistical Analysis
Statistical analyses were carried out using GraphPad Prism 6 software (GraphPad Software
Inc., San Diego, USA) or R (librairies “stats v3.5.1” and “corrplot v0.84”, [40]). Differences between
treatments were searched using one-way ANOVA followed by Tukey’s multiple comparison tests for
most data, with the exception of growth and food consumption data which were subjected to multiple
t-tests with correction for multiple comparison using the Holm-Sidak method. Sweet taste preference
test was analyzed by the one sample t-test to compare to compare data against the 50% (no preference)
value. A p value < 0.05 was considered statistically significant.
3. Results
3.1. Neonatal OS Supplementation Did Not Substantially Affect Rat Growth
Both FOS and αGOS supplementation was associated with a significant transitory reduction
of pup growth in the first days of intervention (PND7 to PND10 and PND6 to PND8 respectively,
Figure S1). When compared with body weights from the CTL group, the differences observed were
only 9.1 to 11.5% and did not significantly affect the cumulative weight gains measured either from
birth until the end of supplementation or for the whole lactation period (Table 2).
Table 2. Bodyweight gain (g) during lactation.
Treatment BW Gain PND0-14 BW Gain PND0-20
CTL 30.4 ± 4.2 1 50.5 ± 6.0
FOS 28.0 ± 3.4 45.7 ± 4.6
GOS/In 29.4 ± 3.3 49.6 ± 5.8
αGOS 27.9 ± 2.7 46.8 ± 5.1
1 Data are means ± SD collected from the total effective of rats (n = 15–16 per group during PND0-14 and n = 8
during PND0-20). BW, bodyweight.
No significant differences in bodyweight were observed between groups after weaning (Figure S2).
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3.2. Neonatal OS Supplementation Exerted a Marked Immediate Impact on Intestinal Environment
3.2.1. OS Supplementation Modified Both Composition and Activity of Neonatal Intestinal Microbiota
Following 16S rDNA sequencing, no significant differences were noticed in raw sequence numbers
between cecocolonic samples collected at PND14/15 (355,245 ± 10,367, 30,306 ± 13,817, 40,275 ± 18,343
and 31,808 ± 10,101 for CTL, FOS, GOS/In and αGOS, respectively) or in percentages of sequences kept
after quality filtering (83.8 ± 4.0, 76.4 ± 18.4, 83.9 ± 4.2, and 81.7 ± 7.1). The cecocolonic contents of
animals supplemented with OS exhibited similar reductions in richness (p < 0.001) compared with
CTL animals (Chao1 values: 66.2 ± 21.0, 72.9 ± 28.1, and 73.9 ± 35.3 for FOS, GOS/In and αGOS,
respectively versus 180.0 ± 35.7 for CTL). The cluster dendrogram generated using weighed UniFrac
metric which illustrates beta or between-sample diversity, highlighted an obvious dissimilarity between
the microbiotas of the OS-supplemented animals and those of animals from the CTL group (Figure 1)
but did not reveal any effect of the nature of the OS.
Figure 1. Hierarchical clustering based on the Ward’s method of phylogenetically informed distance
matrix computed using the weighted UniFrac metric for cecocolonic contents collected at postnatal day
(PND) 14/15 (n = 6 to 8 per group).
When considering bacterial families occurring at more than 0.01% of the total sample abundances
(Table 3), the OS impact was typified by significant decreases in Lactobacillaceae, Bacteroidales S24-7
group, Prevotellaceae, Streptococcaceae, Peptococcaceae, Coriobacteriaceae, Aerococcaceae, Family
XIII, and Rikenellaceae. In addition, OS supplementation decreased Ruminococcaceae abundance
but this impact only reached statistical significance for FOS and αGOS. These decreases in relative
abundance were differently compensated according to the OS: increases in Bifidobacteriaceae reached
statistical significance following FOS and αGOS supplementations, Enterobacteriaceae increased
following αGOS supplementation and Lachnospiraceae increased following GOS/In supplementation.
Significant differences between OS were scarce and only occurred between GOS/In and αGOS in
their impact on Lachnospiraceae (Table 3).
Concurring with these compositional changes, the 10-day supplementation greatly affected
fermentation end-product concentrations in both ileal and colonic contents at PND14/15.
In the ileum, lactate concentration was below the detection limit (0.22 mM) in all animals, and the
concentration of acetate—the sole SCFA present at this age in this intestinal segment—was significantly
increased (p < 0.005) through FOS supplementation (6.9 ± 3.6 mM) compared to CTL (0.3 ± 0.4 mM),
GOS/In (1.6 ± 2.0 mM) and αGOS (0.6 ± 0.8 mM).
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Table 3. Relative abundances (%) for families with abundances > 0.01% at PND14/15 according to the
postnatal OS supplementation.
Family CTL FOS GOSIn αGOS
Actinomycetaceae 0.095 ± 0.084 1 0.028 ± 0.032 0.076 ± 0.056 0.068 ± 0.058
Aerococcaceae 0.086 ± 0.029 a,2 0.011 ± 0.011b 0.015 ± 0.012 b 0.020 ± 0.019 b
Alcaligenaceae 0.020 ± 0.041 0.030 ± 0.047 0.378 ± 0.576 0.036 ± 0.053
Bacteroidaceae 2.352 ± 0.991 6.510 ± 10.047 6.837 ± 5.729 3.719 ± 5.492
Bacteroidales.S24.7 group 6.812 ± 2.953 a 0.053 ± 0.080 b 0.098 ± 0.094 b 0.084 ± 0.103 b
Bifidobacteriaceae 0.624 ± 0.45 a 17.188 ± 12.735 b 7.894 ± 7.947 ab 13.577 ± 10.631 b
Campylobacteraceae 0.009 ± 0.024 0.093 ± 0.220 0.066 ± 0.151 0.294 ± 0.546
Clostridiaceae.1 0.273 ± 0.146 2.413 ± 3.231 5.509 ± 8.749 5.044 ± 4.581
Coriobacteriaceae 0.108 ± 0.039 a 0.039 ± 0.034 b 0.036 ± 0.041 b 0.023 ± 0.018 b
Corynebacteriaceae 0.032 ± 0.023 0.007 ± 0.011 0.020 ± 0.030 0.012 ± 0.023
Desulfovibrionaceae 0.098 ± 0.182 0.000 ± 0.000 0.003 ± 0.008 0.006 ± 0.014
Enterobacteriaceae 13.86 ± 5.97 a 23.48 ± 12.23 ab 19.51 ± 6.69 b 33.42 ± 11.99 b
Enterococcaceae 0.435 ± 0.707 0.145 ± 0.203 2.892 ± 6.293 0.542 ± 0.771
Erysipelotrichaceae 0.682 ± 0.387 4.080 ± 3.988 3.774 ± 4.950 2.766 ± 3.002
Family.XIII 0.062 ± 0.030 a 0.004 ± 0.008 b 0.000 ± 0.000 b 0.001 ± 0.003 b
Lachnospiraceae 6.327 ± 2.300 a 9.787 ± 6.180 ab 15.298 ± 9.544 b 4.962 ± 4.587 b
Lactobacillaceae 57.47 ± 8.72 a 28.74 ± 10.84 b 24.47 ± 5.71 b 31.13 ± 11.24 b
Micrococcaceae 0.140 ± 0.064 0.075 ± 0.074 0.071 ± 0.053 0.110 ± 0.105
Pasteurellaceae 0.582 ± 0.581 0.236 ± 0.235 0.456 ± 0.297 0.394 ± 0.446
Peptococcaceae 0.396 ± 0.182 a 0.006 ± 0.015 b 0.015 ± 0.019 b 0.007 ± 0.021 b
Peptostreptococcaceae 0.747 ± 0.485 0.471 ± 0.262 0.543 ± 0.108 0.640 ± 0.379
Porphyromonadaceae 1.242 ± 1.153 5.924 ± 9.747 9.826 ± 15.228 2.055 ± 5.475
Prevotellaceae 2.136 ± 1.540 a 0.014 ± 0.016 b 0.011 ± 0.018 b 0.028 ± 0.060 b
Rikenellaceae 0.034 ± 0.039 a 0.001 ± 0.004 b 0.000 ± 0.000 b 0.001 ± 0.003 b
Ruminococcaceae 3.242 ± 0.743 a 0.135 ± 0.147 b 1.610 ± 2.622 b 0.406 ± 0.665 b
Streptococcaceae 2.118 ± 0.620 a 0.510 ± 0.316 b 0.586 ± 0.156 b 0.643 ± 0.450 b
1 Data are means ± SD (n = 6 to 8 per group). 2 Within a row, values followed by different letters (a,b,ab) differ
significantly (p < 0.05).
In the cecum, the concentration of total end products increased in all OS groups compared to CTL
(Figure 2). This was mainly due to an increase in SCFA concentration, which only reached statistical
significance in the case of FOS and also an increase in lactate concentration in the case of αGOS.
Increases in total SCFA reflected acetate increases which were significant for both FOS and GOS/In
groups, and paralleled significant decreases in pH values (Table 4). In addition, OS supplementation
shifted microbiotal activity, as evidenced by significant changes in the relative proportions of acetate
(93.8 ± 4.6, 93.1 ± 4.1, and 95.4 ± 2.9% for FOS, GOS/In and αGOS, respectively versus 86.3 ± 4.5% for
CTL) and propionate (5.4 ± 4.6, 5.2 ± 3.4, and 3.6 ± 2.9% for FOS, GOS/In and αGOS, respectively
versus 10.7 ± 3.0% for CTL). Concentration and relative proportions of butyrate—which is scarcely
produced in the neonatal stage—were not affected significantly by supplementation.
Table 4. Concentration (mM) of major short chain fatty acids (SCFA) in cecocolonic contents at PND
14/15.
Treatment Acetate Propionate Butyrate pH
CTL 3.17 ± 1.05 1,a,2 0.39 ± 0.16 0.07 ± 0.04 6.9 ±0.3 a
GOS/In 5.82 ± 1.32 b 0.33 ± 0.21 0.10 ± 0.09 6.3 ±0.2 b
αGOS 5.69 ± 1.77 ab 0.28 ± 0.27 0.05 ± 0.00 6.1 ±0.2 b
FOS 8.00 ± 2.94 b 0.47 ± 0.37 0.06 ± 0.04 6.2 ±0.2 b
1 Data are means ± SD (n = 7 to 8 per group). 2 Within columns, values followed by different letters (a,b,ab) differ
significantly at p < 0.05.
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Figure 2. Cecocolonic concentrations of fermentation end-products. Individual, mean and SD values are
plotted (n = 7 to 8 per group). Different letters indicated significant difference (p < 0.05) between groups.
3.2.2. OS Supplementation Modified both Differentiation and Activity of the Neonatal EEC
In the ileum, a profound effect on the enteroendocrine lineage was induced by neonatal OS
supplementation, as revealed by a significant decrease in Neurog3 expression in the OS groups
compared to CTL, whereas, an early expressed marker in the commitment secretory lineage (Atoh1)
was not affected significantly (Figure 3). The related expression of genes specifically implied in the
differentiation of EECs (Pax4 and Pax6) decreased significantly in OS supplemented groups compared
to CTL, whereas expression of Foxa1 did not vary between the groups. Similar to Pax4 and Pax6,
Neurod1 expression decreased in OS groups compared with CTL, but this did not reach statistical
significance for FOS. Regarding the expression of gene coding for peptides produced by mature L-cells,
Pyy increased significantly in OS groups compared to CTL. At the same time, despite a 2-fold increase
in Gcg expression in the OS groups compared to CTL, this effect was not statistically significant due to
the widely varying expression between samples.
In the proximal colon, the impact of OS supplementation was much more moderate and their
only significant effect was a decrease in the expression of Pax4 (Figure S3).
Along with this profound remodeling in the expression of markers of L-cell differentiation,
the number of GLP-1/ChgrA positive cells, i.e., mature EECs, was higher in the ileum of pups from OS
groups compared to CTL but only reached statistical significance for villi (Figure 4A–C).
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Figure 3. Relative expression of genes implied in the endocrine lineage and in L-cells differentiation
in the ileum. Different letters indicate significant difference between groups (p < 0.05). Data are
fold-change expressed in % of CTL group. Individual values, median with interquartile range are
plotted (n = 7 to 8 per group).
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Figure 4. Effect of oligosaccharides (OS) supplementation on the density of GLP-1 cells in ileum:
(A) in villi (B) in crypts. Different letters indicate significant differences among groups (p < 0.05);
Individual, mean and SD values are plotted (n = 6 to 7 per group). (C) Representative images of
immunofluorescence in ileal sections from a control solution (CTL) (top) and αGOS groups (down),
arrows indicate positive fluorescence in cells: blue (DAPI, nuclei staining), red (GLP-1 cells), green
(ChrgA cells) and merge (GLP-1/ChrgrA cells). Bars indicate 100 μm.
In agreement with this rise in the number of mature enteroendocrine cell (EEC), plasma
concentrations of GLP-1 (Figure 5A) and PYY (Figure 5B) were significantly increased by all the
neonatal OS supplementations, as compared with CTL.
Figure 5. Plasma concentration of (A) Total GLP-1; (B) Total PYY at PND 14/15. Different letters indicate
significant differences among groups (p < 0.05). Individual, mean and SD values are plotted (n = 7 to 8
per group).
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Significant positive associations between plasma concentrations of GLP-1 and PYY and the
ileal expression of their respective genes were evidenced (Figure 6A). Conversely, these plasma
concentrations as well as the density of GLP-1 secreting cells, were inversely correlated with expressions
of Neurog3, Neurod1, Pax4, and Pax6. With respect to associations between microbiota and EEC
descriptors (Figure 6B), only some of the differentiating factors (Pax4, Neurod1, Pax6 and Neurog3)
exhibited significant positive correlations with the abundance of some bacterial families corresponding
to those the abundance of which was significantly reduced by OS, except for Prevotellaceae. For these
factors, the sole negative correlation was that between Neurod1 and abundance of Clostridiaceae.1.
Conversely, the PYY and GLP-1 plasmatic concentrations, EEC densities and Pyy expression, but not
Gcg expression, were negatively correlated with the same families including Prevotellaceae.
Figure 6. Correlograms within EEC descriptors (A) or between these descriptors and the relative
abundances of main bacterial families (B). Positive correlations are displayed in blue and negative
correlations in red. The intensity of the color and the size of the circles are proportional to the correlation
coefficients. Asterisks indicate the level of significance (*, p < 0.05; **, p < 0.01; ***, p < 0.001). On the
right of the correlogram, the color legend shows the correspondence between correlation coefficients
and colors.
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Overall, these results indicate that OS supplementation profoundly modulates neonatal microbiota
in terms of both its composition and its fermentative activity, with repercussions not only in the
cecocolon but also, as exemplified with FOS, in the ileum. An increased density of ileal L-EECs and
their secreted anorectic hormones, GLP-1 and PYY, were observed and unexpectedly the expression of
transcription factors beyond the stage of secretory cell engagement (Atoh1) was inhibited at the same
time. Whether this strong impact of early OS supplementation on satiety peptide-related EECs could
last into later life and affect eating behavior was investigated further.
3.3. Neonatal OS Supplementation Had No Significant Long-Term Consequences
3.3.1. Neonatal OS Supplementation Did Not Significantly Program Enteropeptide Production or
Eating Behavior in Adulthood
To investigate the long-term effect of neonatal supplementation of OS on nutrient sensing in EECs,
once pups reached adulthood, we studied the release of GLP-1 and PYY in response to both a 20-min
test meal (PND 74/76) and an oral bolus of glucose (PND 124/126) after 16 h of fasting.
No significant differences were observed between groups in the amount of food consumed during
the 20-min test meal (Figure 7A). In response to this meal, the plasma concentration of GLP-1 increased
immediately after refeeding and returned to pre-prandial level 120 and 180 min later (Figure 7B).
The total amount of GLP-1 secreted during this period, quantified by AUC, did not differ significantly
between the groups (Figure 7C). PYY secretion did not show any postprandial peak or significant
differences between the groups (data not shown).
Figure 7. Fasting-refeeding test. (A) Food intake measured during refeeding (20 min-meal); (B) Plasma
concentration of total GLP-1 measured during the 3h-kinetic follow-up (means ± SD); (C) Total amount
of GLP-1 secreted during the 0-180min period expressed as AUC. Individuals, means and SD are
plotted. (n = 7 to 8 per groups).
Similarly, at PND 124/126, plasma concentrations of GLP-1 (CTL: 34.4 ± 13.5; GOS/In: 38.6 ± 28.6;
αGOS: 28.9 ± 10.0 and FOS: 37.9 ± 20.6 pM) and PYY (CTL: 84.7 ± 4.0; GOS/In: 88.7 ± 7.8; αGOS:
91.4 ± 7.3 and FOS: 91.5 ± 5.8 pM) measured 2h after an oral bolus of glucose did not show any
significant difference between groups.
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To investigate the long-term effect of a neonatal supplementation of OS on subsequent eating
behavior, we followed up the food consumption from weaning to adulthood, performed a refined
analysis of feeding pattern using physiological cages from PND75 to PND100 and assessed the
preference for sugar taste between PND109 and PND111.
The analysis of food consumption during development, expressed per Kg of body weight to
allow for strict comparison, only revealed a single significant difference which occurred at PND32
between animals from the FOS and CTL groups (Figure 8), an observation which indicates that
neonatal supplementation with OS did not greatly influence the subsequent food intake in our
experimental conditions.
Figure 8. Daily consumption of food in the post-weaning stage, expressed as kilograms of bodyweight.
The asterisk indicates a significant difference between FOS and CTL groups (p < 0.05). Data are means
± SD (n = 7 to 8 by group and day).
This absence of effect on daily food consumption was confirmed by a detailed analysis of food
consumption: we observed no significant difference in meal patterns among the groups (food intake,
food intake per meal, number and duration of meals, latency to eat the first nocturnal meal, satiety
ratio and ingestion rate), whatever the period of measurement (total 20 h period of measurement,
diurnal period (8 h) or nocturnal period (12 h) (Figure 9 and Figure S4).
In the sweet taste preference test, there was no significant difference between groups in terms of
the consumption of saccharin solution expressed as a percentage of daily beverage intake, regardless
of the day of testing (Figure 10). Strikingly, the preference for sweet taste for the GOS/In group
did not reach statistical significance on the first day of the test, in contrast to the FOS and αGOS
groups. However, this preference did not persist on day 2, contrary to what was observed for the CTL
group. This suggests that neonatal supplementation with OS slightly reduced the persistence of sweet
preference in adulthood.
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Figure 10. Preference for sweet taste. Data are means ± SD (n = 7 to 8). Asterisks represent significant
preference as compared with no preference (i.e., 50%, dotted line): *, p < 0.05; **, p < 0.01; ***, p < 0.001.
3.3.2. Neonatal OS Supplementation Did Not Significantly Program Adult Intestinal Microbiota
At adult age (PND 124/126), no significant differences were observed between treatments with
respect to the raw number of sequences obtained, percentages of sequences kept after quality filtering,
or alpha-diversity indexes (data not shown). Similarly, β-diversity analysis (Figure S5), principal
component analysis on OTU abundances (Data not shown) and comparisons of the cumulated relative
abundances at family level (Figure 11) failed to show any significant difference between cecal samples
with respect to neonatal supplementation. Finally, neither ileal nor cecal concentrations of SCFA
showed significant differences between the groups (Table S2).
Figure 11. Impact of postnatal OS-supplementation on cecal microbiota composition at PND124/126:
families distribution expressed as the average of cumulated relative abundances (n = 7 to 8 per group).
Overall, these data did not reveal that neonatal OS supplementation had any programming effect
on adult microbiota.
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4. Discussion
Considering that the regulation of feeding behavior could be programmed from the beginning
of life and controlled by intestinal microbiota, we hypothesized that modifications to the neonatal
microbiota could program adult feeding behavior. We therefore checked the ability of prebiotic-induced
intestinal microbiota modulations to affect the maturation and functioning of L-EECs in suckled male
rats, then assessed whether this resulted in delayed alterations in eating behavior and the secretion of
GI peptides in adulthood. The observed effects are specifically attributable to OS since we adjusted
the compositions of the administered solutions by taking into account the digestible sugar contents
of commercial OS sources. In this study, we show that neonatal supplementation with 3 different
OS strongly impacts cecocolonic microbiota, GLP-1 cell density in the ileum, and the production of
satiety-related peptides during the neonatal period, but does not induce any significant enduring effect
in adulthood on either eating behavior or gut peptide secretion.
The validity of this statement is obviously limited to our operating conditions which represent
both strengths and limitations for our study.
Limitations include the fact that we only studied males in order to avoid the already described
fluctuations in food intake throughout the estrous cycles [41], and did not characterize every components
of eating behaviour such as motivation. However, we believe that the numerous components
investigated allow for consideration of both its homeostatic and hedonic elements. We did not
investigate immediate impact of OS supplementations on feeding behavior to avoid the recognized
stress induced in pups by separation from the mother which would have been required to quantify
milk intake either by gravimetric [42] or deuterated water turnover methods [43]. We did consider
moreover whether neonatal prebiotic supplementation having an impact on the pups’ eating behavior
was beyond the scope of the programming of adult eating behavior. Nevertheless, we reported a
transitory reduction in BW gain in FOS and GOS/In groups between PND6 and PND10 which suggests
that the reducing impact of OS on food intake may also operate in the neonatal period.
Inversely, our study has three major advantages: the combination of hormonal, behavioral
and microbiological analyzes; the minimizing of the influence of lactating mother influence by
supplementing pups from the same litters with the different OS, and finally the use of OS doses
comparable to those actually consumed by toddlers.
4.1. Neonatal OS Supplementation Affected Intestinal Microbiota Despite Its Immaturity
Corroborating our previous findings based on a non-exhaustive analysis of the microbiota [24],
and in concurrence with several in vivo and in vitro studies investigating the impact in adulthood of
OS (including those of the αGOS [44]) on intestinal microbiota, in humans and animals (e.g., [45,46])
and in human infants (see [32] for review), all the oligosaccharides used here dramatically affected
neonatal microbiota in rat pups. This confirms that the prebiotic properties previously demonstrated in
adult rodents (e.g., [30,45,46]), also operate in neonatal pups despite the immaturity of the microbiota
at this stage of development [37].
In addition to these changes in composition and the reduction in microbiota richness, our neonatal
OS supplementations also modified the activity of the microbiota by stimulating the production of
acetate and lactate at the expense of that of propionate. This decrease in propionate concentration
stands out from what is observed in adult rats, for which GOS and FOS are frequently reported as
being particularly stimulating for propionate and/or butyrate production (e.g., [34,47]) and could be
related to the known progressive maturation of the microbiotal capacity to synthesis the different
SCFAs in neonates [37,48]. The production of butyrate is therefore barely detectable before the day 16
of life in rats [37]. In any case, the neonatal OS supplementation we performed resulted in microbiota
that differed greatly from that of unsupplemented animals, an observation which was a prerequisite
for investigating the ability of neonatal microbiota modulation to program adult eating behavior or
gut peptide response.
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4.2. OS Supplementation May Stimulate Ileal EECs to Produce GLP-1/PYY While Acting in Feedback on
Endocrine Precursors
Our results showed that neonatal OS supplementation had immediate effects on mature ileal
GLP-1-cells by increasing the density in villi and the mRNA expression of Gcg and PYY leading to
enhanced plasma concentrations in these two anorectic peptides. These new observations in neonatal
rats are consistent with those reported in adult rats for FOS and GOS/In [33,34,49–51] and are, to our
knowledge, reported here for the first time for αGOS. In one of these previous studies, this increased
production of GLP-1 was related to a higher differentiation of Neurog3-expressing EEC progenitors into
L-cells in the colon [50]. Here, we demonstrate a drastic down-regulation of endocrine lineage-devoted
genes during OS supplementation, mainly in the ileum. This unexpected result is difficult to reconcile
as an effect of OS on early endocrine precursors leading to the production of more L-cell subtypes.
Neurog3 marks the endocrine progenitors and is essential for generating new EECs [52].
Post-neurog3 differentiation and maturation of EECs is controlled by dynamics in transcriptional
factors such Neurod1, Pax4 and Pax6 and many others (Arx, Pdx1, Foxa1 and Foxa2). The hierarchy of
these events is still poorly understood [53] and the extrinsic factors that may interplay remain largely
unknown. For this study, the well-known effect of OS prebiotics in stimulating L-cells cannot simply
be explained by the impact on endocrine precursors, as suggested in the above-mentioned study [50].
Since we know that Neurog3 expression is restricted to immature proliferative cells, the decreased
Neurog3 expression we observed in the ileum may instead reflect a feedback regulation to limit new
EEC generation in response to OS supplementation. A similar observation (decreased duodenal
Neurog3 and increased EEC density) was reported in a model of maternal deprivation [26]. These data
and our own suggest that the postnatal environment affects the differentiation of EEC precursors but
not the proliferation of progenitors, leading to increased EEC density. High levels of circulating GLP-1
have been previously attributed to the increased number of ileal L-cells in Gcgr-deleted mice, and this
effect involved up-regulation of post-neurog3 transcription factors, affecting the proliferation of L-cells
precursors [54]. Here, the expression of these factors, i.e., Neurod1, Pax4 and Pax6, was reduced in
OS-supplemented groups with high circulating levels of GLP-1, suggesting a different mechanism
in the increased density of L-cells. In this respect, it should be noted that although EECs are still
classified according to their major/unique hormone product (as for example GLP-1 for L-cells), it is now
acknowledged that EECs are multihormonal [53,55]. In particular, more recent data has demonstrated
that mature differentiated EECs display hormonal plasticity, allowing them to change their hormonal
products in response to extrinsic factors, such as bone morphogenic proteins (BMP) during their
migration along the crypt-villus axis [56,57]. Thus, the increased L-cell density observed here may be
the result of the direct effect of OS on this plasticity to produce more GLP-1, independently of early
markers of EEC proliferation and differentiation. Interestingly, in this study, the production of CCK—a
key early-satiety peptide—was not affected by the OS supplementation at PND14/15 (data not shown)
reinforcing the specificity of the effect of OS on EECs in producing GLP-1 and PYY in a segment of gut
where CCK is not predominantly produced. How OS can modulate both the identity of EEC subtypes
and/or the expression of GI peptides by acting on extrinsic factors (such as villus-produced BMP) needs
further investigation.
4.3. What are the Putative Mediators of the Massive Effect of Neonatal OS Supplementation on Ileal L-Cells?
Identification of the small intestine rather than the colon as a privileged site for the action of OS
on transcriptional activity has been previously reported in studies involving adult animals [58,59].
Conventionalization of germ-free mice led to similar observations (e.g., [60]). However, a nutritional
modulation by OS supplementation may have a different impact on ileal epithelium compared to
the absence or presence of microbiota. For example, in the Arora’s study [60], conventionalization of
germ-free mice led to the down-regulation of GLP-1 secreting vesicle process in L-cells, whereas we
observed an increase in GLP-1 and PYY production. These contrasting results may stem from either
inter-individual variability, or more likely the great differences in age between the animals studied.
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Nevertheless, our data raise the question of how OS modulation of microbiota could act on ileal L-cells.
The well-known capacity of SCFA (mainly butyrate but also propionate or even, non-consensually,
acetate) to stimulate PYY and/or GLP-1 production [61–63] seems inconsistent with our observation of
an OS-impact mainly localized in the ileum, within the context of no propionate/butyrate synthesis.
Others potential mechanisms include acidification of the luminal milieu or changes in the
pathogen-associated molecular patterns (PAMPs). Zhou et al. [61] showed that changes in pH from
7.5 to 6.5 induce per se an increase in Gcg expression by STC-1 cells in vitro. Apart from this, it is
known that EECs have receptors for PAMPs (i.e., Toll-like receptors) (see [18] for review). This is of
particular interest since it has been demonstrated that some bacterial strains elicit GLP-1 secretion
through signaling agents of the Toll-like receptor system, as illustrated by the fact that a MyD88
blockade triggers GLP-1 secretion induced by bacteria [64].
4.4. OS impact on Eating Behavior, Usually Observed Simultaneously with Their Consumption, Does Not Seem
to Be Programmable
Despite a certain disparity in the literature, possibly related to the heterogeneity in dosage or
methodology, several studies have reported the beneficial effect of OS prebiotics—mainly fructans but
also αGOS, on the eating habits of healthy adults [65,66] or overweight adults [67,68], such as feelings
of reduced hunger, increased satiety or reduced energy consumption. Note that the existing literature
does not establish whether this is also true in infants, who are frequently given prebiotic supplements.
In concurrence with human data, decreased food/energy intake has been evidenced in adult rodents
supplemented with fructans [49,51] or βGOS [34]. In both models, these effects have been related to
SCFA production by colonic bacteria during OS supplementation. For each of the 3 main SCFAs, i.e.,
acetate, propionate and butyrate, it has been demonstrated that they reduce energy intake, particularly
in rodent models of diet-induced obesity [69–71], although conflicting results are reported [72], probably
dependent on the mode (orogastric [71,72], intraperitoneal [70], intracerebroventricular [70], colonic
delivery via fermentable fibers [69,71], etc.) and duration (acute [69,70] vs. chronic [69,72]) of SCFA or
SCFA precursors administration. In humans, this hypothesis has been substantiated for both acetate
and propionate by numerous studies focusing on appetite-related parameters (see [73] for review) as
well as observations of reduced hedonic response to high-energy foods regulated in striatum [74] or
reduced energy intake following the administration of propionate precursors in overweight adults [75].
How these SCFA regulate appetite directly at hypothalamic level [70] or via a vagal-dependent
mechanism [71,72], whether or not implicating an enhanced intestinal satiety peptide (GLP-1 and PYY)
secretion following SCFA interaction with FFAR receptors on L-cells is still a matter of experimental
research in animal models and clinical trials in humans [18].
Since the perinatal environment [6,9,24,26] appears to have a long-lasting impact on each of the
microbiota-EEC-brain axis actors, we had assumed that early modulation of the microbiota associated
with changes in EECs could program eating behavior, a hypothesis which has remained unexplored
until now. However, this hypothesis could not be corroborated in this study as adult feeding behavior
did not seem to be significantly affected by early supplementation with OS, which nonetheless
increased total SCFA, along with increased release of GLP-1 and PYY and L-cell density at the end of
supplementation. This lack of eating behavior programming indicates that none of the presupposed
events (i.e., programming of EEC or vagal sensitivity and/or microbiota programming) occurred under
the test conditions. In fact, no difference in the expression of c-Fos was observed in the nucleus of
the solitary tract in the rat’s brainstem 2 h after administering a bolus of glucose in adult rats (data
not shown). It therefore seems that depending on the nature and intensity of the perinatal stressor
(maternal protein restriction [9], maternal deprivation [26] or postnatal modulation of microbiota by
OS) the long-lasting impact is not systematic. For the microbiota, the lack of programming could be
related to an inadequacy in the timing for applying the modulation, as discussed below.
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4.5. Is Programming of the Microbiota Subject to Particular Timing?
In this study, we did not observe any programming effect of neonatal OS supplementation on adult
microbiota. This result is in line with what we had previously observed for FOS [24] but contradicts
the small-scale programming found after neonatal supplementation with GOS/In in this same study.
This discrepancy may result from the difference in methods used to analyze the composition of the
microbiota, even if it is counterintuitive, since the 16S rDNA sequencing used here is more exhaustive
than the qPCR used previously. As this impact was minor, it may also not have been possible to
reproduce under our new experimental conditions, i.e., a new batch of animals, a different room at our
animal facility, or even a slight difference in the composition of the semi-purified diets we used, since
all these parameters are known to affect the microbiota of laboratory animals (see [76] for review).
The disappearance of this nonetheless drastic effect in our animals at the end of supplementation
raises the question of what is the most favorable period for sustainable modulation of the composition
of the microbiota. In our experimental protocol, prebiotic supplementation was applied for a
short postnatal period and ended before the onset of solid food consumption, whereas studies
reporting programming effects for early supplementation with OS on the subsequent composition
of the microbiota were based on longer-term supplementation, ranging from the prenatal period
(i.e., supplementation of gestating mothers) to complete weaning and even beyond [77,78]. Whether
the supplementation we applied was either not early enough, not late enough or not for a long enough
time is difficult to establish on the sole basis of this comparison. However, in a study by Fugiwara
et al. [77], a difference in adult microbiota composition was observed only in mice offspring that
were supplemented with FOS beyond weaning. Whether this was also true in the Le Bourgot et al.
study [78] cannot be evaluated since all piglets were supplemented with FOS for a few weeks after
weaning. From this, it can be assumed that to be lastingly effective, prebiotics must be able to exert
their microbiotal effect after full weaning, thereby controlling the impact of new bacterial sources
and changes in dynamics of bacterial populations that result from the switch from maternal milk to
solid food. Such a switch has been associated with dramatic changes in microbiota composition and
activity both in humans [79] and rats [37]. This hypothesis would explain why the early-life events
that are known to affect neonatal microbiota composition (i.e., birth mode, infant feeding etc.) are
not associated with significant variations in adult microbiota composition [80], but strict comparisons
between the time windows for supplementation are required for this to be validated.
4.6. All OS Studied Performed Similarly Despite Differences in Their Chemical Characteristics
In our study, the 3 OS studied led to comparable results in terms of both microbiotal impact
and physiological repercussions. With regard to microbiotal changes, the observed modifications,
in particular the acidification of the contents, the less diversified production of SCFA and the reduced
richness of microbiota suggest that OS delays bacterial diversification. This is similar to what is
supposed to happen in breast-fed babies compared with babies fed with unsupplemented formula [81].
The similarity is quite surprising in that the chemical nature of the constituent monomers and the
pattern of glycoside linkages in different OS products are expected to influence the ability of individual
bacteria to grow on them (see [31,82] for reviews). However, our results are consistent with Harris et
al.’s findings [83] that the orientation of glycoside linkage is not a main driver of the SCFA production
profile. When this chemical difference could act, it would primarily modulate the proportion of
butyrate, an SCFA weakly produced in our immature animals. In addition, they also agree with the
similarities of microbiotal impacts reported between βGOS and FOS on the one hand [30], and between
αGOS and βGOS on the other [44].
Thus, our study confirms the prebiotic character of αGOS and, in addition, extends the well-known
activity of FOS and GOS/In as secretagogues of satiety enteropeptides to this new prebiotic, a finding
which is in accordance with the satietogenic effect described in humans [67].
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5. Conclusions
In conclusion, our study depicts that the ability of the OS to modulate EECs as previously
described in adults also operates in the neonatal period, despite the immaturity of the microbiota at
this time. This observation therefore calls into question the nature of the mediators actually involved,
as supposed so far. In addition, our in-depth study of the impacts of the OS on the genes regulating the
differentiation of EEC precursors queries the current understanding of the ontogenesis of these cells.
Finally, our results do not demonstrate any programming impact of OS either on EECs and
food consumption or on the constitution of the adult microbiota. If this holds true for humans, it is
reassuring since this study concerns types and dosages of OS mimicking some of those commonly
prescribed in formula for toddlers.
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Abstract: Small intestinal Paneth cells, enteric glial cells (EGC), and goblet cells maintain gut mucosal
integrity, homeostasis, and influence host physiology locally and through the gut-brain axis. Little is
known about their roles during pregnancy, or how maternal malnutrition impacts these cells and
their development. Pregnant mice were fed a control diet (CON), undernourished by 30% vs. control
(UN), or fed a high fat diet (HF). At day 18.5 (term = 19), gut integrity and function were assessed
by immunohistochemistry and qPCR. UN mothers displayed reduced mRNA expression of Paneth
cell antimicrobial peptides (AMP; Lyz2, Reg3g) and an accumulation of villi goblet cells, while HF
had reduced Reg3g and mucin (Muc2) mRNA and increased lysozyme protein. UN fetuses had
increased mRNA expression of gut transcription factor Sox9, associated with reduced expression of
maturation markers (Cdx2, Muc2), and increased expression of tight junctions (TJ; Cldn-7). HF fetuses
had increased mRNA expression of EGC markers (S100b, Bfabp, Plp1), AMP (Lyz1, Defa1, Reg3g),
and TJ (Cldn-3, Cldn-7), and reduced expression of an AMP-activator (Tlr4). Maternal malnutrition
altered expression of genes that maintain maternal gut homeostasis, and altered fetal gut permeability,
function, and development. This may have long-term implications for host-microbe interactions,
immunity, and offspring gut-brain axis function.
Keywords: malnutrition; gut barrier; development; pregnancy
1. Introduction
The gut is critical to host health and disease development through interactions with microbes
that colonize the gut and establishment of the gut epithelial barrier [1,2]. Major gut functions include
absorption of water and nutrients; secretion of digestive enzymes, bile, and mucus; and motility
of luminal contents down the gastrointestinal tract and in a mixing motion to ensure adequate
contact with the epithelium for absorption [3]. In health, the gut is involved in vitamin synthesis [4],
nutrient metabolism [5], and protection against pathogens [1,6]. It is also important for brain function:
a direct and bidirectional channel of communication exists between the gut and the brain, dubbed the
gut-brain axis, which includes a connection between the enteric and central nervous systems (CNS) [7].
Microbes that reside in the gut, their metabolites [8], hormones [9], and immune factors [10], have been
shown to affect gut and brain function through this axis in humans and animals [7]. Since microbes
and the metabolites they produce can activate host immune, metabolic, and stress pathways once they
leave the gut environment [11], an important part of the gut-microbe-host relationship is the separation
between the gut tissue, the gut ecosystem, and the rest of the host.
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This separation is mediated by the intestinal epithelial barrier, which lies at the interface between
exogenous host factors and the internal gut microenvironment and helps to regulate microbe-host
interactions. During periods of optimal nutrition and host health, two key cell types are involved in
supporting and maintaining this gut barrier: Paneth cells and enteric glial cells (EGCs). Paneth cells
reside in the epithelium of the small intestine (SI), maintain gut integrity and prevent microbial
translocation through production of tight junction (TJ) proteins [12], and produce antimicrobial peptides
(AMPs) which regulate the host-microbe relationship [13]. As well, due to their proximity to crypt
stem cells [14,15], Paneth cells can affect gut epithelial cell differentiation and gut maturation [14,15].
Toll-like receptors (TLRs), which activate the innate immune response when bacterial components
are recognized in the gut environment, are purported to play a key role in inducing Paneth AMP
production [16]. In addition, EGCs are part of the enteric nervous system (ENS) and gut-brain
axis [17], and respond to and control gut inflammation [18,19]. EGCs also influence gut integrity
and permeability [20] through their long cytoplasmic processes which make direct contact with the
barrier [21]. Other enteric cells, such as goblet cells, maintain gut barrier integrity through their
production of mucus [12]. Importantly, Paneth cells and EGCs are established in early development
(Figure S1) [14,22], suggesting they are key for early and lifelong gut and brain health.
The integrity of the gut barrier and the composition and function of the gut microbiome can
be greatly affected by the diet of the host [23–25], since the indigestible polysaccharides in the
host diet become gut bacterial substrates and nutrients [26]. Indeed, adaptations to gut bacterial
metabolism and transcription occur within days of dietary changes in humans [24]. In response to
both over- [27] and undernutrition [28], collectively known as malnutrition, gut barrier function and
integrity can become dysregulated, leading to gut microbial dysbiosis, altered gut function, and a leaky
gut barrier. Yet, few studies have elucidated the effects of malnutrition on Paneth cell [29–33] and
EGC [34,35] development and function (indeed, none have examined EGCs during undernutrition
to our knowledge), or how either of these cells are affected by and/or perpetuate gut dysfunction.
Since the rates of both undernutrition and underweight [36], as well as over-nutrition and obesity [36],
are increasing worldwide, and a compromised gut barrier is both caused by, and leads to, a variety
of immune-related, and chronic diseases, the effects of malnutrition on the gut-host relationship are
important to understand.
During pregnancy, the intestinal epithelial barrier and the microbes contained within the gut are
doubly important, as they protect both the mother and, by association, the fetus from harmful bacteria
and xenobiotics [1,37], produce nutrients required for pregnancy health [38], and absorb nutrients into
the blood stream that are vital to fetal development [39,40]. We and others have shown that maternal
malnutrition impacts the maternal gut microbiome [41–44] and is associated with increased levels
inflammation in the maternal gut and peripheral circulation [41,44]. In offspring, a mature intestinal
epithelial barrier ensures a healthy and homeostatic gut environment [45], which allows the offspring to
appropriately respond to infections [45], absorb and produce nutrients [16], and likely establish optimal
communication with the brain and other organs [7]. Still, little is known about how malnutrition
impacts the maternal epithelial barrier during pregnancy, a ‘stress-test’ in itself, or whether maternal
malnutrition adversely programmes fetal gut development and function. Additionally, although we
know that Paneth cells [14] and EGCs [46,47] are laid down and functional in early life, we know
less about how early life adversity, including poor nutrition, or gut microbes, may influence their
development and function.
We therefore sought to answer two questions: how does malnutrition during pregnancy affect
maternal gut barrier function, and does maternal malnutrition impact fetal gut integrity, function,
and development? We focused on Paneth cells and EGCs to answer these questions as these cells
may be critical for long-term gut function and communication with the brain. We hypothesized that
malnutrition would lead to an adverse maternal gut environment, and that mothers fed a high fat (HF)
diet and their offspring would display the most affected gut function, since our previous work has
demonstrated that the maternal gut is especially affected by a HF diet [41]. We also hypothesized that,
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due to the changes in maternal diets and gut environments, the fetal gut would display aberrant gut
integrity and function and EGC development, with different outcomes in fetuses from undernourished
(UN) and HF mothers.
2. Materials and Methods
2.1. Animal Model
All housing and breeding procedures were approved by the Animal Care Committee at Mount Sinai
Hospital (Toronto, ON, Canada; AUP 16-0091H). Male and female C57BL/6J mice (Jackson Laboratories,
Bar Harbor, ME, USA) were housed using a 12:12 light:dark cycle at 25 ◦C, with free access to food and
water. Females were randomized into three diet groups: mice fed control diet ad libitum before and
throughout pregnancy (CON, n= 7); mice fed control diet ad libitum before mating and undernourished
by 30% from gestational day (d) 5.5 to 17.5 (UN, n = 7); and mice fed high fat diet (60% of calories
as fat) ad libitum from 8 weeks prior to mating and through pregnancy (HF, n = 8). Males were fed
control diet ad libitum and mated with females at ~10 weeks of age. Females were housed individually
following confirmation of pregnancy status (presence of vaginal sperm plug). Dams were weighed
weekly before and daily during pregnancy.
2.2. Maternal SI and Fetal Gut Collection
Dams were sacrificed by cervical dislocation at d18.5 (term = d19). Fetuses were collected,
weighed, and at random, one male and female fetus from each litter was used for fetal biospecimen
collections. Maternal and fetal gastrointestinal (GI) tracts were dissected as detailed previously [41].
A 2–5 mm piece of maternal SI from the mid portion of the SI (representing the jejunum) and
the entire fetal gut were flash frozen in liquid nitrogen then stored at −80 ◦C for later molecular
analyses. Another 2–5 mm of maternal SI from the mid portion was flushed with buffered 4%
paraformaldehyde (PFA), cut longitudinally, and cut into two pieces for fixing in 4% PFA at 4 ◦C
overnight. Fixed SI were washed thrice with 1× PBS and stored in 70% ethanol until paraffin embedded
for later immunohistochemical analyses.
2.3. RNA Extraction and mRNA Expression Analysis
Total RNA was extracted from maternal SI and fetal guts using the Tissue Lyser II (Qiagen, Hilden,
NRW, Germany) and RNA extraction kits following manufacturer’s instructions (QIAGEN RNeasy Plus
Mini Kit, Toronto, ON, Canada). Eluted RNA quality and quantity were assessed by spectrophotometry
(DeNovix, Wilmington, DE, USA), and 1 μg of RNA was reverse transcribed using 5× iScript Reverse
Transcription Supermix (Bio-Rad, Mississauga, ON, Canada).
We focused on genes involved in gut barrier function, integrity, and development to
establish how maternal malnutrition may impact the maternal gut and, by consequence, fetal gut
and ENS development (Table 1). mRNA expression data were normalized to the geometric
mean of the three stably-expressed reference genes: TATA-Box Binding Protein (Tbp), Tyrosine
3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta (Ywhaz), and Beta-actin
(Actb). Primers were designed from gene sequences found in the NCBI Nucleotide Database or taken
from the literature and analyzed using NCBI Primer-BLAST and Oligo Calc (Northwestern University,
Evanston, IL, USA) for appropriate gene targeting and properties. Amplification and detection of
mRNA expression was measured using CFX384 Touch Real-Time PCR Detection System (Bio-Rad).
Samples, standards, and controls were pipetted in triplicate. Inter-run calibrators and non-template
controls were run alongside each gene to normalize between plates and to assess contamination,
respectively. The PCR cycling conditions were: 30 s at 95 ◦C, 40 × 5 s at 95 ◦C, 20 s at 60 ◦C. Data were
analyzed applying the Pfafflmethod [48].
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Table 1. Primer sequences for quantitative PCR.
Gene Sequence 5’–3’ Source
Gut barrier function markers
Lyz1 F-GGGAACCTGTGACCTGTCTT Accession: NM_013590.4
R-GCCTCATGACACTGGGAACA
Lyz2 F-TCTACTGCAGCTCATTCGGT Accession: NM_017372.3
R-CTTAGAGGGGAAATCGAGGGAA
Pla2g2 F-AGGATTCCCCCAAGGATGCCAC PMID: 19855381
R-CAGCCGTTTCTGACAGGAGTTCTGG
Defa1 F-TCAAGAGGCTGCAAAGGAAGAGAAC PMID: 19855381
R-TGGTCTCCATGTTCAGCGACAGC
Defa5 F-CTTGTCCTGCTGGCCTTCC Accession: NM_007851.2
R-TAGACACAGCCTGGTCCTCT
Reg3g F-CCATCTTCACGTAGCAGC PMID: 22723890
R-CAAGATGTCCTGAGGGC
Tlr4 Bio-Rad (Mississauga, ON, Canada) Assay ID: qMmuCID0023548













EGC maturation and function markers






Gdnf F-ACCAGTGACTCCAATATGCCTG Accession: NM_001301357.1
R-CTGCCGCTTGTTTATCTGGTG
Sox10 Bio-Rad (Mississauga, ON, Canada) Assay ID: qMmuCID0007045
Plp1 Bio-Rad (Mississauga, ON, Canada) Assay ID: qMmuCED0061105




















Lyz, Lysozyme; Pla2g2, Phospholipase A2 Group II; Defa, Alpha Defensin; Reg3g, Regenerating Family Member 3
Gamma; Tlr4, Toll-Like Receptor 4; Muc2, Mucin 2; Cldn, Claudin; Bfabp, Brain-Type Fatty Acid-Binding Protein; S100b,
S100 Calcium Binding Protein B; Gdnf, Glial-Derived Neurotrophic Factor; Sox10, SRY-Box 10; Plp1, Proteolipid
Protein 1; Cdx2, Caudal Type Homeobox 2; Sox9, SRY-Box 9; Ywhaz, Tyrosine 3-Monooxygenase/Tryptophan
5-Monooxygenase Activation Protein Zeta; Tbp, TATA-Box Binding Protein; Actb, Beta-actin; F, Forward primer; R,
Reverse primer; PMID, PubMed Identification.
2.4. Expression and Localization of Lysozyme Protein and Quantification of Goblet Cells in Maternal SI
Immunohistochemistry (IHC) was used to localize and semi-quantify immunoreactive (ir) staining
of lysozyme (Lyz) and to quantify goblet cell number. Five millimeter sections of maternal SI were cut
from paraffin-embedded blocks and mounted onto glass slides. For lysozyme staining, sections were
deparaffinized and rehydrated in descending alcohol series and quenched with 3% hydrogen peroxide
in 90% ethanol for 20 min at room temperature. Sections underwent antigen retrieval by sodium
citrate/citric acid solution and microwaved for 10 min, then blocked in serum-free protein blocking
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solution (Agilent Dako, Santa Clara, CA, USA) for 1 h at room temperature, and incubated overnight at
4 ◦C with rabbit anti-lysozyme antibody (1:200 dilution; product #PA1-29680, Thermo Fisher Scientific,
Waltham, MA, USA). Negative control sections were probed with normal rabbit IgG (0.4 μg/μL,
1:200; #sc-2027, Santa Cruz Biotechnology, Dallas, TX, USA). Sections were then incubated with goat
biotinylated anti-rabbit secondary antibody (1:200; #BA-1000, Vector Labs, Burlingame, CA, USA) for
1 h at room temperature, followed by 1 h incubation with streptavidin-horseradish peroxidase (1:2000
in 1× PBS; Invitrogen, Carlsbad, CA, USA). Antibody-antigen interactions were visualized using DAB
for 40 s (Vectastain DAB ABC kit, Vector Labs). Sections were counterstained with Gills I haematoxylin
to provide greater contrast and to stain nuclei. Semi-quantitative analyses of ir-lysozyme staining
intensity was performed using computerized image analysis (Image-Pro Plus 4.5, Media Cybernetics,
Rockville, MD, USA; and Olympus BX61 microscope, Shinjuku, Tokyo, Japan). A superimage was
composited from individual images (at 20×magnification) captured along the entire SI section from
each dam. To semi-quantitatively measure staining intensity in each image (where higher levels of
staining intensity may represent higher Lyz protein expression), an algorithm was developed (using
Visiopharm NewCAST Analysis software, Hørsholm, Denmark) to detect intensity of DAB staining for
ir-Lyz in four levels of intensity: low, moderate, high, and strong. Staining intensity for each of the
four levels was summed across all images within a superimage for each animal. CON mothers had
a mean ± SEM (range) of 10.3 ± 0.7 (7–13) images per superimage, UN had 10 ± 0.8 (7–13) images, and
HF had 9 ± 0.6 (7–12) images. There was no statistical difference between diet groups in the number of
images per superimage (p = 0.37).
For goblet cell quantification, sections were stained with alcian blue, which stains acetic mucins
and acid mucosubstances. Sections were deparaffinized and rehydrated in descending alcohol series
then incubated in 3% glacial acetic acid, followed by alcian blue (Sigma-Aldrich, Oakville, ON, Canada)
and 0.1% nuclear fast red counterstain (Electron Microscopy Sciences, Hatfield, PA, USA). Eight images
were randomly captured at 20× for each section (Leica DMIL LED inverted microscope, Wetzlar,
Germany; and QCapture Pro software, Surrey, BC, Canada). We first counted the number of alcian
blue positive cells (goblet cells) in one villus and one crypt nearest to the villus in each of the eight
images and took the average across the images to determine the mean number of goblet cells in a villus
and crypt for each animal. We also counted the number of alcian blue positive cells in two villi and two
crypts nearest to these villi in each of four images (randomly selected from the eight images). The total
number of epithelial cells in the same villi and crypts were also counted. The number of alcian blue
positive cells and total epithelial cells across the two villi and two crypts in each image were summed.
Then, the number of alcian blue positive cells and total epithelial cells were averaged across the four
images (separately for villi and crypts) to obtain the average number of goblet cells and epithelial cells
and the percentage of goblet cells per two villi or crypts for each animal. A researcher blinded to the
experimental groups performed the counting.
2.5. Data Analysis
Data were checked for normality using the Shapiro–Wilk test and equal variance using Levene’s
test. Outliers were excluded from analyses. Non-parametric data were transformed by applying either
logarithmic, square root, or cube root transformations. Differences between dietary groups for outcome
measures were analyzed using: (1) ANOVA with Tukey’s post hoc, (2) Kruskal–Wallis/Wilcoxon test
with Steel–Dwass post hoc for non-parametric data, or (3) Welch’s test with Games–Howell post hoc
for normal data with unequal variance (p < 0.05) using JMP 13 software (SAS Institute, Cary, NC,
USA). For qPCR and IHC data, biological replicates were CON n = 6–7 (n = 10–14 fetuses); UN n = 6–7
(n = 7–9 fetuses); and HF n = 7–8 (n = 13–15 fetuses). Data are shown as quantile box plots with 95%
confidence diamonds; p < 0.05.
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3. Results
3.1. Malnutrition Was Associated with Reduced Gut Barrier Function and Integrity
In UN mothers, SI mRNA expression levels of AMP genes Lyz2 (p = 0.02, Figure 1B) and Reg3g
(p = 0.003, Figure 1C) were decreased compared to CON. HF mothers had reduced mRNA expression
levels of Reg3g (p = 0.003, Figure 1C) and Muc2 (p = 0.001, Figure 1G) in SI compared to CON. There was
no effect of maternal diet on the expression of AMP genes Lyz1, Defa1, Defa5, and Pla2g2 (Figure 1A,D–F).
The average number of goblet cells, sites of mucus secretion, was higher in SI villi, but not crypts, of
UN mothers compared CON (Figure 2). Proportion of goblet cells relative to total number of epithelial




Figure 1. Maternal malnutrition was associated with altered gene expression of antimicrobial peptides
and mucin. Maternal UN was associated with decreased mRNA expression of antimicrobial peptide
genes Lyz2 (p = 0.02) and Reg3g (p = 0.003) vs. CON, while HF diet was associated with decreased Reg3g
(p = 0.003) and mucin (Muc2; p = 0.001) mRNA expression vs. CON (n = 6–8/group). Groups with
different letters are significantly different (p < 0.05). UN, undernourished; HF, high fat; CON, control.
73
Nutrients 2019, 11, 1375
Figure 2. Maternal malnutrition may influence small intestinal goblet cell number. (A) Staining of
goblet cells by alcian blue in small intestine (20×magnification). Arrows indicate goblet cells. Mean
number of goblet cells across 8 villi (B) or crypts (C). Mean percentage of goblet cells (proportion of
total number of epithelial cells) in villi (D) or crypts (E). There were a greater number of goblet cells in
UN villi vs. CON (p = 0.008; n = 6–8/group). Groups with different letters are significantly different
(p < 0.05). UN, undernourished; HF, high fat; CON, control.
3.2. Maternal HF Diet May Be Associated with Increased Lyz Production
Lyz protein was localized to Paneth cells in the crypts of the maternal SI (Figure 3A). In the SI of
HF dams, semi-quantitative analyses revealed a significant reduction in the levels of low-intensity Lyz
staining (p = 0.03, Figure 3B) compared to CON, which may suggest an overall greater production
of this AMP in HF mothers. Further, an overall difference in moderate-intensity staining (p = 0.04;
Figure 3C) was detected, but there was no difference between groups with post hoc testing, and there
were no differences between diet groups in high- or strong-intensity staining levels (Figure 3D,E).
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Figure 3. Maternal HF diet was associated with less low-intensity lysozyme staining in intestinal crypts.
(A) Representative images of lysozyme protein immunoreactivity (ir) staining show localization to the
crypts of the maternal small intestine (SI) at d18.5, with negative control inset (40× magnification).
Arrows indicate lysozyme proteins within Paneth cells. (B–E) Lyz staining was quantified into
low, moderate, high, and strong intensities, representing increasing levels of protein expression
(n = 6–8/group). Semi-quantitative analysis revealed less low-intensity Lyz staining in SI from HF
mothers (p = 0.03) vs. CON, and an overall difference in moderate-intensity Lyz staining (p = 0.04),
but no difference between groups with post hoc testing. Groups with different letters are significantly
different (p < 0.05). UN, undernourished; HF, high fat; CON, control.
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3.3. Maternal UN Was Associated with Delayed Fetal Gut Development and Reduced Mucus Production
UN, but not HF, fetuses showed increased mRNA expression of the gut transcription factor Sox9
(p = 0.02, Figure 4A) compared to CON, and an associated decrease in the mRNA expression levels of




Figure 4. UN fetuses displayed activation of a gut transcription factor that represses gut barrier
development and mucus production. Maternal UN was associated with increased fetal gut mRNA
expression of Sox9 (p = 0.02) vs. CON, and decreased Muc2 (p = 0.002) and Cdx2 (p = 0.003) vs. CON
(n= 8–15/group). Groups with different letters are significantly different (p< 0.05). UN, undernourished;
HF, high fat; CON, control.
3.4. Maternal HF Diet Was Associated with Increased Fetal EGC Development
Fetuses from HF-fed mothers had increased mRNA expression levels of EGC markers Bfabp (0.003,
Figure 5A) and S100b (p < 0.001, Figure 5B) compared to CON, and increased Plp1 (p = 0.04, Figure 5C)
compared to UN. There were no differences in gut mRNA expression levels of the EGC marker Sox10
and EGC neurotrophic factor Gdnf in fetuses exposed to different maternal diets (Figure 5D,E).
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Figure 5. HF fetuses showed activation of enteric glial cell markers in the gut. Maternal HF diet
was associated with increased fetal gut mRNA expression of enteric glial cells (EGC) markers S100b
(p < 0.001) and Bfabp (p = 0.003) vs. CON, and Plp1 (p = 0.04) vs. UN (n = 7–15/group). Groups with
different letters are significantly different (p < 0.05). UN, undernourished; HF, high fat; CON, control.
3.5. Maternal HF Diet Was Associated with Increased Fetal Gut Barrier Function and Integrity
HF, but not UN, fetuses had increased mRNA expression levels of Paneth AMPs Lyz1 (p = 0.007,
Figure 6A), Reg3g (p = 0.01, Figure 6C), and Defa1 (p = 0.001, Figure 6D), and lower gut mRNA
expression levels of Tlr4 (p = 0.02, Figure 6E) compared to CON. No between-group differences were
detected in Lyz2 fetal gut mRNA expression levels (Figure 6B). Maternal HF diet was also associated
with an increase in fetal gut mRNA expression of TJ genes Cldn-3 (p = 0.008, Figure 7A) and Cldn-7
(p < 0.001, Figure 7B) compared to CON, while UN fetuses only displayed increased mRNA expression
of Cldn-7 compared to CON (p < 0.001, Figure 7B).
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Figure 6. HF fetuses showed an upregulation of gut barrier function genes and downregulation of
a microbe-sensing receptor. Maternal HF diet was associated with increased mRNA expression of
antimicrobial peptide (AMP) genes Lyz1 (p = 0.007), Reg3g (p = 0.01), and Defa1 (p = 0.001) in the fetal
gut vs. CON, though mRNA expression of the purported AMP-activating receptor Tlr4 was decreased
in these fetuses (p = 0.02) vs. CON (n = 9–15/group). Groups with different letters are significantly
different (p < 0.05). UN, undernourished; HF, high fat; CON, control.
Figure 7. Maternal malnutrition altered fetal gut tight junction gene expression. Maternal UN was
associated with increased mRNA expression of Cldn-7 (p < 0.001) in fetal gut vs. CON, while fetuses
from HF mothers increased Cldn-3 (p = 0.008) and Cldn-7 (p < 0.001) mRNA expression vs. CON
(n= 9–15/group). Groups with different letters are significantly different (p< 0.05). UN, undernourished;
HF, high fat; CON, control.
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3.6. Maternal Malnutrition Altered Fetal Gut mRNA Expression in Males More than in Females
Data on fetal outcomes were also stratified by sex (Figures 8–11). We found that maternal HF
diet was associated with increased mRNA expression of genes involved in EGC maturation (Bfabp,
Plp1, and S100b), gut barrier function (Lyz1 and Lyz2), and gut barrier integrity (Cldn-3 and Cldn-7) in
the male fetal gut (p < 0.05, Figures 9–11) compared to CON. Maternal HF diet was also associated
with reduced male fetal gut mRNA expression of the microbe-sensing toll-like receptor Tlr4 (p = 0.03,
Figure 10E) compared to CON. Male UN fetuses showed a reduction in fetal gut mRNA expression of
gut differentiation and maturation markers Cdx2 (p = 0.02, Figure 8B) and Muc2 (p < 0.001, Figure 8C),
and an upregulation of EGC marker Bfabp (p < 0.001, Figure 9A) and TJ gene Cldn-7 (p = 0.004,
Figure 11B).
Figure 8. Maternal UN affected fetal gut barrier maturity in both sexes and mucus layer maturity in
male fetuses only. Maternal UN was associated with increased gut transcription factor Sox9 (p = 0.004)
vs. CON and decreased Cdx2 (p = 0.02) vs. HF in female fetal guts, and reduced Cdx2 (p = 0.02)
and Muc2 (p < 0.001) vs. CON in male fetal guts (n = 3–8/group). Groups with different letters are
significantly different (p < 0.05). UN, undernourished; HF, high fat; CON, control.
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Figure 9. Maternal HF diet was associated with increased mRNA expression of enteric glial cell
markers in male fetuses. In male fetal guts, maternal HF diet was associated with increased Bfabp
(p < 0.001), S100b (p < 0.001), and Plp1 (p = 0.001), while maternal UN was associated with increased
Bfabp (p < 0.001). Maternal malnutrition (UN and HF) did not affect enteric glial cell development in
female fetal guts (n = 3–8/group). Groups with different letters are significantly different (p < 0.05). UN,
undernourished; HF, high fat; CON, control.
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Figure 10. Maternal HF diet was associated with increased expression of antimicrobial peptides and
decreased expression of microbe-sensing receptor in male fetuses. In male fetal guts, maternal HF
diet was associated with increased Lyz1 (p < 0.001) and Lyz2 (p < 0.001), and decreased Tlr4 (p = 0.03)
mRNA expression levels. Maternal malnutrition (UN and HF) did not affect Defa1 or Reg3g expression
levels in male fetuses or antimicrobial peptide levels in female fetal guts (n = 3–8/group). Groups with
different letters are significantly different (p < 0.05). UN, undernourished; HF, high fat; CON, control.
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Figure 11. Maternal malnutrition was associated with an increase in gut tight junction gene expression
in both fetal sexes. In male fetal guts, maternal HF diet was associated with increased Cldn-3 (p = 0.02)
and Cldn-7 (p = 0.004), while maternal UN was associated with increased Cldn-7 (p = 0.004); in
female fetal guts, maternal UN was associated with increased Cldn-3 (p = 0.03) mRNA expression
(n = 3–8/group). Groups with different letters are significantly different (p < 0.05). UN, undernourished;
HF, high fat; CON, control.
In female fetal guts, maternal UN was associated with increased mRNA expression of gut
differentiation transcription factor Sox9 (p = 0.004, Figure 8A) compared to CON, and decreased gut
maturation marker Cdx2 (p = 0.02, Figure 8B), though only compared to HF. Maternal UN was also
associated with increased TJ gene Cldn-3 (p = 0.03, Figure 11A) in female fetuses compared to CON.
4. Discussion
Despite the growing body of evidence linking the gut and its resident microbes to health [2,7],
few studies have investigated these relationships in the mother during pregnancy or the developing
fetus. Additionally, although we know that key enteric cells that support the gut barrier and establish
communication with the brain are laid down and functional in early life [49–51], we know less about
how early life nutritional adversity or altered gut microbes may influence their development and
function [52,53]. Since malnutrition is an important insult to pregnancies and their outcomes [54],
our study is the first to determine the effect of maternal malnutrition on maternal and fetal intestinal
barrier integrity and function, and its implications for fetal development.
Extensive research has demonstrated that high fat diets markedly alter the diversity
and composition of gut microbes [32,55–59], resulting in long-term aberrations in gut barrier
integrity [32,55–57,60] and function [32,55,61] and chronic inflammation [32,56,57]. As a result,
we hypothesized that mothers fed a HF diet would show pronounced changes in gut function.
We found that maternal HF diet was associated with reduced mRNA expression of Paneth cell AMP
Reg3g, which targets Gram-positive bacteria [62], no change in mRNA expression of AMPs Lyz1
and Lyz2, and less low-intensity Lyz staining, which may suggest an overall greater production of
Lyz protein, which can target both Gram-positive and Gram-negative bacteria [63]. These results
are analogous to those where HF feeding for 8 weeks in non-pregnant mice was associated with
a reduction in Reg3g SI mRNA expression and no expression changes in Lyz1 [61]. Maternal HF diet
was also associated with lower mRNA expression levels of the goblet cell-produced Muc2, which when
translated, becomes the main component of the mucus layer: the first line of defense against gut
infections and inflammation [64]. Although this was not associated with an increase in the number
of goblet cells in HF SI, our mRNA results align with a study where male and female mice fed a HF
diet from weeks 6–22 of life had a reduction in mRNA expression levels of Muc2 and cryptidins
(Paneth AMPs) [65]. Since Reg3g is critical to Muc2 distribution and spatial segregation of the
gut epithelium and bacteria [62,66,67], concurrent downregulation of these genes due to a HF diet
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may further alter the mucus layer and reduce gut barrier defenses against microbes, resulting in
bacterial contact with the epithelium, increased gut inflammation, gut tissue damage, and bacterial
translocation [62].
Similar to high fat diets, undernutrition is known to be a significant insult to gut barrier integrity
and function, increasing gut permeability [68–70], gut and peripheral inflammation [68,69], and bacterial
translocation [71], and altering gut barrier structure [72] and enteric cell function [73,74]. Despite this,
and to the best of our knowledge, our study is the first to investigate the effects of undernutrition on the
maternal gut barrier during pregnancy. We hypothesized that undernutrition would lead to adverse
changes in the maternal gut environment. We found that moderate maternal UN was associated
with lower mRNA expression levels of Paneth cell AMPs (Lyz2 and Reg3g), suggesting reduced gut
barrier function and ability to maintain gut-microbe homeostasis. This is consistent with findings
from a study where 48 h of starvation in non-pregnant mice led to a reduction in SI mRNA and
protein expression of Reg3g and Lyz, and a hyper-permeable barrier [33]. Since AMPs limit bacterial
contact with the gut barrier [75], a reduction in their expression has been associated with increased
bacterial adherence to the barrier [76] and bacterial translocation [1,33,77]. Moreover, AMPs have been
shown to block the release of IL-1β from activated immune cells [78], a pro-inflammatory cytokine
which exacerbates gut barrier permeability by creating gaps between TJ proteins [78–80]. These data
suggest that undernutrition may compromise the host’s ability to mount an appropriate immune
response through AMP pathways, resulting in increased susceptibility to infections and a leaky gut.
In fact, malnutrition is known to impair gut immune functioning, causing increased susceptibility to
environmental insults due to altered cytokine production [81]. This may be of particular concern in
pregnancies where undernutrition/underweight and infection often coexist, such as in populations
with low socioeconomic status [23,70]. Yet, even prior to bacteria reaching the gut barrier, a mucosal
layer produced by goblet cells provides protection. We found that UN mothers had an increased
number of villus-residing goblet cells, which may suggest an attempt to strengthen the gut barrier to
offset the consequences of reduced AMP expression, such as the heightened propensity for leaky gut.
Though early life development is key to setting healthy trajectories throughout life [82], little is
known about how perinatal events shape fetal gut development. Therefore, we were interested in
the effect of maternal malnutrition on fetal gut and ENS development and function. We focused on
the consequence of this nutritional adversity on genes involved in gut maturation and differentiation,
EGC development, Paneth AMP production, and TJ formation. Consistent with our hypothesis,
fetuses from HF mothers seemed to be most affected by an adverse nutritional exposure, as evidenced
by significantly altered expression levels of nine of the 15 genes tested. HF diet was associated with
changes in fetal EGC development, gut AMP production, and TJ expression. In fetuses from HF-fed
dams, we found increased mRNA expression of specific and widely-expressed [17,46,83] markers of
EGCs S100b, Bfabp, and Plp1, the latter of which to our knowledge has not been previously examined
in the mouse fetal gut. This increase in EGC markers may be in response to the higher inflammatory
environment in HF pregnancies that we have previously described [41], since EGCs are important for
regulating inflammatory pathways [84] and gut barrier integrity [20,84]. During intestinal inflammation
in adult animals, EGCs respond to pro-inflammatory signals and reverse inflammation-induced ENS
damage [85] by driving enteric neuron death through nitric oxide production [41,43,44] and triggering
ENS neurogenesis [86]. Previously, EGC proliferation was shown to occur in infant rats whose mothers
were fed HF diets perinatally, though mRNA and protein expression of local pro-inflammatory cytokines
were unchanged at all postnatal timepoints examined (2, 4, 6, and 12 weeks) [35]. Together with our
results, this may suggest that maternal HF diet exposure in utero may reprogram mechanisms in
the fetus that establish gut-brain connections and communication and increase EGC development to
reduce gut inflammation by the time of birth, thereby negating some of the fetal ENS damage incurred
during development. Future experiments should examine whether these changes in the fetal gut are
associated with altered brain development and function.
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Additionally, fetuses from HF mothers showed an increase in gut mRNA expression levels of AMP
genes Lyz1 (but not Lyz2), Defa1, and Reg3g. This is in contrast to studies in adult mice [27,32,55,65] that
have demonstrated that HF diets decrease gut levels of AMPs, though one study [29] found differing
results between the mRNA and protein levels. Nevertheless, our study is the first to our knowledge to
uncover how maternal malnutrition alters expression levels of AMPs in near-term fetuses and is the
first to assess Reg3g mRNA expression in fetal tissues. Due to the lack of other developed immune
mechanisms, fetuses may be increasing the expression of AMP genes to regulate and protect themselves
from the pro-inflammatory fetal environment observed in HF pregnancies [87–90]. In parallel to the
upregulation of AMPs, we observed reduced expression of Tlr4 mRNA in HF fetal gut, despite that,
at least in adult models, Tlr4 is known to initiate AMP production [91,92]. Nonetheless, depending on
tissue type, the same TLR can downregulate, upregulate, or not affect AMP production [93], adding to
the complexity of the TLR-AMP relationship which is further compounded by the lack of work on TLR
function in fetal gut tissue.
In mammals, 24 members of the claudin family exist, each with unique charge-selectivity
preferences that dictate barrier permeability and tight junction structure and function [94]. Of the
claudin family, Cldn-3 and Cldn-7 are the amongst the most highly expressed in all sections of the mouse
GI tract [95]. Cldn-3 has previously been shown to be affected by HF diets [60] and commensal bacterial
colonization [96], while Cldn-7 has been found to have functions outside of barrier integrity, such as
maintenance of intestinal homeostasis [97], and both its mRNA and protein are highly expressed in the
small and large intestine [97]. Still, expression levels of neither Cldn-3 nor Cldn-7 have been recorded
in mouse fetal guts. In our study, fetuses from HF mothers showed an increase in mRNA expression of
both TJs Cldn-3 and Cldn-7, however these data run counter to the effects of HF diets on TJ expression
in adult mice and rats [56,57,60]. Research on the ontogeny and development of tight junction proteins
in the fetal mouse gut is scarce, though in human fetuses, tight junction proteins appear at 8–10 weeks
of gestation and begin to assemble junctional complexes (continuous, belt-like structures around cells)
at 10–12 weeks [98]. Nevertheless, most of the development of the tight junction proteins and gut
integrity occurs in postnatal life [94], indicating that the prenatal fetal gut may be particularly sensitive
and vulnerable to the effects of adverse in utero exposures due to a permeable gut barrier. As HF
fetuses showed increased expression of TJ proteins, which is consistent with their increased expression
of EGC markers, it may be that HF fetuses are compensating for a highly inflammatory maternal
environment by tightening the gut barrier.
Similar to HF fetuses, we hypothesized that fetal growth restriction would lead to aberrant gut
barrier development in fetuses from UN mothers. Accordingly, we found that UN fetuses had increased
expression of the gut transcription factor Sox9, which is known to repress the expression of Muc2 and
Cdx2 through activation of the Wnt-β-Catenin-TCF4 pathway [99], and reduced mRNA expression of
mucus (Muc2) and gut differentiation (Cdx2) genes. These data are indicative of immature gut barrier
development, and consistent with the reduced weight of these fetuses compared to CON and HF
fetuses. Importantly, an immature gut may be associated with increased susceptibility to inflammatory
and infectious insults, due to reduced gut barrier integrity and function, gut dysbiosis [100–102],
and irreversible [103] aberrant nutrient absorption [103–106]. This has long-term implications for
growth-restricted offspring, including those born too soon, such as preterm infants, who are at
greater risk for necrotizing enterocolitis [107–109] and nutrient malabsorption [103,105,106] due to
poor gut development and function. Despite the changes in gut maturation and mucus production,
fetuses from UN mothers showed an increase in gut Cldn-7, but not Cldn-3, mRNA expression,
which might suggest an attempt to increase barrier integrity to compensate for the gut barrier
immaturity. Lastly, our sex-stratified data suggest that the majority of observed group differences
were driven by male fetuses, which is consistent with numerous reports which demonstrate that male
fetuses are more susceptible to perinatal insults, especially due to maternal malnutrition [110–115].
One limitation of our study is our focus on gene expression, especially in fetal samples where
sample volume is extremely limited. Findings from qPCR data can direct future experiments that
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examine changes at the protein level. Another limitation is the low n-number in the female fetal
UN group; thus, sex-stratified changes in mRNA expression should be interpreted with caution.
Lastly, although our study is cross-sectional, we focused on an important developmental time (d18.5)
that can serve as an indicator of embryonic/fetal experiences and provide information that could
explain neonatal development and adaptations. Future studies should examine when changes in
Paneth cell and EGC development and function are initiated in the pregnant mother and developing
offspring, and how long they persist, which could point to critical windows for intervention to correct
adverse health and developmental trajectories set by malnutrition.
5. Conclusions
Our study is the first to examine the effect of both over- and undernutrition in parallel,
during gestation in mice, and reveal the impact of maternal malnutrition on fetal gut Paneth cell
function and EGC development—cells vital for gut barrier function and gut-brain axis connection.
Our results indicate that malnutrition before and during gestation has adverse consequences for fetal
gut development, maternal and fetal gut function, and potentially long-term programming of gut
and brain function and gut immunity. If our findings are applicable to humans, this work may help
inform research on dietary interventions that aim to prevent or mitigate the effects of being exposed to
suboptimal nutrition in pregnancy (for mothers) and in early life (for offspring). Future work should
place special focus on vulnerable populations wherein malnutrition and infection are more likely to
coexist during pregnancy, exacerbating the negative repercussions of both noxious states on maternal
and offspring wellbeing.
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Abstract: In adults, fermentation of high amylose maize starch (HAMS), a resistant starch (RS), has
a prebiotic effect. Were such a capacity to exist in infants, intake of RS might programme the gut
microbiota during a critical developmental period. This study aimed to determine if infant faecal
inocula possess the capacity to ferment HAMS or acetylated-HAMS (HAMSA) and characterise
associated changes to microbial composition. Faecal samples were collected from 17 healthy infants
at two timepoints: Preweaning and within 10 weeks of first solids. Fermentation was assessed using
in vitro batch fermentation. Following 24 h incubation, pH, short-chain fatty acid (SCFA) production
and microbial composition were compared to parallel control incubations. In preweaning infants,
there was a significant decrease at 24 h in pH between control and HAMS incubations and a significant
increase in the production of total SCFAs, indicating fermentation. Fermentation of HAMS increased
further following commencement of solids. Fermentation of RS with weaning faecal inocula increased
Shannon’s diversity index (H) and was associated with increased abundance of Bifidobacterium and
Bacteroides. In conclusion, the faecal inocula from infants is capable of RS fermentation, independent
of stage of weaning, but introduction of solids increases this fermentation capacity. RS may thus
function as a novel infant prebiotic.
Keywords: short-chain fatty acid (SCFA); pH; dietary fibre; gut health; prebiotic
1. Introduction
The initiation of solid foods in early infant feeding represents a dynamic period of change in the
composition of the gut microbiota [1]. This period is also critical to child development with implications
for general nutrition and immune development, amongst other benefits [1]. The administration of
prebiotics during this period could have profound health consequences [2] as they are non-digestible,
generally safe and inexpensive food ingredients that selectively stimulate the growth and/or activity of
one or a limited number of bacterial species that already reside in the colon [3].
In adults, high amylose maize starch (HAMS), a cultivar obtained through selective breeding, may
function as a prebiotic [4]. It is a form of resistant starch (RS), which is defined as the sum of starch
and products of starch degradation which have not been absorbed in the small intestine of healthy
individuals and which become available for microbial fermentation in the colon [5]. RS is classified
into five types and several of these starches have been shown to alter gut fermentation and change
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gut microbial composition [5]. HAMS is an example of a type 2 RS. Starches may also be chemically
modified (type 4 RS) to reduce their digestibility and obtain favourable physicochemical properties.
Acylated type 4 RSs may also increase the delivery of short-chain fatty acids (SCFAs) directly to the
colon. One example of this is acetylated-HAMS (HAMSA), which is esterified with acetyl groups.
Due to significant differences in the composition and function of infant and adult gut microbiota,
the potential of RS to function as a prebiotic in infants cannot be extrapolated from adult studies. It is
possible that the relatively immature gut microbial ecosystem of the infant may not have acquired the
necessary diversity of bacteria to ferment a complex carbohydrate such as RS [6,7].
Due to the relative inaccessibility of the proximal colon and portal vein, in vivo measurement
of substrate digestion and fermentation requires highly invasive procedures and feeding studies to
preweaning infants that are not practical. In vitro static batch fermentation is a rapid, inexpensive
method to initially assess substrate fermentation and has been widely used to evaluate the fermentation
capacity of both adult and infant faecal inocula [8,9]. Substrate fermentation during in vitro batch
fermentation studies is evidenced by substrate disappearance, increased production of SCFAs, a decrease
in pH, gas generation, or differences in microbial composition in those ferments containing the substrate
when compared to a control. The control incubation does not have an added substrate.
In the present study, we used an in vitro batch fermentation system that simulates human colonic
fermentation to determine: (1) The capacity of infant faecal inocula, pre-weaning and weaned, to
ferment pre-digested HAMS and HAMSA by monitoring changes in the activity (fermentation) and
community structure of the faecal microbiota of preweaning and early weaning infants; and (2) whether
the introduction of solids into the diet (weaning) influences these variables.
2. Materials and Methods
2.1. Study Design
We conducted an observational study in which faecal samples were collected from infants, prior
to and following weaning (commencement of first solid foods). The first faecal sample was collected
from 8 weeks of age until weaning, while the second sample was collected within 10 weeks of weaning
commencing. Collected samples were incubated in vitro with fermentable substrates to address the
aims. Each infant was expected to provide two samples, one for each time point. This study complied
with National Health and Medical Research Council (Australia) guidelines relating to ethical conduct in
human research and was reviewed and approved by the Southern Adelaide Clinical Human Research
Ethics Committee (September 2013, 339.13).
2.2. Participants and Intervention
Caregivers of preweaning infants were recruited either by direct approach following childbirth
and prior to hospital discharge or through advertisements in a local parenting magazine. Inclusion
criteria included that the infant was full term at birth with a gestational age of more than 38 weeks; at or
above the 10th percentile for weight at birth and with no known cardiac, respiratory or gastrointestinal
disease. Infants were excluded if they or their mothers received probiotic supplementation or antibiotics
post-delivery and prior to stool collection. The mode of infant feeding, breastfed or bottle-fed or mixed
(not exclusively breast fed), was recorded. There were 17 preweaning infants and 16 of these infants
went on to provide weaning samples.
2.3. Faecal Sample Collection and Processing
Within 15 min of an infant passing a motion, stool was collected from a disposable nappy using a
sterile container, placed into an airtight bag and put into a portable freezer set at −20 ◦C. Within two
hours, the sample was processed in the laboratory. Working within an anaerobic cabinet containing
5% H2, 5% CO2, and 90% N2, the faecal samples were homogenised in 50% glycerol (1:1 dilution)
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and stored at −80 ◦C until further analysis. The use of frozen samples compared to fresh samples in
fermentation experiments has been previously validated [10].
2.4. Carbohydrates and Chemicals
The two RSs, HAMS (Hylon VII) and modified HAMS (HAMSA-Crispfilm) were obtained from
Ingredion, USA. Hylon VII is composed of 70% amylose and 30% amylopectin. It is estimated that
Hylon VII contains 50 g of RS per 100 g [11]. Crispfilm (CF) has a Hylon VII backbone and has
undergone a further esterification process to form a starch acetate. The degree of acetylation of CF is less
than 2.5%, the limit imposed by U.S. Food and Drug Administration (FDA) food regulation and CF has
Generally Recognized as Safe (GRAS) status. Lactulose was obtained from Sigma-Aldrich, Australia.
2.5. In Vitro Fermentation
An in vitro pre-digestion step was performed to simulate the digestive action of the infant small
intestine prior to the fermentation experiments [12]. See Appendix A.1, for further detail of the
pre-digestion method. The in vitro fermentation method was based on the technique described by
Edwards et al. [13] and Goni et al. [14]. For each preweaning infant sample there were three groups of
incubations: HAMS, lactulose and the control. The control incubation had no additional substrate and
lactulose was added to confirm that viable bacteria were present in the faecal inocula of each subject.
For weaning infant samples there were four incubations, with HAMSA as the additional group, along
with HAMS, lactulose and the control. HAMSA was not tested in preweaning infants due to small
sample volumes. All fermentations were performed in triplicate for each donor/substrate at 0 and 24 h
time points. Briefly, 100 mg of pre-digested starch residue was weighed into triplicate 15 mL sterile
culture tubes together with 8–10 sterile 2.5 mm glass beads and 9 mL of autoclaved fermentation media.
Frozen homogenised faecal material from participants was thawed and a 10% w/v faecal slurry was
prepared by homogenisation and dilution in pre-reduced phosphate-buffered saline (PBS) (0.1 M, pH
7.2). Working within an anaerobic chamber, 1 mL of faecal slurry was added to each fermentation tube
(1% w/v). Controls were incubated in parallel with incubations containing HAMS, lactulose or HAMSA.
Tubes were incubated under anaerobic conditions with gentle agitation for 24 h. Fermentation was
terminated at 0 h (Blanks) and at 24 h samples by centrifugation at 13,000× g, 4 ◦C for 10 min and the
supernatant was stored at −80 ◦C for further measurements.
2.6. SCFA and pH
SCFA concentration was determined using capillary column gas chromatography according to
McOrist et al. [15]. A digital pH meter was used to measure pH. Fermentation of the substrate was
deemed to have occurred if there was a statistically significant decrease in pH and an increase in
production of SCFA at 24 h in ferments containing added RS when compared to the respective control.
2.7. Molecular and Sequence Analysis
2.7.1. DNA Extraction
DNA was extracted from ferments using bead beating followed by the MoBio PowerMag
Microbiome RNA/DNA isolation kit (Qiagen, Hilden, Germany) optimised for epMotion (Eppendorf,
Hamburg, Germany) platforms (see Appendix A.2). Due to the recognised variation in fermentation
between replicates during in vitro batch fermentation [16], DNA was extracted from a pooled sample
containing 1 mL from each ferment replicate.
2.7.2. Real-time Quantitative Polymerase Chain Reaction (qPCR)
Selected bacteria including bifidobacterium, lactobacillus and total bacteria, were quantified by
specific primers targeting the 16S rRNA gene using qPCR. See Appendix A, Table A1, for primer
sequences and the optimised qPCR conditions. The ability of a substrate to selectively stimulate
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the growth of a given bacterial taxon was determined by comparing incubations with either HAMS
or HAMSA to the 24 h control. All qPCR analysis was performed on the CFX 384TM real-time
PCR detection system (Bio-Rad, Hercules, CA, USA) (See Appendix A.3). Absolute abundance was
estimated according to Christophersen et al. [17].
2.7.3. Sequencing of 16S Ribosomal RNA Encoding Gene Amplicons
16S ribosomal DNA gene sequencing was performed on DNA extracted from each participant’s
24 h fermentation samples (preweaning control, preweaning HAMS, weaning HAMS, weaning
HAMSA, weaning control). The 24 h samples were chosen as the fermentation is not only affected
by the added substrate but also by the remaining substrates in the faecal slurry. We therefore believe
the true control for each subject and substrate is a control fermentation with no added substrate to
take into account the available substrate in the faecal slurry. The methods outlined in Illumina’s 16S
Metagenomic Sequencing Library Preparation protocol (Illumina, San Diego, CA, USA) were followed
with minor adjustments made to PCR thermal cycle conditions, as described in Appendix A.4.
2.7.4. Taxonomic Assignments to 16S Reads
An in-house (CSIRO) amplicon clustering and classification pipeline (GHAP) based on tools from
Usearch [18] and a Ribosomal Database Project (RDP) classifier [19] combined with locally written tools
for demultiplexing and generating Operational Taxonomic Unit (OTU) tables were used to process
the amplicon sequence data. Following the merging of paired reads, dereplication, clustering at 97%
and chimera checking were also performed using the pipeline. Classification of the reads was then
performed by using the RDP to assign taxonomy and by finding the closest match to the OTU from a
set of reference 16S sequences [19]. OTUs were defined at a 97% sequence similarity level and classified
to genus level. Sequences which were not classified using the pipeline were manually blasted against
the NCBI database.
2.8. Statistical Analysis
For SCFA and pH results, data normality was assessed using the Shapiro–Wilk test using SPSS
Version 22.0. A boxplot of the dataset was used to identify outliers within preweaning and weaning
groups, Univariate ANOVA with Bonferroni correction was used to analyse for differences in starting
pH and total SCFA of the different groups within the weaning and preweaning infants. Due to
differences in the number of formula and breastfed infants, a general linear mixed model was used to
determine if within the preweaning group, the method of feeding influenced the effect of incubation
with HAMS on both change in pH and total SCFA production. A repeated measures two-factor
ANOVA was used to determine if there was an effect of weaning on parameters of HAMS fermentation
(pH and total SCFA) when compared to controls. Values are presented as means ± their standard
errors. Statistical significance was accepted as p < 0.05.
For analysis of the molecular results, the qPCR values were log10 transformed and the means
were compared using Student’s t-test. Microbial abundance at 24 h was compared with those at 0 h for
each substrate. Multivariate analysis of the sequencing data was performed using PRIMER 7 with
PERMANOVA (PRIMER-e, Auckland, New Zealand). Statistical analysis of Bray-Curtis dissimilarities
were calculated using relative abundance of bacterial genera at the family level following 24 h of
fermentation. Alpha diversity index was also calculated at the family level. Principal coordinate
analysis (PCOA) was used to visualise the dissimilarity data.
3. Results
The seventeen participants provided a preweaning sample, with all but one of these infants also
providing a second (weaning) sample (see Table 1).
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Exclusively Breast-Fed 10 10 3.32 ± 0.37 a 7.03 ± 0.27 b
Mixed 7 6 3.29 ± 0.22 a 7.39 ± 0.21 b
Total 17 16 3.31 ± 0.23 7.16 ± 0.18
SE: Standard error. Means in a row without a common superscript letter differ significantly (p < 0.05).
3.1. SCFA and pH Levels
The Shapiro–Wilk test confirmed a normal distribution of faecal pH and SCFA data in both
preweaning and weaning incubation samples. One participant, in the preweaning exclusively
breast-fed group, was noted to have an outlier for total SCFA for each substrate. Parallel series of
calculations performed with and without the inclusion of this participant’s data did not alter the final
statistical conclusions. Within the preweaning group, linear mixed model analysis revealed no effect of
mode of feeding (exclusively breast fed or mixed) on SCFA (p = 0.754) or pH (p = 0.809), following
incubation with either substrate (HAMS or lactulose).
Results for initial, final and change in pH at 24 h following incubation are presented in Table 2.
All incubations, including the lactulose, resulted in a significant decrease in pH at 24 h. In both
weaning and preweaning groups the decrease in pH was significantly greater following incubation
with HAMS than in the controls, consistent with active fermentation of HAMS. It was expected to
observe a decrease in pH for control samples due to residual substrate in the faecal inoculate. In the
weaning group, incubation with HAMSA also led to a decrease in pH when compared to the control.
Table 2. Initial and final change in pH following incubation of infant faecal microbiota with high
amylose maize starch (HAMS) and other substrates. Mean ± SE.
Preweaning Weaning
Control HAMS Lactulose Control HAMS HAMSA Lactulose
Initial pH
(0 h) 7.64 ± 0.03
a 7.63 ± 0.03 a 7.69 ± 0.03 a 7.66 ± 0.03 a 7.65 ± 0.02 a 7.65 ± 0.03 a 7.72 ± 0.04 a
Final pH
(24 h) 6.72 ± 0.08
a 6.40 ± 0.09 b,* 4.73 ± 0.12 c,* 6.77 ± 0.05 a 6.43 ± 0.05 b,* 6.37 ± 0.04 b,* 4.65 ± 0.08 c,*
Δ pH −0.93 ± 0.07 a −1.21 ± 0.06 b,* −3.03 ± 0.06 c,* −0.82 ± 0.07 a −1.14 ± 0.08 b,* −1.09 ± 0.10 b,* −2.89 ± 0.20 c,*
Within the preweaning and weaning groups a one-way ANOVA was used. Unlike superscript letters within each
row are significantly different (Bonferroni adjusted p < 0.05). * defined as different from control (p < 0.05). HAMSA:
High Amylose Maize Starch Acetylated.
Analysis of variance showed no effect of the substrates on initial pH, p = 0.36. A repeated measures
two-factor ANOVA revealed an effect of HAMS p < 0.001, but not stage of weaning on change in pH,
p = 0.34. There was no interaction between the substrate and stage of weaning p = 0.54, indicating
that the introduction of solids did not influence the effect of incubation with HAMS on change in pH
when compared to controls. The means and standard error thereof for total and major individual
production of SCFAs at 24 h are shown in Table 3. In the faecal inocula of the preweaning group there
was a significant increase in the concentration of SCFAs, acetate and butyrate when HAMS was added
compared to the controls, indicating that the preweaning faecal inocula had some capacity to utilise
HAMS as a substrate.
In the faecal inocula from weaned infants, there was a significant increase in the production of
total SCFAs, acetate and propionate for both HAMSA and HAMS. A significant increase in butyrate
was seen only with HAMS and not HAMSA. These changes confirmed fermentation of the RSs by the
infant faecal inocula. The molar ratios for all the substrates confirmed previous findings that, in young
infants, acetate is by far the dominant SCFA during fermentation.
In relation to total SCFA concentration, a two-way repeated measures ANOVA demonstrated a
significant interaction between incubation with HAMS and stage of weaning, p = 0.015, suggesting that
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the fermentation of HAMS is enhanced post the introduction of solids. A pair-wise comparison with
Bonferroni correction revealed no statistically significant effect of weaning on total SCFA concentration,
p = 0.06. However, there was a statistically significant effect for HAMS p < 0.001.
Table 3. Short-chain fatty acid (SCFA) concentrations (mmol/L) following incubation with test substrates
using pre- and weaning infant faecal inoculum. Mean ± SE.
Preweaning Weaning
Control HAMS Lactulose Control HAMS HAMSA Lactulose
Total SCFA # 16.68 ± 1.7 a 23.70 ± 1.7 b,* 61.84 ± 5.4 c,* 20.11 ± 2.3 a 34.85 ± 4.0 b,* 37.81 ± 4.2 b,* 78.27 ± 4.5 c,*
Acetate 14.70 ± 1.5 a 20.93 ± 1.5 b,* 56.11 ± 6.5 c,* 16.98 ± 2.1 a 27.73 ± 3.3 b,* 30.27 ± 3.1 b,* 73.42 ± 5.0 c,*
Propionate 0.83 ± 0.17 a 1.33 ± 0.33 a 1.13 ± 0.80 a 1.60 ± 0.32 a 4.14 ± 0.91 b* 5.56 ± 1.2 c* 2.89 ± 0.74 a,b,c,*
Butyrate 0.36 ± 0.13 a 0.74 ± 0.26 b 0.27 ± 0.12 a 1.09 ± 0.26 a 2.20 ± 0.59 b* 1.23 ± 0.33 a 1.81 ± 1.1 a
# Total SCFA (mmol/L) = sum of acetate, propionate, butyrate and minor SCFAs (valeric, caproic, isobutyric,
isovaleric). Within the preweaning and weaning groups a one-way ANOVA was used. Unlike superscript letters
within each row are significantly different (Bonferroni adjusted p< 0.05). * defined as different from control (p < 0.05).
3.2. Microbial Community Analysis
Across all samples collected at 24 h there were 321 operational taxonomic units identified, with
an average of 94 OTUs per sample (59–213). For preweaning faecal fermentation samples, a total of
632,032 usable reads were obtained and for weaning, 873,706 reads were obtained for downstream
analysis. DNA from two samples from the preweaning group failed to amplify during library
preparation for unknown reasons and therefore these participants were omitted from sequence analysis.
Sequences were classified at each phylogenetic level from phylum to genus.
3.2.1. Alpha Diversity
Alpha diversity was calculated in this study, although the study uses an in vitro model (closed
system), because changes in diversity can still be observed as the Shannon index combines species
richness and their relative abundances. In the preweaning group at 24 h of incubation, there was
no significant difference in the Shannon Index between bacterial communities following incubation
with HAMS or the controls. For example, at the family level, a one-way ANOVA determined that, in
the preweaning group, the overall mean of the log(e) of the Shannon Index did not differ between
the control and the HAMS incubations (p = 0.10). The Shannon Diversity Index boxplot based on
OTU abundance at the family level is presented in Figure 1A. In the weaning group, at the family
level, there was a significant increase in the Shannon index in the RS groups compared to the controls
(p = 0.05). However, the type of RS (HAMSA or HAMS) did not have an effect on this measure of
diversity. The Shannon Diversity Index boxplot based on OTU abundance at the family level for the
weaning infants is presented in Figure 1B.
Figure 1. Boxplot of diversity at family level in (A) preweaning and (B) weaning infant faecal inocula
following 24 h in vitro fermentation. Boxes indicate 25th to 75th percentiles, with mean values marked
as a line and whiskers indicating minimum and maximum values. Different letters mean significantly
different from each other (p < 0.05).
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3.2.2. Beta Diversity
Among the preweaning samples, multivariate analysis did not reveal an effect of HAMS on
microbial community structure (p > 0.05). However, in the weaning samples, the effect of both HAMS
and HAMSA were significant (p < 0.05), compared to the controls. Pairwise comparison was performed
to investigate the differences between the two test groups. This demonstrated that both RSs had a
similar effect on community structure (p = 0.97) (see Figure 2). It is apparent that samples from the
same individual clustered closely.
 
 
Figure 2. Principal coordinate analysis of the Bray-Curtis dissimilarity matrix for (A) preweaning and
(B) weaning samples, calculated at the family level. PCO: Principal Coordinate Analysis.
3.2.3. Relative Abundance
In order to identify the changes in the composition of bacterial communities that might utilise the
RSs, the relative abundance of bacterial groups in fermentation fluid at 24 h of incubation was assessed.
The relative abundance was calculated and is presented in Appendix A, Table A2. Across all levels
of classification, there were a number of statistically significant differences in the relative abundance
of bacteria between HAMS and controls in the weaning group when compared to the preweaning
group. At the phyla level in weaning infants, there was a significant increase in the proportion of
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Actinobacteria and Bacteroidetes at 24 h of fermentation for both RSs in comparison to the controls
(p < 0.05). There was also a significant reduction in Proteobacteria following incubation with both
HAMS and HAMSA (p < 0.05). At a genus level in weaning infants, the abundances of Bacteroides
and Bifidobacterium were significantly increased following incubation with the RSs when compared to
controls (p < 0.05).
Incubation with both HAMS and HAMSA led to a concomitant reduction in the relative abundance
of Enterobacter. Compared to the control, the relative abundance of Ruminococcus was significantly
increased following incubation with HAMSA (p = 0.01), but not HAMS (p = 0.58). Figure 3 illustrates
microbial composition after 24 h of fermentation at a genus level for each substrate, with a relative
abundance threshold of 0.1%.
 
Figure 3. Genus-level composition of the microbial community after sequencing. DNA from 24 h
in vitro fermentations of infant faecal inocula. Bacterial genus with a relative abundance of less than
1% are grouped as “other”.
3.2.4. Quantitative PCR
All qPCR assays had previously been verified using single cell colony sequencing and they
were found to be 100% specific to the bacterial group assigned. In preweaning infants, the absolute
abundance for total bacteria increased after 24 h of fermentation in HAMS and controls (see Table 4)
compared to time 0 h in the controls (representative of the baseline). However, at 24 h the absolute
abundance of total bacteria, bifidobacteria and Lactobacillus did not differ between the control and
the HAMS incubations. In the weaning infants, following 24 h of in vitro fermentation, the absolute
abundance of total bacteria, bifidobacteria and Lactobacillus increased in all three groups (control,
HAMS and HAMSA) compared to time 0 h controls. While there was no difference in the absolute
abundance of total bacteria or Lactobacillus at 24 h compared to the control, the absolute abundance of
Bifidobacterium was significantly greater in HAMS and HAMSA compared to controls. This indicates
that both RS’s can stimulate the growth of Bifidobacterium in the faecal microbiota of weaning infants.
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Table 4. 16S rDNA copy numbers (log 10 copy numbers mL−1 fermentation effluent) of specific bacterial
groups before (0 h) and after 24 h of in vitro fermentation with infant faecal inocula and test substrates,
as determined by qPCR. Mean ± SE.
Total Bacteria Lactobacillus Bifidobacterium
Substrate 0 h 24 h 0 h 24 h 0 h 24 h
Preweaning control (n = 17) 6.6 ± 0.15 7.18 ± 0.24 a,* 4.26 ± 0.4 4.19 ± 0.23 a 6.06 ± 0.09 6.08 ± 0.32 a
HAMS (n = 17) 7.21 ± 0.1 a,* 4.02 ± 0.28 a 6.39 ± 0.25 a
Weaning
Control
(n = 16) 6.65 ± 0.07 7.32 ± 0.06
a,* 2.9 ± 0.27 3.34 ± 0.86 a 5.09 ± 0.31 5.56 ± 0.21 a
HAMSA
(n = 16) 7.42 ± 0.06
a,* 3.52 ± 0.91 a 6.21 ± 0.10 b,*
HAMS
(n = 15) 7.47 ± 0.05
a,* 3.49 ± 0.89 a 6.04 ± 0.19 b,*
In the preweaning and weaning groups, within column values which do not share a superscript letter are significantly
different (p < 0.05). * Significant difference between 0 and 24 h values for each substrate, p < 0.05.
4. Discussion
A divergence in the intake of fibre between those living in Western countries and those consuming
a predominantly agrarian diet, as occurs in many rural parts of the world, emerges as soon as solids are
introduced into the infant diet [1]. Thus, targeted manipulation of fibre content in the early diet may
affect the emerging gut microbiota during a critical period and lead to functional and compositional
changes which could benefit the host’s developing immune system [20,21]. It is within such a context
that we were interested in whether forms of RS, which function as a prebiotic in adults, could have a
role in infancy.
In both the weaning and preweaning groups, the production of SCFAs by the faecal inocula
from these infants was significantly greater in the presence of HAMS when compared to controls.
While fermentation might be expected in faeces from the weaning cohort, it is surprising that the
microbiota of preweaning infants already possess capacity to ferment starch. However, this capacity
did increase significantly post commencement of complementary feeds.
Previous results regarding the potential of young infant faecal bacteria to ferment complex
carbohydrates, are conflicting. An early study by Parrett et al. suggested that the capacity of human
faecal microbiota to ferment complex carbohydrates does not emerge for several months after solids are
commenced [6]. In contrast, Christian et al. found that the faecal microbiota of early weaning infants is
highly efficient at fermenting the digestible waxy maize starch [8]. Heterogeneity in methodologies
across in vitro fermentation studies, including the inclusion or exclusion of substrate pre-digestion, the
age of study participants and the preparation of faecal inocula, limits comparison of results across
studies. In this study, we used a substrate pre-digestion which reflects the low level of alpha-amylase
in the infant gut.
There was no significant difference in the production of total SCFAs, especially acetate, between
HAMS and HAMSA (which is acetylated HAMS). It might be that the degree of substitution was
insufficient for cleavage of the esterified acetate to achieve a statistically significant increase in the
overall pool of acetate. It could also be that infant microbiota might not have yet acquired the esterase
capacity needed to cleave the additional acetate.
Surprisingly, and despite the fermentation findings, our molecular findings showed little difference
in bacterial composition following incubation of HAMS with the preweaning infant inocula in
comparison to the controls. There were no selective differences in the abundance of groups of bacteria
following incubation of HAMS with the preweaning infant inocula, in comparison to the controls.
However, within ten weeks of commencing solids, the molecular changes within the weaning infant
faecal incubations suggest emergence of such a capacity. If selective stimulation of Bifidobacterium and
an increase in the production of SCFAs are components of the prebiotic definition [2] then, based on
these findings, HAMS and HAMSA may well function as a novel prebiotics during infancy.
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A significant number of Bifidobacterium spp. possess genes belonging to the GH13 family of glycosyl
hydrolases (GH) [22,23]. Enzymes belonging to this family are heavily involved in the degradation
of starch and starch related-substrates [24]. Despite the relatively high abundance of Bifidobacterium
in preweaning infant inocula, several possibilities exist for why there were no significant differences
in microbial profile between controls and substrate incubations. It could be that the significant
inter-individual variation in the gut microbial composition of preweaning infants might have masked
the capacity to establish substrate level differences in the microbial profile [25]. Another explanation
rests upon differences in metabolic function amongst various members of the Bifidobacterium genus.
Depending on the particular ecological niche, given the myriad of metabolic pathways available to
Bifidobacterium spp., selective pressure will support the growth of those Bifidobacterium spp. that are able
to utilise the substrates that are most available [22]. Metagenomic studies have demonstrated differences
in which bifidobacterial GH genes are transcribed between infants and adults [26]. For example,
in breast feeding infants, there is greater transcription of bifidobacterial GH genes that are involved
in the degradation of Human Milk Oligosaccharides (HMO) and mucin, compared to adults which
reveals a greater predominance of bifidobacterial GH encoding genes involved in the breakdown
of complex plant-derived carbohydrates [26]. Following the introduction of solids, when more
complex carbohydrates escape the digestive enzymes of the host and are encountered by the infant
gut microbiota, those microbial genes that are involved in the utilisation of these novel nutrients will
be switched on [27]. Given the immaturity of pancreatic function in the young infant, following the
initiation of solids, significant amounts of dietary starch will enter the infant’s colon. This will favour a
selective increase in the expression of genes associated with starch utilisation and may account for the
findings in the weaning faecal inocula.
Despite the recognised relevance of Bifidobacterium to starch utilisation, it had been suggested
that Ruminococcus bromii, a member of the Firmicutes, is a keystone species in the degradation of
HAMS [28]. Our results cannot confirm this assertion. While there was a selective increase in the
relative abundance of Ruminococcus spp. following incubation with HAMSA, there was no such
increase following incubation of HAMS with the weaning infant inocula. This was despite evidence
of starch utilization, as seen in the increase in the relative abundance of other groups of bacteria in
comparison to the controls. This suggests that many strains of bacteria are able to utilise HAMS, which
aligns with studies conducted in pigs [29,30]. Members of Bacteroidetes, a dominant bacterial phylum
in the mammalian gut, also encode numerous discrete polysaccharide utilisation loci (PULs) that may
facilitate starch utilisation. Incubation of weaning infant faecal inocula with both RSs led to an increase
in the relative abundance of Bacteroidetes and an increase in the ratio of Bacteroidetes:Firmicutes.
An increase in the ratio of Bacteroidetes:Firmicutes may be associated with several positive health
outcomes, including reduced risks of obesity and intestinal inflammation [31].
The concordance between HAMS and HAMSA in relation to the effects on microbial composition
and diversity observed in this study could be due to the minimal nature of the chemical modification.
The HAMSA starch used in this study is approved for consumption in infant foods. For starch acetate,
the FDA and the WHO have stipulated an acetyl group’s percentage below 2.5 g/100 g (corresponding
to a maximum Degree of Substitution (DS) of 0.1) for a food application. Although HAMS with higher
degrees of acetylation have been shown to facilitate increased delivery of SCFA into the human colon,
their comparable effects on the gut microbiota have not yet been examined [32].
In a study feeding modified and unmodified RS to adult participants, different effects on faecal
microbiota composition between the two starches were found [33]. The authors found the intake of
the modified, but not the unmodified starch, over a three-week period led to a significant increase in
the abundance of Actinobacteria and Bacteroides. Using our in vitro model, we demonstrated a similar
taxonomic effect following incubation of the weaning infant feces with the modified RS. However, in
contrast to Martinez et al. (2010) we found incubation of the unmodified RS led to similar taxonomic
changes at the phylum level. From a translational viewpoint, if HAMS is eventually used in infant nutrition,
the unmodified form may have greater appeal to caregivers due to its lack of chemical modification.
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Being an in vitro design, our study has inherent limitations. The high relative abundance of
Proteobacteria at 24 h of incubation, particularly in the controls, reflects a difference between in vitro
and in vivo conditions and suggests that in vitro conditions might have favoured the growth of
Proteobacteria. This also reflects that not all bacteria grow in vitro and faeces contain a large proportion
of dead bacteria which may not be representative of the living mucosal-adherent and/or luminal bacteria
in the gut. The limited availability of infant faecal inocula also precluded comparative evaluation of
the fermentation of the chosen RS to other substrates which may already be recognised as prebiotics in
infants, e.g., fructo-oligosaccharides (FOS). To circumvent this, it might have been possible to pool
the faecal samples from different donors. However, individual variation in the microbiota might be
greater than the effects of treatment.
A further limitation was that the actual degradation of the substrate in each ferment was not
measured. It is not uncommon for in vitro fermentation studies to omit this measurement, instead
relying, as we have done, on the products of fermentation and changes in microbial composition to
provide an estimate of fermentation. It should also be noted that, irrespective of the benefits to gut
health, RS may impact the nutritional status of the infant diet. Therefore, further studies are required
to determine a safe dose of RS for highly vulnerable populations, such as growing babies and children.
Ultimately, any claim to prebiotic status for HAMS during the infant period must be supported
by well-designed human studies. Inulin, fructo-oligosaccharides and galacto-oligosaccharides, the
subjects of several randomised controlled trials, are generally held to be the main substrates to have
prebiotic potential during infancy. However, these agents are costly to produce and, particularly in
the case of FOS and galacto-oligosaccharides (GOS) due to their small size, confer a luminal osmotic
effect and are rapidly fermented. These features carry the risk of precipitating undesirable clinical
effects, such as diarrhoea and abdominal discomfort. HAMS has several advantages. It can be readily
cultivated, is slowly fermented and does not produce an osmotic effect in the large intestine. It can also
be readily incorporated into foods without altering the processing or organoleptic properties [34].
5. Conclusions
This study confirms that faecal inocula, whether preweaning or at weaning infants has the
capacity to utilise HAMS and HAMSA as a potential substrate. Incubation with both starches
selectively stimulated Bifidobacterium copy numbers and increased the Bacteroidetes:Firmicutes ratio,
outcomes that, if replicated in direct feeding studies, may be associated with beneficial health outcomes.
These findings justify further in vivo infant studies to examine the short- and long-term effects of
different doses of HAMS during weaning on the composition and function of the emerging gut
microbiota and clinical outcomes.
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Appendix A
Appendix A.1. Pre-Digestion Method
5 g of test starch was accurately weighted into tubes (8) and incubated with 25 mL of pepsin
(1 g/mL, made up in 0.02 mol HCl/L, pH 2, for 30 min at 37 ◦C. The next phase of digestion was replicated
by neutralisation with sodium hydroxide (0.02 M) and incubation with 25 mL of amyloglucosidase
(200 U/mL) and alpha-amylase (1.5 U/mL) solution for 5 h in a shaking water bath at 37 ◦C. Following
the incubation, contents were pooled and transferred into a beaker containing 80% ethanol and left
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overnight. The supernatant was then removed and the residue was washed with 80% ethanol. This was
then centrifuged (2000× g for 10 min), followed by the removal of the supernatant. Washing with
alcohol, centrifuging and removal of the supernatant was repeated four times. Following air-drying
in the fume hood for another 24 h, the residue was collected for use in the small-scale batch in vitro
fermentation method. Only one batch of pre-digestion was performed for each substrate and this
provided sufficient amounts for all the required incubations.
Appendix A.2. DNA Extraction Method
DNA was extracted using the PowerMag Microbiome DNA Isolation kit (Qiagen, Hilden,
Germany) from a pooled sample containing 1 mL from each ferment replicate. No DNA was extracted
from ferments incubated with lactulose as human faecal microbiota of all age groups are recognised to
readily ferment lactulose. The purpose of incubation with the lactulose was only to confirm the viability
of the faecal microbiota from the particular participant. A sample of 1 mL from each of triplicate
ferments was transferred into three separate 2 mL Eppendorf tubes and centrifuged at 13,000× g at
4 ◦C for 5 min using a bench centrifuge (Eppendorf, Hamburg, Germany). Each resulting cell pellet
was retained and the supernatant discarded. Heated PowerMag Microbiome lysis solution (650 μL)
was added to the first of the three tubes (each containing the cell pellet) and mixed thoroughly. All the
solution was then transferred into the second tube, mixed, and the contents transferred into the third
tube, which was also subjected to vigorous mixing. Sterile 0.4 g PowerMag glass beads were added to
the final tube and the sample was homogenised for 3 min at maximum speed on a Mini-Beadbeater
(BioSpec Products, Bartlesville, OK, USA). The tube was then centrifuged for 5 min at 13,000× g at room
temperature. The supernatant was transferred into fresh PCR-grade 1.75 mL tubes. 30 μL of Proteinase
K was added to the supernatant, mixed and kept for 10 min at 70 ◦C. 30 μL of PowerMag Inhibitor
Removal Solution was then added to each sample and mixed well. The samples were incubated
at room temperature for 5 min and then were again centrifuged at 13,000× g and the supernatants
transferred to a fresh 2 mL Deep Well Plate, ensuring no transfer of any residual pellet. 5 μL of RNAse
was added to each well of this Deep Well Plate.
The extraction method was completed on the Eppendorf epMotion 5075TMX platform following
the manufactures instructions using the PowerMag Microbiome DNA Isolation kit. Reagents used
in this programme included Clear Mag Wash Solution, the Clear Mag Binding Solution and Clear
Mag Beads. Briefly, using the automated wash and elution protocol, beads and a binding solution
were added to each well and mixed together. In this process, the DNA would adhere to the beads
after which the plate was transported to a magnet and the waste removed. This process was repeated
3 times with the lysate and binding solution followed by an ethanol wash. Low heat was applied to
remove traces of ethanol and an elution buffer was added. This released the nucleic acids from the
beads and the elute was separated from the beads and stored at −80 ◦C.







Temp (◦C) Time (s)
Total Bacteria
UnivF TCCTACGGGAGGCAGCAGT








500 56 20 [37]Bifi-R CCACATCCAGCGTCCAC
Appendix A.3. qPCR
All qPCR analysis was performed on the CFX 384TM real-time PCR detection system (Bio-Rad,
Hercules). Reactions were performed in triplicate, with a total reaction volume of 10 μL. Each reaction
consisted of 3 μL (2.8 ng/μL) of DNA template and 7 μL PCR mixture containing 5μL of SYBR
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mix, bovine serum albumin (0.2 μL), forward (0.1 μL) and reverse primers (0.1 μL) (2.5 ng/μL) and
PCR-grade water (1.6 μL). The qPCR cycling conditions had an initial hot start at 98 ◦C for 3 min,
followed by 35 cycles of two step qPCR with denaturing at 98 ◦C for 15 s using the annealing/elongation
temperatures as in Table 1. Fluorescence intensities were detected during the last step of each cycle.
qPCR melting curves were obtained after amplification by continuously collecting fluorescence intensity
measurements as the reactions were slowly heated from 55 to 95 ◦C in increments of 0.50 ◦C/s.
Appendix A.4. Next Generation Sequencing
The methods outlined in Illumina’s “16S Metagenomic Sequencing Library Preparation” protocol
were followed [38] with adjustments made to PCR thermal cycle conditions, as detailed below.
The hypervariable region V4 of the 16SrRNA gene was amplified from the extracted DNA using
modified primer pairs with Illumina adapter overhang sequences. The full-length primer sequences
using standard IUPAC nucleotide nomenclature were:
16S Amplicon PCR Forward Primer =
5′-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGGTGCCAGCMGCCGCGGTAA-3′
Amplicon PCR Reverse Primer =
5′-TCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGGACTACHVGGGTWTCTAAT-3′
A two-step PCR process was required. The PCR reaction contained 5 μL of forward primer (1 nM),
5 μL of reverse primer (1 nM) and 12.5 μL of 2 × KAPA H-iFi Hotstart ReadyMix (KAPA Biosystems,
Wilmington, MA, USA) in a total volume of 25 μL. The PCR reaction was performed on a Veriti Thermal
Cycler (Thermo Fisher Scientific, Waltham, MA, USA) using the following programme: 25 cycles of
95 ◦C for 30 s, 55 ◦C for 30 s, 72 ◦C for 30 s followed by holding at 72 ◦C for a further 5 min. Following
a clean-up of the PCR product, indexing PCR was performed. This step used the Nextera XT Index
Kit to attach the dual indices and the Illumina sequencing adapters. The manufacturer’s instructions
were followed as described in the Illumina library preparation protocol, as mentioned above. The final
library was pair-end sequenced using a MiSeq Reagent Kit v3 on the Illumina MiSeq platform. Library
preparation and sequencing was performed at Flinders University, South Australia. A standard t-test
was used to compare the relative abundances of control and test groups at the different taxonomic
levels (see Table A2).
Table A2. Percent abundance of the dominant major bacterial taxa at each taxonomic level.
Taxonomy
Preweaning (n = 15) Weaning (n = 14)
Control HAMS p Value Control HAMS p Value mHAMS p Value
Phylum
Actinobacteria 12.50 15.48 0.35 10.16 18.55 0.004 17.88 0.004
Bacteroidetes 7.87 7.29 0.86 4.73 13.04 0.001 15.56 0.03
Firmicutes 33.33 37.74 0.09 33.5 32.51 0.79 34.37 0.11
Proteobacteria 46.23 39.39 0.17 51.27 35.76 0.001 32.06 0.004
Class/subclass
Actinobacteria 12.51 15.48 0.35 10.17 18.56 0.004 17.88 0.004
Bacilli 13.46 18.74 0.02 14.48 16.83 0.32 19.04 0.08
Bacteroidia 7.87 7.29 0.86 4.73 13.04 0.001 15.56 0.001
Clostridia 17.71 16.28 0.58 16.25 12.31 0.26 10.79 0.07
Gammaproteobacteria 46.10 39.13 0.17 50.69 35.19 <0.001 31.56 <0.001
Order
Bacteroidales 7.87 7.29 0.86 4.73 13.04 0.001 15.56 0.001
Bifidobacteriales 11.64 14.73 0.32 9.12 16.83 0.01 16.33 0.01
Clostridiales 17.71 16.27 0.58 16.24 12.30 0.26 10.79 0.07
Enterobacteriales 45.98 39.04 0.17 50.61 35.16 <0.001 31.51 <0.001
Erysipelotrichales 1.77 1.73 0.93 0.25 0.54 0.07 0.77 0.09
Lactobacillales 12.81 17.67 0.03 14.44 16.58 0.36 19.03 0.08
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Table A2. Cont.
Taxonomy
Preweaning (n = 15) Weaning (n = 14)
Control HAMS p Value Control HAMS p Value mHAMS p Value
Family
Bifidobacteriaceae 11.67 14.82 0.32 9.31 17.54 0.007 16.86 0.004
Bacteroidaceae 7.49 7.06 0.89 4.60 12.91 <0.001 14.34 0.002
Enterococcaceae 12.42 17.04 0.03 12.79 13.96 0.61 16.32 0.16
Clostridiceae 14.58 13.44 0.67 7.71 5.22 0.27 4.98 0.13
Erysipelotrichaceae 1.77 1.73 0.94 0.26 0.55 0.07 0.78 0.08
Peptostreptococcaceae 1.99 1.57 0.45 3.14 0.94 0.04 0.54 0.02
Ruminococcaceae 0.42 0.34 0.34 1.59 1.46 0.62 2.02 0.28
Enterobacteriaceae 46.12 39.19 0.17 51.19 35.88 <0.001 32.20 <0.001
Genus
Bacteroides 7.48 7.02 0.89 4.54 12.56 0.009 13.92 0.002
Bifidobacterium 11.64 14.73 0.32 9.12 16.83 0.006 16.33 0.006
Clostridium 14.53 13.38 0.67 7.44 5.09 0.27 4.78 0.11
Enterobacter 30.31 24.89 0.21 32.32 18.21 <0.001 15.02 <0.001
Enterococcus 12.40 16.99 0.03 12.72 13.75 0.65 16.12 0.18
Escherichia/Shigella 15.05 13.67 0.73 16.39 15.88 0.73 15.59 0.67
Ruminococcus 0.22 0.17 0.43 0.50 0.56 0.58 1.35 0.01
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Abstract: Most professional and international organizations recommend folic acid supplementation
for women planning pregnancy. Various studies have shown high levels of non-compliance with
this recommendation. This study aimed to identify sociodemographic characteristics related to this
compliance. The analyses were based on 16,809 women from the French nationwide ELFE cohort
(Etude Longitudinale Française depuis l’Enfance). Folic acid supplementation was assessed at delivery,
and sociodemographic characteristics were collected at two months postpartum. The association
between sociodemographic characteristics and compliance with recommendations on folic acid
supplementation (no supplementation, periconceptional supplementation, and supplementation only
after the periconceptional period) was examined using multivariate multinomial logistic regression.
Only 26% of French women received folic acid supplementation during the periconceptional period,
10% of women received supplementation after the periconceptional period, and 64% received
no supplementation. Young maternal age, low education level, low family income, multiparity,
single parenthood, maternal unemployment, maternal overweight, and smoking during pregnancy
were related to lower likelihood of folic acid supplementation during the periconceptional period
compared to no supplementation. These associations were not explained by unplanned pregnancy.
Immigrant and underweight women were more likely to receive folic acid supplementation after
the periconceptional period. Our study confirms great social disparities in France regarding the
compliance with the recommendations on folic acid supplementation.
Keywords: folic acid supplementation; pregnancy; epidemiology; social inequalities
1. Introduction
Neural tube defects are one of the most common congenital diseases in Europe [1] and,
in France, represent 1.3 cases (live births, fetal deaths, termination of pregnancy for fetal anomaly) per
1000 births [2]. Randomized trials have proved the efficacy of folic acid supplementation during the
periconceptional period in neural tube defects prevention [3–5].
Most professional and international organizations, including the World Health Organization,
recommend folic acid supplementation for women planning pregnancy [6,7]. However, the specifically
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targeted population groups (e.g., women of childbearing age, women planning pregnancy, women
of childbearing age without safe contraception) and the timing or duration of the supplementation
recommendations vary across countries. In North America, maternal folic acid intake is addressed by
the folic acid fortification of food products (flours, cereals) [8], whereas, in Europe, the prevention policy
is based on supplementation exclusively. In France, the latest guidelines from the Agency for Food,
Environmental, and Occupational Health & Safety reinforced the need for folic acid supplementation
for women within the periconceptional period (eight weeks before and eight weeks after conception)
to achieve a daily intake of 400 μg dietary folate equivalents [9].
The neural tube defects prevention policy based on folic acid supplementation during the
periconceptional period assumes that pregnancies are planned and that future mothers visit health
professionals before pregnancy. However, in Europe, 45% of pregnancies were unintended in 2012 [10],
and women from disadvantaged households tend to have lower access to health services, particularly
for preventive care [11–13].
Within this context, the objective of the present study was to identify sociodemographic
characteristics associated with compliance with recommendations on folic acid supplementation
to prevent neural tube defects in France, with a special focus on the timing of this supplementation,
on the basis of a national survey performed in 2011 on women giving birth.
2. Materials and Methods
2.1. Study Population
The present study was based on the ELFE study (Etude Longitudinale Française depuis l’Enfance),
a multidisciplinary study comprising a nationally representative birth cohort, which included
18,258 children born in 349 randomly selected maternity units in France in 2011 [14]. Inclusion
took place during 25 selected recruitment days over 4 waves encompassing 4 to 8 days each and all
4 seasons. Inclusion criteria were as follows: children born after 33 weeks of gestation, mothers aged
18 years or older and who were not planning to move outside of metropolitan France during the
following three years. Foreign families could also participate in the study if mothers were able to read
French, Arabic, Turkish, or English. Participating mothers signed informed consent for themselves
and their child. A total of 51% of contacted parents agreed to participate. Data were collected through
standardized interviews conducted by trained midwives and through self-completed questionnaires.
The follow-up of this birth cohort is ongoing.
The ELFE study was given ethical approval by the Advisory Committee for the Treatment
of Information on Health Research (Comité Consultatif sur le Traitement des Informations pour
la Recherche en Santé), the National Agency Regulating Data Protection (Commission National
Informatique et Libertés), and the National Statistics Council.
2.2. Maternal Characteristics
Mothers were first interviewed in the maternity ward after delivery, to collect information about
their pregnancy, their newborn, and their general characteristics (employment status, education
level, age). Two months post-partum, telephone interviews with mothers and fathers took place,
which included additional questions on demographic and socioeconomic characteristics such as
country of birth, educational level, employment, monthly income, and number of family members.
As family data were more comprehensively collected during the two-month-post-partum interview
than during the maternity interview and because family sociodemographic characteristics only
marginally evolved within two months, we prioritized data collected at two months in our analyses.
The sociodemographic characteristics collected during the maternity stay were used only in the case
of missing values in the two-months-post-partuminterview. Maternal characteristics included in
the analyses were: migration status (native French, immigrant, descendant of immigrants), age at
first delivery (18–25 years, 25–29 years, 30–34 years, ≥35 years), family type (traditional, stepfamily,
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one-parent family), educational level measured on the basis of the highest academic degree attained
(<secondary school, secondary school, high school, two-year university degree, ≥three-year university
degree), employment status (employed, housewife/parental leave, retired/disability/unemployed,
student, other), monthly family income (≤€1500, €1501–2300, €2301–3000, €3001–4000, €4001–5000,
>€5000), smoking status (never smoked, smoked only before pregnancy, smoked until early pregnancy,
smoked during the whole pregnancy), planned pregnancy, and fertility treatment.
2.3. Folic Acid Supplementation
Information on maternal folic acid supplementation was collected retrospectively at the maternity
unit during face-to-face interviews utilizing five questions: ‘Have you taken folic acid (also called
vitamin B9) before and/or during pregnancy (to prevent nervous system abnormalities)?’ ‘If yes,
indicate the periods of time you took it: one to three months before pregnancy (yes/no), in the first two
months of pregnancy (yes/no), between the second and sixth month of pregnancy (yes/no), beyond six
months of pregnancy (yes/no)’. Women were divided into three groups according to their folic acid
supplementation: supplementation during the periconceptional period (before pregnancy and/or first
two months of pregnancy), late supplementation (only after the second month of pregnancy), and no
supplementation. No information about family history of neural tube defects or folic acid supplements
dosages was collected.
2.4. Sample Selection
Women who withdrew consent within the first year (n = 128) or for whom it was not possible
to verify the eligibility criteria due to missing data (n = 350) were excluded from the study, resulting
in 17,574 eligible mothers. We also excluded women with missing data (n = 3418), leaving a total of
14,156 women in the main analyses.
2.5. Statistical Analyses
Comparisons between excluded and included subjects were conducted with chi-square tests.
In order to provide representative descriptive statistics of births in 2011 in France, the descriptive
data (rates) were weighted to consider the sampling design and biases related to non-consent. Weighting
also included calibration on margins from the state register of statistical data and the 2010 French
National Perinatal study [15] regarding the following variables: age, region, marital status, migration
status, level of education, and primiparity.
Associations between sociodemographic variables and folic acid supplementation were tested
by multivariable multinomial logistic regression, including maternal characteristics (maternal age at
first delivery, parity, family composition, migration status, education level, employment status, family
income, pre pregnancy body mass index (BMI), smoking status), and additionally adjusted for mothers’
region of residence, size of maternity unit, and wave of recruitment.
Several sensitivity analyses were performed. First, analyses were performed only for women
with planned pregnancy and without fertility treatment, in order to check that the associations
between familial characteristics and compliance with folic acid supplementation guidelines were
not driven by the specific cases of unplanned pregnancy or fertility treatment. Then, we calculated
weighted multivariate models. Afterward, using multiple imputations to deal with missing data on
sociodemographic variables, using the SAS software. We assumed that data were missing at random
and generated five independent datasets using the fully conditional specification method (MI procedure,
FCS statement, NIMPUTE option) and then calculated pooled effect estimates (MIANALYSE procedure).
Imputation model variables included both the potentially predicting non-response and the outcomes.
Categorical variables were imputed using a multinomial model, ordinal or binary variables using
logistic regressions, and continuous variables using linear regressions. Further details are available in
Supplementary Table S1.
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3. Results
Women excluded from our analysis were younger, more likely to be single, born in a country
other than France, had a lower education level, were less likely to be employed during pregnancy, and
had quit smoking before pregnancy compared to women included in our analysis (Table 1).
Table 1. Study sample characteristics.
Excluded Women Included Women p-Value
N 3418 14,156
Age at delivery (years) 29.4 (5.7) 30.4 (4.9) <0.0001
Birth order <0.0001
First child 43.7% (1491) 45.0% (6365)
Second child 33.5% (1142) 36.0% (5101)
Third child 14.3% (488) 13.8% (1949)
Fourth child or more 8.5% (291) 5.2% (741)
Single parenthood <0.0001
Yes 12.4% (414) 3.9% (548)
No 87.6% (2928) 96.1% (13,549)
Country of birth <0.0001
France 78.5% (2599) 88.9% (12,516)
Another country 21.5% (713) 11.1% (1568)
Education level <0.0001
Primary school 11.2% (376) 3.5% (491)
Secondary school 20.0% (673) 12.6% (1783)
General high school 11.2% (378) 7.2% (1023)
Technical/professional high school 15.7% (530) 12.3% (1741)
University 41.9% (1410) 64.4% (9116)
Employment status <0.0001
Employed 59.3% (1968) 72.7% (10,298)
Housewife/parental leave 2.5% (83) 3.4% (485)
Retired/disability/unemployed 11.9% (395) 12.0% (1702)
Student 21.7% (721) 10.1% (1424)
Other 4.6% (154) 1.7% (247)
Pre-pregnancy body mass index (kg/m2) 23.7 (5.1) 23.4 (4.7) 0.0138
Smoking status <0.0001
Never smoked 59.0% (1902) 56.7% (8020)
Smoked only before pregnancy 18.1% (585) 23.7% (3356)
Smoked only during early pregnancy 4.0% (130) 3.9% (559)
Smoker during the whole pregnancy 18.9% (608) 15.7% (2221)
Values are % (n).
The weighted rate of folic acid supplementation was 26.0% during the periconceptional period
and 9.9% for supplementation started only after the first two months of pregnancy. A total of 64.1% of
women did not receive folic acid supplementation before or during pregnancy.
Bivariable associations between maternal characteristics and folic acid supplementation are shown
in Table 2.
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Only (N = 1308)
p-Value
Age at first delivery <0.0001
<25 years 3611 74.9% 15.1% 9.6%
25–29 years 6134 59.9% 31.3% 8.7%
30–34 years 3412 50.7% 38.7% 9.8%
≥35 years 999 49.9% 39.3% 9.6%
Parity <0.0001
First child 6365 55.2% 35.4% 9.0%
Second child 5101 63.4% 26.9% 9.3%
Third child 1949 67.9% 21.8% 9.7%
Fourth child or more 741 78.4% 10.9% 10.1%
Family composition <0.0001
Traditional 12,499 59.7% 30.6% 9.2%
Single parenthood 532 80.7% 11.1% 8.8%
Stepfamily 1125 68.8% 20.9% 10.3%
Migration <0.0001
Native French 10,229 60.9% 30.1% 8.7%
First-generation immigrant 1582 64.0% 23.5% 11.7%
Second-generation immigrant 2345 61.7% 27.9% 9.7%
Educational level <0.0001
<Secondary school 999 76.9% 11.8% 10.1%
Secondary school 2010 75.3% 16.3% 8.9%
High school 2620 66.4% 23.9% 8.9%
Two-year university degree 3199 58.6% 31.8% 9.5%
Three-year university degree 2495 52.3% 37.8% 9.4%
≥Five-year university degree 2833 46.5% 43.4% 9.0%
Employment status <0.0001
Employed 10,298 57.0% 33.7% 9.0%
Student 485 61.8% 30.4% 8.7%
Unemployed 1702 68.5% 20.6% 11.2%
Housewife/parental leave 1424 74.6% 13.9% 9.6%
Other 247 71.8% 21.9% 6.9%
Family income <0.0001
<€1500/month 1417 78.4% 12.3% 9.2%
€1501–2300/month 2177 69.3% 19.5% 10.5%
€2301–3000/month 3974 61.4% 29.3% 9.1%
€3001–4000/month 3745 56.6% 33.8% 9.2%
€4001–5000/month 1551 50.0% 40.1% 9.1%
>€5000/month 1292 45.5% 45.9% 8.0%
Smoking status <0.0001
Never smoked 8020 59.7% 30.5% 9.3%
Smoked only before pregnancy 3356 56.7% 33.7% 9.0%
Smoked only during early pregnancy 559 68.8% 21.6% 10.7%
Smoked during the whole pregnancy 2221 72.2% 18.3% 9.1%
Planned pregnancy <0.0001
No 1203 74.6% 15.3% 10.1%
Yes 12,079 58.8% 31.6% 9.0%
Previous treatment for infertility <0.0001
No 12,915 63.0% 27.2% 9.4%
Yes 1105 42.4% 49.6% 7.4%
Values are n and weighted %. Chi-square tests on weighted data.
Women were less likely to take folic acid supplementation during the periconceptional period,
compared to no pre-conceptional supplementation, when they were younger, multiparous, single,
with low education level, low family income, unemployed during pregnancy, and smoked during
pregnancy (Table 3). Compared to mothers who had never smoked, women who had quit smoking
before pregnancy were more likely to take folic acid supplementation during the periconceptional
period, whereas the relationship was inverse for those women who smoked during the whole pregnancy.
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Table 3. Multivariate associations between sociodemographic characteristics and timing of folic acid
supplementation (n = 14,156).
Folic Acid Supplementation
(Reference = No Supplementation)
Periconceptional
Supplementation
Late Supplementation Only p-Value
Age at first delivery <0.0001
<25 years 0.72 [0.64–0.81] 1.04 [0.88–1.23]
25–29 years 1 [Ref] 1 [Ref]
30–34 years 1.23 [1.12–1.36] 1.32 [1.13–1.54]
≥35 years 1.30 [1.12–1.51] 1.33 [1.04–1.71]
Birth order <0.0001
First child 1 [Ref] 1 [Ref]
Second child 0.62 [0.57–0.68] 0.92 [0.80–1.05]
Third child 0.58 [0.51–0.66] 0.96 [0.80–1.17]
Fourth child or more 0.40 [0.32–0.51] 0.87 [0.66–1.16]
Family composition <0.0001
Traditional 1 [Ref] 1 [Ref]
Single-parenthood 0.73 [0.56–0.96] 0.80 [0.57–1.12]
Stepfamily 1.22 [1.04–1.43] 1.21 [0.97–1.51]
Migration <0.0001
Native French 1 [Ref] 1 [Ref]
Immigrant 0.90 [0.79–1.04] 1.31 [1.08–1.59]
Descendant of immigrant 0.92 [0.83–1.03] 1.07 [0.90–1.26]
Education level <0.0001
<Secondary school 0.47 [0.38–0.59] 0.73 [0.54–0.98]
Secondary school 0.51 [0.43–0.61] 0.67 [0.52–0.87]
High school 0.68 [0.60–0.79] 0.74 [0.59–0.93]
Two-year university degree 0.76 [0.68–0.86] 0.89 [0.73–1.09]
Three-year university degree 0.89 [0.79–1.00] 0.90 [0.74–1.11]
≥Five-year university degree 1 [Ref] 1 [Ref]
Employment status <0.0001
Employed 1 [Ref] 1 [Ref]
Retired/disability/unemployed 0.86 [0.75–0.98] 1.20 [1.00–1.45]
Housewife/parental leave 0.82 [0.69–0.97] 0.93 [0.74–1.16]
Other 0.84 [0.62–1.14] 0.64 [0.38–1.07]
Student 1.11 [0.90–1.37] 1.00 [0.71–1.41]
Monthly family income <0.0001
<€1500 0.62 [0.51–0.75] 0.89 [0.69–1.14]
€1501–2300 0.77 [0.68–0.89] 1.06 [0.87–1.28]
€2301–3000 1 [Ref] 1 [Ref]
€3001–4000 1.05 [0.94–1.16] 1.03 [0.87–1.22]
€4001–5000 1.10 [0.95–1.26] 0.98 [0.77–1.23]
>€5000 1.32 [1.13–1.54] 0.91 [0.69–1.19]
Pre-pregnancy body mass index <0.0001
<18.5 kg/m2 1.06 [0.91–1.23] 1.31 [1.05–1.63]
18.5–24.9 kg/m2 1 [Ref] 1 [Ref]
25.0–29.9 kg/m2 0.79 [0.71–0.88] 0.93 [0.79–1.10]
30 kg/m2 or more 0.72 [0.62–0.84] 0.96 [0.78–1.18]
Smoking status <0.0001
Never smoked 1 [Ref] 1 [Ref]
Only before pregnancy 1.10 [1.01–1.21] 1.04 [0.89–1.21]
Only during early pregnancy 0.72 [0.58–0.88] 1.09 [0.82–1.47]
During the whole pregnancy 0.68 [0.60–0.77] 0.89 [0.74–1.07]
Values are adjusted OR [95% CI]. Multivariate multinomial logistic regression, also adjusted for maternal region of
residence, size of maternity unit, and wave of recruitment.
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Women were more likely to start folic acid supplementation after the periconceptional period
when they were older, underweight before pregnancy, or immigrant.
The results were very similar when the specific weighting to deal with non-inclusion bias was
used in sensitivity analyses (Supplementary Table S2). Moreover, the results were not modified by
excluding women with an unplanned pregnancy and those with fertility treatment. In the analysis
by multiple imputation with five independent datasets, the findings were very consistent with those
described in our main analysis.
4. Discussion
The results from our study revealed that only 26% of French pregnant women received folic acid
supplementation during the periconceptional period. Moreover, we found that all dimensions related
to the socioeconomic level (young maternal age, low education level, employment status, income,
and single parenthood) were independently related to a lower odds ratio of pre-conceptional folic acid
supplementation. These associations remained after excluding women with an unplanned pregnancy
or those who had received fertility treatment.
In most countries in Europe, the rates of periconceptional supplementation are still low,
even though guidelines on this public health issue were introduced more than 15 years ago.
Most countries report folic acid supplementation rates of 25–35% during the periconceptional period [16].
In the Dutch Generation R cohort, 37% of women received folic acid supplementation within the
appropriate period [17]. The results were lower in Norway and Denmark, with 10% and 14% of women
receiving folic acid supplementation during the periconceptional period, respectively [18,19]. In France,
the results from the 2010 National Perinatal Survey indicated that 24% of women received folic acid
supplementation in the periconceptional period [20], which is consistent with the rate highlighted in
the present study. This low compliance with the folic acid supplementation guidelines could impair
the effectiveness of the current neural tube defects prevention policy, and some studies have indicated
that the implementation of the recommendations on folic acid supplementation is not clearly related to
a decrease in the incidence of neural tube defects [21–23].
Folic acid supplementation rates vary according to country, but sociodemographic variables
such as younger age of women and lower family income have consistently been associated with
lower rates of folic acid supplementation [17,18,24–26]. European supplementation policies similar
to those of France, without fortification policies, might, therefore, play a role in maintaining social
inequalities [27,28]. In our study, social inequalities in periconceptional folic acid supplementation
remained even when pregnancy planning was considered. This finding accentuates the poor preventive
care during early pregnancy of the most socially disadvantaged women. The main reasons may be
a decreased awareness in disadvantaged populations regarding this recommendation as well as their
lower use of health care facilities [29,30]. To address this issue in the Netherlands, a mass media
campaign was implemented in 1995 to increase the rate of folic acid supplementation [30].
Interestingly, in our study, women who stopped smoking before pregnancy were more likely
to have folic acid supplementation during the periconceptional period, suggesting that they were
probably more inclined to follow guidelines related to pregnancy and be involved in preventive
care. This situation may give some leads for further folic acid supplementation strategies, such as
considering the preventive prenatal care as a specific moment to address women’s general health
(nutrition, lifestyle, physical activity, smoking cessation).
Preventing neural tube defects by folic acid supplementation is a difficult goal to achieve,
as changes in behavior are difficult to generate, and the human reproduction period can be long [31].
Indeed, the time between planning a pregnancy and becoming pregnant may take several months or
even years, and women have first to achieve and maintain the objective of acid folic intake. To address
this issue, more than 40 countries have decided to fortify foods with folic acid, and this strategy
appears to be the most effective today [8,23,29,32]. This strategy could be particularly relevant for
young and low-income women, because these groups of women are more likely to have unplanned
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pregnancies and less likely to receive or respond to health-promotion messages [16]. Studies in Canada
suggest an improved efficacy of food fortification policies: while no effect on the incidence of neural
tube defects was observed after recommendations of folic acid periconceptional supplementation
between 1993 and 1997, a marked decrease in the incidence of neural tube defects was observed
after food fortification implementation in 1997 [8,23]. The target group of this fortification policy are
women of childbearing age, even though the general population has increased dietary folate intake [29].
This fortification strategy aims to supplement women continuously during their reproductive period,
reaching women with unplanned pregnancies, and to limit social inequalities in health [8,33]. In 2017,
a recommendation by the US Preventive Services Task Force (USPSTF) reinforced the importance
of folic acid supplementation for all women of childbearing age (even in the absence of planned
pregnancies) in addition to food fortification [34]. One of the disadvantages of this strategy concerns
elderly people. Indeed, high folate intake may mask anemia resulting from vitamin B12 deficiency,
which may cause neurological deterioration [35]. Moreover, there is a supposed relation between high
intake of folic acid and cancer risk (especially colorectal cancer), even though human epidemiological
data are inconclusive [36]. Even if voluntary fortification is very common in Europe (e.g., breakfast
cereals, dairy products, fruit juices), mandatory food fortification is not practiced in any European
countries mainly because of this cancer risk [36]. In France, systematic flour fortification with folic acid
was considered. A pilot study to assess risks and benefits was proposed in early 2000s but ultimately
was not launched. Our findings could contribute to this debate [37].
Some maternal characteristics, such as immigrant status and pre-pregnancy underweight status,
were specifically related to folic acid supplementation only after the periconceptional period. This could
be due to the fact that this late supplementation is not taken for the prevention of neural tube defects
but is started following treatment for other pregnancy issues. The WHO recommends daily oral iron
and folic acid supplementation among pregnant women to prevent maternal anaemia, puerperal
sepsis, low birth weight, and preterm birth [38]. In the ELFE study, women who had started folic acid
supplementation only after the periconceptional period were more likely to have haemoglobin levels
below 11 g/100 mL during pregnancy (15% vs 20%, p < 0.0001), compared to women who received folic
acid supplementation during the periconceptional period. Immigrant and underweight women are
probably more at risk of maternal anaemia [39] and low birth weight.
The ELFE cohort is a representative study of births from the year 2011 in metropolitan France
(excluding very premature babies), and descriptive statistics used weighted data to provide accurate
prevalence of folic acid supplementation. In our multivariate analysis of the association between
familial characteristics and folic acid supplementation, we excluded part of the sample because of
missing data. The comparison of the characteristics of the women included versus those of the women
excluded from the analysis showed that women with a higher educational level were overrepresented
in the study, which may have implications for generalizing the findings. However, in sensitivity
analyses based on multiple imputations of missing data, the results remained similar. Because women
were recruited at delivery, it is necessary to acknowledge that miscarriages or medical abortions
due to congenital malformations related to folic acid condition were not included in the present
study. The main strengths of the ELFE study include the large sample size and the wide range of
sociodemographic variables, which allowed us to demonstrate that various components of the social
background were related to compliance with folic acid supplementation guidelines. Unfortunately,
we were not able to distinguish between the timing patterns of folic acid supplementation related to
neural tube defects prevention from supplementation for other purposes. Moreover, as we did not
record the dose of folic acid consumed by women, we were not able to identify women with folic
acid intake higher than the tolerable upper limit of 1000 μg/day [40]. Finally, the study design did not
allow to assess the effect of such supplementation on birth outcomes as stillbirth, very premature birth,
and termination of pregnancy.
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5. Conclusions
Our study confirms low rates of folic acid supplementation during the periconceptional
period as well as great social disparities concerning the use of maternal periconceptional folic
acid supplementation. Therefore, it is important to find alternative methods, especially for vulnerable
populations, to increase the effectiveness of prevention policies by considering media campaign.
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Abstract: Undernutrition during early life may lead to obesity in adulthood. This study was
conducted to examine the relationship between famine exposure during early life and the risk of
abdominal obesity in adulthood. A total of 18,984 and 16,594 adults were surveyed in 2002 and
2010–2012 in two nationally representative cross-sectional surveys, namely China Nutrition and
Health Survey, respectively. The risk of abdominal obesity was evaluated for participants born during
1956–1961 and compared with that of participants born during 1962–1964. The overall prevalence of
abdominal obesity in adulthood showed a positive association with famine exposure during early
life. The odds ratios of famine exposure were 1.31 (1.19–1.44) and 1.28 (1.17–1.40) in 2002 during fetal
life and infancy and 1.09 (1.00–1.19) in 2012 during fetal life, respectively. The relationships between
famine exposure and abdominal obesity across the famine exposure groups were distinct among
females and those who lived in urban areas and were physical inactive (p < 0.05). Exposure to famine
during early life was associated with increased risks of abdominal obesity in adulthood, which was
partially alleviated by healthy lifestyle factors (e.g., physical activity).
Keywords: undernutrition; abdominal obesity; fetal; infant; adulthood
1. Introduction
Overweight and obesity, as well as abdominal obesity, in middle age are strongly related to all-cause
mortality and morbidity of chronic diseases such as diabetes and hypertension and other metabolic
diseases [1,2]. Several risk factors have been considered to be responsible for the development
of systemic obesity and abdominal obesity, such as diet, lifestyle, and genetic background [3].
The Developmental Origins of Health and Disease hypothesis suggests that [4–6] undernutrition
during early life may be associated with obesity. Nutritional status during critical window periods of
early life may have long-lasting effects on health in adulthood. Famine study is a commonly used
approach to test the hypothesis in humans. Undernutrition is considered as natural exposure in
a famine. For example, the Dutch ”hungry winter” famine and the Great Chinese Famine were used to
evaluate the “fetal origins” hypothesis [7].
Previous studies have primarily focused on the relationship between famine and body mass
index (BMI) and/or systemic obesity [8–12]. The relationship between early-life famine exposure and
waist circumference and/or abdominal obesity in later life has been less studied. Abdominal obesity is
a well-established risk factor for metabolic diseases, independent of BMI [13], and could influence the
risk for disease through increased insulin resistance [14]. Therefore, it is important to explore the risk
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factors of abdominal obesity. The Great Chinese Famine is an opportunity to evaluate the correlations
between famine exposure during early life and abdominal obesity in adulthood.
The Great Chinese Famine that occurred during 1959–1961 is one of the most disastrous catastrophes
in human history, resulting in 20–30 million deaths [15–17] throughout China. The Dutch famine
occurred within a well-nourished population and may have led to less severe effects on human
health [18]. In contrast, the Great Chinese Famine had longer duration, and food availability was more
severely curtailed nationwide. Thus, a greater impact of the Great Chinese Famine on adult health can
be expected than that of the Dutch famine. Therefore, national studies on the Great Chinese Famine
are good resources for investigating the relationship between famine and the subsequent effects of
malnutrition in early years on abdominal obesity and other chronic diseases and also for assessing
whether adult lifestyle would alter the effect of the famine.
Two nationally representative cross-sectional surveys were conducted 40 and 50 years after the
Great Chinese Famine in 2002 and 2010–2012 in China, respectively. These surveys could be good
sources for analyzing the relationship between famine and abdominal obesity in participants of middle
age and pre-elder age.
2. Participants and Methods
2.1. Design and Participants
Data were extracted from the China Nutrition and Health Survey (CNHS), a nationally
representative cross-sectional study on nutrition and chronic diseases. A stratified,
multistage probability cluster sampling design was used in this survey, which has been described
in detail previously [19]. In the present study, data from two surveys of CNHS conducted in 2002
and 2010–2012 were used to evaluate the long-lasting impact of famine on abdominal obesity, 40 and
50 years after the occurrence of the Great Chinese Famine, respectively. The study population
consisted of participants with date of birth (DOB) between October 1, 1956, and September 30, 1964.
To minimize misclassification of the exposure periods, participants with DOB between October 1, 1958,
and September 30, 1959, and between October 1, 1961, and September 30, 1962, were excluded because
the exact dates of the start and the end of the Chinese famine were not available in different regions.
The total sample size was 18,984 adults from CNHS 2002 and 16,594 adults from CNHS 2010–2012.
All procedures involving participants were approved by the Medical Ethics Committee at the National
Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention. All participants
provided their written informed consent.
2.2. Famine Exposure
Participants were categorized into the following three predefined groups according to their
DOB: (1) nonexposed, with DOB between October 1, 1962, and September 30, 1964, (2) fetal-exposed,
with DOB between October 1, 1959, and September 30, 1961, and (3) infant-exposed, with DOB between
October 1, 1956, and September 30, 1958. Mean ages of the participants in these three exposed groups
were respectively 38.6, 41.6, and 44.6 years in 2002 and 48.2, 51.2, and 54.1 years in 2010–2012.
Although the Great Chinese Famine affected the entire mainland of China, its severity varied
across provinces due to different weather conditions, population density, and local policies pertaining
to food shortage [20]. The severity of the famine was determined based on the excess death rate
(EDR) of each province [20]. Participants were classified into severe famine exposure group and
moderate famine exposure group based on residential provinces after excluding participants without
local permanent residency. The EDR was calculated as the percentage change in mortality rate from
the mean level in 1956–1958 to the highest value during the period 1959–1961 [20]. The median of the
EDR was used as the cutoff point, which was consistent with other studies [21]. Provinces with an EDR
equal to or above the cutoff point were categorized as severe famine exposure areas, and otherwise as
moderate famine exposure areas.
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2.3. Anthropometric Measurements
Anthropometric measurements included body weight, height, and waist circumference.
Height was measured using a stadiometer (model no. SG-210, Nantong yue kin cervix equipment Co.,
Ltd, Nantong, China) after removing shoes, and body weight was measured with light clothes using
a beam scale (model no. RGT-14-RT, Wuxi Weighing Factory Co., Ltd, Wuxi, China). Waist circumference
was measured using a waist circumference tape (model no.0403, Nanjing Kongki Commodity Co.,
Ltd, Nanjing, China) only after breathing out. The accuracy of the height, waist circumference,
and weight measurements was 0.1 cm, 0.1 cm, and 0.1 kg, respectively. The anthropometric
measurements were made according to standard anthropometric measurement methods in health
surveillance [22]. All anthropometric measurement staff were trained according to the standard
procedure. Standardized tests were conducted for all trainees, and only those being trained and passing
an examination were given a qualification certificate for conducting anthropometric measurements.
Each anthropometric measurement staffwas retested partially to ensure the inter-rater reliability for
each anthropometric measurement. Height and weight were used to calculate BMI, by dividing weight
(kg) by height squared (m2). Systemic obesity and abdominal obesity were defined using the Chinese
criteria of weight for adults [23]. Systemic obesity was defined as BMI ≥28 kg/m2. Overweight was
defined as BMI ≥24 and <28 kg/m2. Abdominal obesity was defined as waist circumference >90 cm in
men and ≥85 cm in women.
2.4. Covariates
Residential areas were classified into urban and rural. Physical activity was categorized into
active and inactive level, wherein regular exercise for >20 min each time, including various activities
such as running, swimming, and performing Tai Chi, was defined as active level. Current drinking
status and current smoking status were considered as dichotomous variables based on the answer in
the questionnaires (yes or no). Current drinking was defined as participants drinking alcohol in the
past year, irrespective of the amount drunk. Current smoking was defined as smoking regularly every
day or irregularly. Education level was categorized into dichotomous variable, where high school or
above was considered as high educational level, otherwise as low educational level.
2.5. Statistical Analyses
The SAS version 9.4 (SAS Institute Inc., Cary, NC, USA) was used for all statistical analyses,
and a two-sided p value <0.05 was considered to be statistically significant. Odds of abdominal obesity
for the fetal-exposed group and the infant-exposed group, compared with the nonexposed group,
were examined by the maximum likelihood method using the logistic regression model. Analyses were
adjusted for sex, residential areas, education level, marital status, household income, current drinking
status, current smoking status, and physical activity. To investigate whether the associations between
fetal and infant exposure to famine and abdominal obesity were affected by social environment in
later life, we subsequently stratified the analyses according to sex, residential areas, physical activity,
and education level. The odds ratios (95% confidence interval (CI)) of abdominal obesity in the
fetal- and infant-exposed groups compared with the nonexposed group were calculated within each
category of the stratified variables. The stratified variables were not adjusted in the corresponding
models. The odds ratios (95% CI) were plotted in a graph using Stata 13.0. Sensitivity analysis was
also performed in this study. First, we selected the 75th percentile of EDR as the cutoff point, and an
EDR of 150.0% was used to define the severity of famine for the purpose of distinguishing severely
and moderately severely affected famine areas more significantly. Second, participants with BMI
≥28.0 kg/m2 who were categorized as having systemic obesity according to the Chinese criteria were
excluded to prevent the interaction between systemic obesity and abdominal obesity.
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3. Results
Table 1 lists the basic characteristics of participants according to famine exposure. A total of 4352
(22.9%) and 6469 (34.1%) participants in CNHS 2002 and 4126 (24.9%) and 5975 (36.0%) participants
in CNHS 2010–2012 were exposed to the Great Chinese Famine during their fetal and infant period,
respectively. Compared with the nonexposed group, participants in the fetal-exposed group had
a significantly greater waist circumference in both 2002 and 2010–2012 (both p < 0.05 after Bonferroni
correction), whereas the infant-exposed group showed a greater waist circumference only in 2002.
The prevalence rates of abdominal obesity in nonexposed, fetal-exposed, and infant-exposed groups
were 15.5%, 19.4%, and 18.9% in 2002 and 31.6%, 33.3%, and 32.6% in 2010–2012, respectively.
Table 1. Characteristics of study population according to Chinese famine exposure.
All Nonexposed Fetal-Exposed Infant-Exposed
Birth date 1962.10–1964.9 1959.10–1961.9 1956.10–1958.9
Recruitment in 2002
N, % 18984 8163 (43.0) 4352 (22.9) 6469 (34.1)
Moderately exposed, % 40.7 37.8 45.8 41.0
Severely exposed, % 59.3 62.2 54.3 59.0
Age, years, mean (SD) 41.3 (2.6) 38.6 (0.6) 41.6 (0.6) 44.6 (0.6)
Female (%) 55.2 55.8 55.4 54.3
Height, cm, mean (SD) 160.9 (8.2) 161.2 (8.2) 161.0 (8.1) 160.4 (8.2) *
Weight, kg, mean (SD) 60.7 (10.8) 60.6 (10.8) 61.3 (10.9) * 60.4 (10.8)
WC, cm, mean (SD) 78.2 (9.5) 77.7 (9.4) 78.8 (9.6) * 78.5 (9.6) *
BMI, kg/m2, mean (SD) 23.4 (3.3) 23.2 (3.2) 23.6 (3.4) * 23.4 (3.4) *
Overweight (%) 38.2 36.3 41.3 38.4
Obesity (%) 8.9 8.2 9.7 9.4
Pre-central Obesity (%) 31.6 29.5 33.8 32.8
Central Obesity (%) 17.6 15.5 19.4 18.9
Recruitment in 2012
N, % 16594 6493 (39.1) 4126 (24.9) 5975 (36.0)
Moderately exposed, % 50.8 49.5 55.5 49.0
Severely exposed, % 49.2 50.5 44.5 51.0
Age, years, mean (SD) 51.1 (2.7) 48.2 (0.9) 51.2 (0.9) 54.1 (1.0)
Female (%) 57.8 58.7 56.7 57.5
Height, cm, mean (SD) 160.4 (8.1) 160.7 (7.9) 160.5 (8.0) 160.0 (8.2) *
Weight, kg, mean (SD) 62.8 (10.7) 63.1 (10.7) 63.0 (10.7) 62.2 (10.7) *
WC, cm, mean (SD) 82.8 (9.8) 82.6 (9.8) 83.1 (9.7) * 82.7 (9.8)
BMI, kg/m2, mean (SD) 24.3 (3.4) 24.4 (3.4) 24.4 (3.4) 24.2 (3.4) *
Overweight (%) 51.3 51.8 52.1 50.3
Obesity (%) 13.7 14.5 13.8 12.8
Pre-central Obesity (%) 52.5 51.8 53.8 52.4
Central Obesity (%) 32.4 31.6 33.3 32.6
WC: Waist circumference. BMI: Body mass index. Overweight, systemic obesity, and central obesity were defined
using the Chinese criteria for adults. Moderately exposed was defined as an excess death rate lower than 50.0%.
* p < 0.05 (Bonferroni correction); statistical significance was compared with the nonexposed group (October 1962 to
September 1964).
Table 2 shows the associations of famine exposure with abdominal obesity risk and the stratified
analysis according to famine severity. In general, the prevalence of abdominal obesity in 2010–2012
was higher than that in 2002 in each group. Compared with the nonexposed group (1962.10–1964.9),
participants had a significantly higher prevalence of abdominal obesity in both 2002 and 2010–2012
with an odds ratio (95% CI) of 1.31 (1.19–1.44) and 1.09 (1.00–1.19) in the fetal-exposed group
(1959.10–1961.9) and only in 2002 with an odds ratio (95% CI) of 1.28 (1.17–1.40) in the infant-exposed
group (1956.10–1958.9). After stratification of the study areas according to famine severity, participants
showed a significantly higher prevalence of abdominal obesity in severely affected famine areas in
both 2002 and 2010–2012 with an odds ratio (95% CI) of 1.32 (1.14–1.52) and 1.13 (1.01–1.27) in the
fetal-exposed group; in the infant-exposed group, the higher prevalence of abdominal obesity was
statistically significant only in 2002 compared with that in the nonexposed group. All odds ratios were
adjusted for sex, residential areas, education level, marital status, household income, current drinking
status, current smoking status, and physical activity.
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Table 2. Associations of famine exposure with central obesity risk in different severity of famine areas
Nonexposed Fetal-Exposed Infant-Exposed
Central Obesity in 2002
Waist circumference (cm) 77.7 (9.4) 78.8 (9.6) 78.5 (9.6)
Prevalence (%) 15.5 19.4 18.9
Odds ratio (95% CI) 1.00 (Ref) 1.31 (1.19–1.44) 1.28 (1.17–1.40)
p <0.0001 <0.0001
Stratified by famine severity
Moderately exposed
Waist circumference (cm) 78.5 (9.6) 79.5 (9.9) 79.8 (9.9)
Prevalence (%) 18.0 22.4 23.2
Odds ratio (95% CI) 1.00 (Ref) 1.32 (1.14–1.52) 1.40 (1.23–1.60)
p 0.0002 0.0075
Severely exposed
Waist circumference (cm) 77.1 (9.2) 78.2 (9.3) 77.5 (9.2)
Prevalence (%) 14.0 17.0 15.9
Odds ratio (95% CI) 1.00 (Ref) 1.24 (1.08–1.42) 1.17 (1.03–1.32)
p 0.0022 0.0139
Central Obesity in 2012
Waist circumference (cm) 82.6 (9.8) 83.1 (9.7) 82.7 (9.8)
Prevalence (%) 31.6 33.3 32.6
Odds ratio (95% CI) 1.00 (Ref) 1.09 (1.00–1.19) 1.04 (0.97–1.13)
p 0.0493 0.2823
Stratified by famine severity
Moderately exposed
Waist circumference (cm) 82.9 (9.9) 83.2 (9.9) 82.9 (9.7)
Prevalence (%) 33.0 33.5 33.6
Odds ratio (95% CI) 1.00 (Ref) 1.03 (0.91–1.17) 1.02 (0.91–1.15)
p 0.6473 0.7145
Severely exposed
Waist circumference (cm) 82.4 (9.7) 82.9 (9.5) 82.6 (9.8)
Prevalence (%) 30.6 33.2 31.9
Odds ratio (95% CI) 1.00 (Ref) 1.13 (1.01–1.27) 1.05 (0.95–1.16)
p 0.0331 0.3327
All odds ratios used the nonexposed group as the reference. Odds ratio (95% CI): adjusted for sex,
residential areas, education level, marital status, household income, current drinking status, current smoking status,
and physical activity.
Table 3 shows the results of the sensitivity analysis. The severely affected famine areas were
defined as those with an EDR ≥150% (sensitivity analyses A). Participants who were born in severely
affected famine areas had a significantly higher prevalence of abdominal obesity in both 2002 and
2010–2012 in the fetal–exposed group. In the infant-exposed group, the higher prevalence of abdominal
obesity was statistically significant only in 2002.
In addition, participants with BMI ≥28 kg/m2 were excluded in sensitivity analyses B. The results
of the fetal-exposed group were similar to those in sensitivity analyses A. After excluding the effect of
systemic obesity, the rate of abdominal obesity was higher in the severely affected famine areas than
that in the moderately severely affected famine areas in 2010–2012.
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Table 3. Associations of famine exposure with central obesity risk in different severity of famine areas:
sensitivity analyses.
Nonexposed Fetal-Exposed Infant-Exposed
Central Obesity in 2002
Sensitivity analyses A
Moderately exposed
Prevalence (%) 17.0 20.4 20.9
Odds ratio (95% CI) 1.00 (Ref) 1.26 (1.13–1.41) 1.33 (1.20–1.47)
p <0.0001 <0.0001
Severely exposed
Prevalence (%) 11.7 15.0 11.3




Prevalence (%) 11.0 13.8 15.2
Odds ratio (95% CI) 1.00 (Ref) 1.26 (1.13–1.41) 1.33 (1.20–1.47)
p <0.0001 <0.0001
Severely exposed
Prevalence (%) 8.2 11.0 9.6
Odds ratio (95% CI) 1.00 (Ref) 1.28 (1.01–1.62) 0.93 (0.75–1.16)
p 0.0411 0.5348
Central Obesity in 2012
Sensitivity analyses A
Moderately exposed
Prevalence (%) 32.3 32.7 32.9
Odds ratio (95% CI) 1.00 (Ref) 1.02 (0.93–1.12) 1.01 (0.93–1.10)
p 0.6629 0.8198
Severely exposed
Prevalence (%) 29.5 35.8 31.7




Prevalence (%) 22.4 22.2 23.7
Odds ratio (95% CI) 1.00 (Ref) 0.98 (0.84–1.15) 1.06 (0.92–1.22)
p 0.8308 0.4090
Severely exposed
Prevalence (%) 21.1 25.2 23.9
Odds ratio (95% CI) 1.00 (Ref) 1.27 (1.11–1.45) 1.17 (1.04–1.32)
p 0.0005 0.0102
Sensitivity analyses A: Defining severity of famine according to excess death rate 150%; Sensitivity analyses B:
Excluding participants with BMI≥ 28.0 kg/m2. All odds ratios used the nonexposed group as the reference. Odds ratio
(95% CI): adjusted for sex, residential areas, education level, marital status, household income, current drinking
status, current smoking status, and physical activity.
In CNHS 2002 and CNHS 2010–2012, the risk of famine exposure associated with abdominal obesity
was detected among female, inactive participants, those who lived in urban areas, and those with
high level of education (Figure 1). The results were adjusted for sex, residential areas, education level,
marital status, household income, current drinking status, current smoking status, and physical activity.
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Figure 1. Subgroup analyses of the association between central obesity and famine exposure groups.
(a) Associations of famine exposure with central obesity risk by sex; (b) Associations of famine
exposure with central obesity risk by area; (c) Associations of famine exposure with central obesity
risk by physical activity; (d) Associations of famine exposure with central obesity risk by education
level. Model adjusted for sex, residential areas, education level, marital status, household income,
current drinking status, current smoking status, and physical activity. Stratified variables were not
adjusted in the corresponding models. CI, confidence interval. All odds ratios used the nonexposed
group as the reference.
4. Discussion
Based on two nationally representative studies, the present investigation found that exposure to
the Great Chinese Famine during early life increased the risk of abdominal obesity in later adulthood,
especially among female, inactive participants, those who lived in urban areas, and those with high
education level. The risk of abdominal obesity had a longer lasting effect on those who experienced
the Great Chinese Famine in their fetal period. Current unhealthy lifestyle factors would exacerbate
the effect of early-life exposure to famine on abdominal obesity.
Low birth weight has been considered to be a risk factor for obesity in adults, which indicated
that exposure to famine during early life might increase the risk of obesity in adulthood [8,9].
Some studies reported that fetal or infant exposure to famine could reduce the risk of systemic obesity
in adulthood [10,11]. In addition, a few studies have reported that there was no association between
famine exposure during some stages of early life and later obesity [12]. However, these previous studies
were different in terms of the duration of famine exposure and famine severity, and the recruitment
periods were also inconsistent. For example, compared with the Dutch famine (one winter), the Chinese
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famine lasted longer (3 years) and was more severe. Furthermore, abdominal obesity was more harmful
to metabolic diseases than systemic obesity. Because no study had evaluated the association between
Chinese early-life famine exposure and abdominal obesity in adulthood during different life stages,
data from CNHS 2002 and 2012 were an opportunity to fill the gap.
The fetal origin of adult disease hypothesis, also referred to as the Barker hypothesis, proposed that
alterations in fetal nutrition and endocrine status lead to developmental adaptations that permanently
change the body structure, physiology, and metabolism, thereby predisposing individuals to
cardiovascular, metabolic, and endocrine diseases in adult life [4–6]. Several precise mechanisms
might explain the associations between fetal famine exposure and risk of abdominal obesity in later
life. First, early-life malnutrition might alter the neuroendocrine function, including induction of the
hypothalamic–pituitary–adrenal cortical axis, which results in excessive secretion of glucocorticoids and
fat accumulation in later life [24,25]. Second, a probable mechanism is that nutritional deprivation in
early life affects the expression of related genes and would change the dietary behavior. Evidence from
the Dutch famine study has suggested that prenatal exposure to famine would increase the preference
for fatty food and might contribute to more atherogenic lipid profiles in later life, such as belly
fat [26]. Third, findings from epigenetic studies have suggested that early malnutrition could lead
to abnormal DNA methylation of genes, which was associated with obesity and insulin resistance
in adulthood [27]. The above mentioned abnormalities could result in excessive fat deposition.
Furthermore, hypertension, diabetes, and coronary heart disease were found to be associated with
early-life malnutrition, indicating a relationship between famine exposure and obesity in adulthood [28].
The adaptive sex ratio adjustment hypothesis suggested that mothers who experience nutritional
stress would be more likely to give birth to female babies. This is because nutrition cost was less
expensive for female babies than for male babies, and female babies had a better opportunity to survive
in the harsh environment [29]. Male survivors may have “acceptable” nutrition exposure during early
life because vulnerable male babies were difficult to survive. On the other hand, male survivors may
also be associated with the culture of son preference in China [30]. Famine might predispose female
survivors to the risk of developing chronic degenerative diseases in adulthood, including obesity.
Evidence has shown that undernutrition during early life had larger long-term impacts on females
than on males [24,31,32]. Consistent with these findings, our study has also demonstrated a higher
prevalence of abdominal obesity among female survivors in the Great Chinese Famine.
A mismatch between early life and adult life environment may explain the association between
famine exposure and risk of abdominal obesity [33–35]. Nutrition restriction during early life and
exposure to a “rich” environment (rich nutrition, high socioeconomic status, etc.) in later life might
increase an individual’s susceptibility or risk of developing obesity and other chronic diseases.
Data from the CNHS 2002 showed that modern diet exacerbated the effects of famine in relation
to diabetes and hypertension [21,36]. In the present study, participants who lived in urban areas
or had a high education level had an increased risk for abdominal obesity across fetal and infant
famine exposure groups, which might also be attributed to the modernized life. It has been suggested
that people who lived in urban areas and had a high education level were more likely to have
a high-energy-dense western dietary pattern in China [19,37,38]. Furthermore, the present study
results have demonstrated that the adverse effects of undernutrition during early life were likely to be
exacerbated by unhealthy lifestyle factors during later adulthood. Unhealthy lifestyle in the fetal- and
infant-exposed groups, including inadequate levels of physical activity, imposed an increased risk of
abdominal obesity compared to that in the nonexposed group. These findings further highlighted the
importance of a healthy lifestyle in the prevention of adult chronic diseases.
The association between famine exposure and abdominal obesity disappeared in the 2010–2012
survey, such as in rural participants and those with low education level. The significant association
existed for the female participants, but the odds ratio became smaller. Overall, the association was
attenuated among participants, except for physically inactive participants in 2010–2012. This might be
related to the trajectory of the human body shape over the course of the lives. Zhai et al [1] showed
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that the waist circumference of Chinese adults increased gradually during early age, whereas it began
to decline with aging. The trajectory was slightly different between gender, wherein males began
to develop a thinner body shape in their 40s and females did so in their 50s. This phenomenon
could explain why the association disappeared among males in their 50s but remained in the females.
The trajectory of the human body shape could also explain the change in other subgroups, such as
the residential area and the education group. The risk of abdominal obesity in participants living in
urban areas and having a high education level was still steady and might be related to their exposure
to a “rich” environment in later life. However, rural participants with a low education level showed
a declining trajectory of waist circumference in the absence of exposure to a “rich” environment.
This study has some limitations. First, the lack of birth weight data might be a concern.
However, fetal programming could also occur without any marked effects on birth size [39], and hence
this was not considered as a major limitation. Second, the Chinese famine affected almost the entire
country. Therefore, participants had to be classified into different groups based on their birth date rather
than exposure areas or nonexposure areas. Despite these limitations, our research also had irreplaceable
advantages. The Great Chinese Famine lasted much longer and affected more people than other
famines. This study could also demonstrate further convincing results. Data from two large, nationally
representative cross-sectional surveys conducted 40 and 50 years later in 2002 and 2010–2012 after the
Chinese famine were used in this study along with detailed information regarding sociodemographic
characteristics, lifestyle factors, and birthplace. Therefore, our research provides valuable evidence
on the hypothesis of the combined association between early-life famine exposure and later life
environment and the risk of abdominal obesity in adulthood. In addition, undernutrition during
early life was associated with metabolic diseases, including metabolic syndrome, diabetes mellitus,
and stroke, which would occur around the age of 60 years. In future, more studies investigating the
abovementioned diseases are warranted. Furthermore, China might face a high incidence of metabolic
diseases in the forthcoming years.
5. Conclusions
Early-life exposure to the Great Chinese Famine exacerbated the risk of abdominal obesity,
especially in females or those who lived in urban areas or were physically inactive. A healthy lifestyle
might partially alleviate the adverse effects. The results suggest that promoting a healthy lifestyle
should be considered as a critical strategy for the prevention of chronic diseases in adult life.
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Abstract: The in utero and early postnatal environments play essential roles in offspring growth and
development. Standardizing or reducing pup litter size can independently compromise long-term
health likely due to altered milk quality, thus limiting translational potential. This study investigated
the effect reducing litter size has on milk quality and offspring outcomes. On gestation day 18,
dams underwent sham or bilateral uterine vessel ligation surgery to generate dams with normal
(Control) and altered (Restricted) milk quality/composition. At birth, pups were cross-fostered onto
separate dams with either an unadjusted or reduced litter size. Plasma parathyroid hormone-related
protein was increased in Reduced litter pups, whereas ionic calcium and total body calcium were
decreased. These data suggest Reduced litter pups have dysregulated calcium homeostasis in
early postnatal life, which may impair bone mineralization decreasing adult bone bending strength.
Dams suckling Reduced litter pups had increased milk long-chain monounsaturated fatty acid and
omega-3 docosahexaenoic acid. Reduced litter pups suckled by Normal milk quality/composition
dams had increased milk omega-6 linoleic and arachidonic acids. Reduced litter male adult offspring
had elevated blood pressure. This study highlights care must be taken when interpreting data from
research that alters litter size as it may mask subtle cardiometabolic health effects.
Keywords: reduced litter size; postnatal calcium homeostasis; adult bone health; milk composition
1. Introduction
It is well known that the in utero and early postnatal environments play crucial roles in offspring
growth, development and long-term health. David Barker first demonstrated a causal link between size
at birth and later-life cardiovascular disease [1,2], which has been since expanded to include several
adverse pregnancy perturbations, including fetal growth restriction [3,4], maternal undernutrition [5,6],
maternal alcohol consumption [7,8] and maternal stress [9,10]. Postnatal growth rate and development
is directly proportional to the quality and quantity of milk produced and is particularly influenced by
fatty acid composition [11]. Specifically, high intakes of omega-3 fatty acids in early postnatal life is
associated with reduced fat deposition and improved cardiometabolic health [12,13].
More recent experimental studies have demonstrated that altered maternal nutrition during the
lactation period can program adult offspring cardiometabolic disease. Specifically, pups suckled by
Nutrients 2019, 11, 118; doi:10.3390/nu11010118 www.mdpi.com/journal/nutrients130
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dams fed a cafeteria diet during lactation exhibit a “thin-outside-fat-inside phenotype” (lean with
increased abdominal fat) and impaired metabolic health in adulthood [14]. Whereas, male offspring
cross-fostered onto a dam fed an isocaloric low-protein diet (6% protein) throughout pregnancy and
lactation have increased blood pressure and renal dysfunction [15,16]. As milk is the sole source of
nutrition during early postnatal life, these studies strongly support a role for altered milk quality
and/or quantity as a mechanism through which maternal nutritional status during lactation influences
offspring disease.
In the developmental programming field, many researchers standardize or reduce litter size at
birth to normalize milk intake across pups and cohorts [17], with the degree of litter size reduction
dependent on the experimental model and research question [18–25]. A previous study identified
that pup body weight and development during lactation is dependent on litter size at birth [26],
which the authors hypothesize is likely due to mutual maternal and offspring adjustment to a
genetically determined litter size [26]. This suggests that studies that cull pups to standardize litter
size have the potential to disturb this biological process and that the original litter size may continue
to have some influence on offspring development. In line with this, we previously demonstrated that
reducing the litter size of healthy Wistar Kyoto (WKY) rat dams at birth (from 10–14 pups per litter to
5 pups per litter) decreases offspring body weight during early life and increases adult male blood
pressure likely due to mesenteric artery stiffness and compromises bone health [27–31]. Whereas,
severely reducing litter size to 3 pups (inducing early postnatal overnutrition) increases offspring body
weight by weaning, alters cardiac structure and function and programs poor metabolic health [32,33].
Thus, there is a need to better understand the impact of reducing litter sizes to differing extents on the
subsequent outcomes of the pups.
The mechanism behind this disease programming due to reducing litter size is likely due to
its effect on milk composition. Specifically, we have recently demonstrated that both the dam and
pup can modulate the maternal milk composition [34]. Thus, dams suckling growth restricted pups
have improved milk fatty acid composition (characterized by increased LC-polyunsaturated fatty
acid (PUFA) and LC-monounsaturated fatty acid (MUFA)), which is likely to be a compensatory
mechanism aimed at supporting pup growth and organ development [34]. This finding suggests that
the decreased pup milk intake, rather than poor milk quality, results in the aforementioned long-term
disease [27–29]. Therefore, it is possible that reducing litter size at birth to 5 pups (similarly to the
reduction in litter size we observe following uteroplacental insufficiency surgery) can itself induce
changes in the early postnatal environment that has consequences for adult health outcomes and may
thus mask or exacerbate any offspring outcomes due to adverse pregnancy and/or lactational events.
Therefore, the aim of this study was to investigate the effect of reducing litter size at birth on
pup postnatal growth and development, mammary development and maternal milk composition.
We additionally characterized if there were sex-specific differences in long-term cardiometabolic and
bone health outcomes due to reducing litter size at birth and whether these outcomes were exacerbated
if the pup was suckled by a dam with altered milk quality/composition.
2. Materials and Methods
2.1. Animals
All experiments were approved by The University of Melbourne’s animal experimentation ethics
sub-committee (AEC: 02081) following the National Health and Medical Research Councils (NHMRC)
Australian code for the care and use of animals for scientific purposes. Female WKY rats (9 to
13 weeks of age) were obtained from the Animal Resources Centre (Canning Vale, WA, Australia)
and provided with a 12-h light/dark cycle at 19–22 ◦C with ad libitum access to food and water.
To generate rats with ‘normal’ and ‘altered’ milk quality/composition, rats were mated and surgery
performed on day 18 of gestation (term = 22 days) as described previously [35]. Briefly, F0 pregnant
rats were randomly allocated to a sham (Normal milk quality/composition; Control; n = 7–8 per
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group) or uteroplacental insufficiency (Altered milk quality/composition; Restricted; n = 8 per group)
group, that experience premature lactogenesis [30], and were anaesthetized with 4% isoflurane and
650 mL/min oxygen flow (reduced to 3.2% isoflurane and 250 mL/min oxygen flow when suturing to
aid in the animals recovery) to reduce the duration of anesthetic exposure and aid in recovery [35].
Rats were then allowed to deliver naturally (Figure 1a). Pups from the sham (Control) operated
dams were cross-fostered 1 day after birth (PN1) randomly onto separate dams (Control or Restricted)
where the litter size was unaltered from the surrogate (Standard) or reduced to 5 pups (Reduced)
giving rise to four experimental groups (Figure 1b); Standard litter size suckled by Normal milk
quality/composition dams (mean litter size 10.38; range 9–12 pups), Reduced litter size suckled by
Normal milk quality/composition (mean litter size 5.00; range 5 pups), Standard litter size suckled
by Altered milk quality/composition dams (mean litter size 11.50; range 7–15 pups) and Reduced
litter size suckled by Altered milk quality/composition (mean litter size 6.00; range 3–9 pups) with
n = 15–18 dams per group [17,31,36–38]. Birth weight (3.5 ± 0.4 g vs. 4.0 ± 0.04 g for Restricted and
Control dams, respectively) and litter size (8.5 ± 0.4 pups vs. 11.1 ± 0.4 pups for Restricted and Control
dams, respectively) of pups born to ligation surgery (Restricted; Altered milk quality/composition)
dams was reduced compared to sham-operated (Control; Normal milk quality/composition) dams.
 
(a) (b) 
Figure 1. Study design. (a) Pregnant Wistar Kyoto (WKY) rats underwent Sham (white) or
uteroplacental insufficiency (UPI; grey) surgery on day 18 of gestation (E18) and allowed to
deliver naturally at birth. (b) On postnatal day 1 (PN1) pups from the Sham surgery dams were
cross-fostered onto separate Sham (with Normal milk quality/composition) or UPI (with Altered milk
quality/composition) dams with either an intact or reduced litter size.
2.2. Study 1: Postnatal Study
On the morning of PN6, one cohort of pups were removed from their dam and weighed, killed via
decapitation, and blood was collected and pooled within litters. Aprotinin (Sigma-Aldrich; Castle Hill,
NSW, Australia) was added to the tubes used for plasma PTHrP analysis [39]. One pup per litter
was frozen whole and stored at −20 ◦C for whole body calcium analysis. Pup stomach contents were
collected for fatty acid analysis. Dams were anaesthetized (Ketamine (50 mg/kg; Parnell Laboratories,
Alexandria, NSW, Australia) and Ilium Xylazil-20 (10 mg/kg; Troy Laboratories, Glendenning, NSW,
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Australia)) 4–6 h after removal of the pup to allow milk to accumulate and milk was collected
following gentle massage of the left mammary gland and teats without the need for hormonal
stimulation [40], then euthanized by cardiac puncture with blood collected for subsequent analysis.
The mammary glands were dissected, weighed and the right mammary gland immediately snap
frozen in liquid nitrogen or fixed in 10% neutral buffered formalin (Perrigo; Balcatta, WA, Australia)
for histological analysis.
2.2.1. Mammary ‘Real-Time’ PCR and Histology
‘Real-time’ PCR was used to quantitate milk protein gene expression in mammary tissue on PN6
as described previously with n = 3–7 dams per group [30]. Briefly, RNA was extracted from mammary
tissue using the Polytron PT 3100 (Biolab; Clayton, VIC, Australia) homogenizer and a commercially
available kit (RNeasy Lipid Tissue Mini Kit from Qiagen; Chadstone, VIC, Australia). RNA was
then DNase treated using the Ambion DNA free kit (Life Technologies; Mulgrave, VIC, Australia).
First strand cDNA was generated from 1 μg RNA using the Superscript II Single Stranded cDNA kit
(Life Technologies). qPCR was performed then conducted against the milk protein genes Pthrp, b-casein
and a-lactalbumin with Ribosomal 18S as the reference gene [34]. The reaction was activated by heating
the mixture to 95 ◦C for 10 min, then ‘Real-time’ PCR reactions were ran for 40 cycles of 95 ◦C for 15 s
and 60 ◦C for 60 s. For relative quantification of gene expression, a multiplex comparative threshold
cycle method was employed [35]. 18S values were not different between treatments.
Fixed mammary tissue was processed into paraffin blocks, sectioned at 5 μm and stained with
hematoxylin and eosin (n = 4–5 per group). Five sections per sample were analyzed for alveolar
area and number using ImagePro Software (Medai Cybernetics; Warrendale, PA, United States of
America) [40].
2.2.2. PTHrP, Corticosterone, Calcium and Electrolyte Measurements
Plasma, milk and mammary tissue concentrations of PTHrP were quantified by a N-terminal
radioimmunoassay with a minimum detection limit of 2 pmol/L, and intra- and inter-assay coefficients
of variation of 4.8% and 13.6% respectively with n = 7–9 per group [41]. Plasma corticosterone was
measured by enzyme immunoassay validated for direct measurements in diluted plasma following
the manufacturer’s protocol (Cayman Chemical; Ann Arbor, MI, United States of America) with a
minimum detection limit of 30 pg/mL, and intra- and inter-assay coefficients of variation of 7.4% and
7.0% respectively (n = 4–8 per group). Total calcium concentrations were determined using colorimetric
spectrometry using the Synchron CX-5 Clinical System (Beckman Coulter; Lane Cove, NSW, Australia)
and ionic calcium (active or free calcium; regulated by PTHrP), sodium and potassium concentrations
were determined using ion selective electrodes correcting for pH (Ciba-Corning model 644; Cambridge,
MA, United States of America) from milk as well as from pup and maternal plasma (n = 5–8 per
group) [39,42]. Total calcium concentration in the pup body was determined after ashing using the
CX-5 Analyzer (n = 7–9 per group) [30,40]. Total protein and lactose concentrations were analyzed as
described previously with n = 4–6 per group [30].
2.2.3. Fatty Acid Analysis
Total fatty acid composition of the milk was determined by the direct trans-esterification method
of Lepage and Roy [43] as previously described [34] with n = 6–7 dams per group. Briefly, 50 to 100 μL
of milk was placed into a screw-capped Teflon-lined tube containing C23:0 as an internal standard.
After the 1-h trans-esterification procedure and recovery of the fatty acid methyl esters (FAMEs) in the
benzene phase, the FAMEs were analyzed by capillary gas liquid chromatography. FAMEs were then
separated and measured on a Shimadzu (17A) gas chromatograph with flame ionization detection.
A 50 mm × 0.25 mm BPX-70 fused silica capillary column (SGE Scientific; Ringwood, VIC, Australia)
with a film thickness of 0.25 μm was used in conjunction with a Shimadzu on-column auto-injector.
Ultrahigh purity hydrogen was used as a carrier gas at a flow rate of 2 mL/min. A temperature
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gradient program was used with an initial temperature of 170 ◦C, increasing at 3 ◦C/min to 218 ◦C.
Identification of the FAMEs was made by comparison with the retention times of chromatography
reference standard mixtures (Nu-Chek Prep; Elysian, MN, United States of America) [44].
2.3. Study 2: Lactation and Adult Study
Another cohort of pups stayed with their cross-fostered dam until weaning (PN35) and were
weighed from birth (PN1) to weaning (PN3, PN6, PN10, PN14, PN17, PN21, PN24, PN28 and PN35)
to determine pup growth and milk intake. Pups were weighed during a 1-h maternal separation
period followed by a 3-h re-feeding period. Milk intake was calculated as a percentage of pup body
weight gain after feeding compared to pre-feeding [30] and the area under the milk intake curve
was calculated between PN3 and PN17 as an index of milk consumption. After weaning, male
and female pups were housed separately. At 6 months, offspring (1 male and 1 female per litter)
underwent an intra-arterial glucose tolerance test (IAGTT) and tail-cuff blood pressure measurements
as previously described [36–38]. Rats were then weighed and anaesthetized with an intraperitoneal
injection (50 mg/kg Ketamine and 10 mg/kg Ilium Xylazil-20) and the right hind limbs were collected;
all females underwent post-mortem when they were in estrous.
2.3.1. Bone Analyses
The right hind limb was dissected to separate the femur bone from soft tissue and femur
length measured using digital calipers (n = 9–19 per group per sex). Individual femurs then
underwent peripheral quantitative computed tomography (pQCT) to measure bone volumetric content,
density and stress strain index using methods previously described [31,45–47]. Briefly, two slices of
1 mm thickness (voxel size 0.1000 mm3, peel mode 20, contour mode 1) were taken at distances of
15% and 50% from the reference line to quantify both trabecular and cortical bone tissue, respectively.
A tissue density of 280 mg/cm3 or less was identified as trabecular bone, whereas a density of
710 mg/cm3 was representative of cortical bone. Automatic density thresholding (400 mg/cm3)
was used to eliminate the effects of any soft tissue which may have remained on the femur after
dissection. Bone mineral content, density, and stress strain index (index of bone bending strength)
were then measured.
2.3.2. Plasma Analyses
Plasma were analyzed for glucose using enzymatic fluorometric analysis and insulin using a rat
insulin radioimmunoassay kit (Merck Millipore; Bayswater, VIC, Australia) as previously described
(n = 6–11 per group per sex) [38,48]. Fasting plasma glucose and insulin was taken as the average
of two-time points (10 and 5 min before injection). First-phase insulin secretion was calculated as
the incremental area under the insulin curve between 0 and 5 min after the intra-arterial injection of
glucose. Homeostasis model assessment for insulin resistance (HOMA-IR) was then determined [38].
2.4. Statistical Analysis
Data were analyzed using a two-way ANOVA to determine differences between Pup (Standard
or Reduced litter size) and Dam (Normal or Altered milk quality/composition) groups. If an
interaction was present in the two-way ANOVA, a Tukey’s post-hoc test was performed to identify
any effect of reducing litter size within each maternal group and any effect altering maternal milk
quality/composition has on pup outcomes based on litter size. Where appropriate data analysis was
performed on each sex. ANOVA statistical analysis was performed using SPSS Statistics 22 (IBM;
St Leondards, NSW, Australia). All data are presented as mean ± SEM and a p < 0.05 was assessed as
being statistically significant.
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3. Results
3.1. Growth to Weaning
As mentioned previously, dams that underwent uteroplacental insufficiency surgery gave birth to
pups that were growth restricted. Not surprisingly, however, birth weight in the four experimental
groups was not different (as only offspring from Sham-operated dams were utilized in the study)
and litter size was decreased in the groups that had their litter size Reduced at birth on PN1 and
PN6, with no differences in cannibalism across groups by PN6 (Table 1). From PN6 male (all ages)
and female (except for PN14, PN21 and PN28) body weight was decreased (−6% and −7% for males
and females, respectively) if they were suckled by a dam with Altered milk quality/composition.
Body weight at weaning was not, however, different between groups (PN35; Table 1).
Table 1. Cross-fostered litter size at postnatal day (PN) 6 and body weight from birth (PN1) to weaning













PN1 10.4 ± 0.4 11.5 ± 0.9 5.0 ± 0.0 6.0 ± 0.7 p = 0.0001 ns 1 ns
PN6 8.9 ± 0.6 8.6 ± 0.8 4.7 ± 0.3 5.25 ± 0.8 p = 0.0001 ns ns
Cannibalism 1.5 ± 0.5 2.9 ± 1.0 1.0 ± 0.7 0.8 ± 0.3 ns ns ns
Body Weight (g)
PN1
Male 4.17 ± 0.12 4.13 ± 0.10 4.23 ± 0.15 3.99 ± 0.13 ns ns ns
Female 3.87 ± 0.12 3.98 ± 0.06 3.98 ± 0.06 3.94 ± 0.11 ns ns ns
PN3
Male 5.62 ± 0.11 5.42 ± 0.15 5.41 ± 0.14 5.12 ± 0.15 ns ns ns
Female 5.38 ± 0.12 5.16 ± 0.20 5.23 ± 0.14 4.91 ± 0.14 ns ns ns
PN6
Male 8.54 ± 0.21 8.31 ± 0.23 8.66 ± 0.38 7.65 ± 0.30 ns p = 0.039 ns
Female 8.17 ± 0.21 7.91 ± 0.37 8.29 ± 5.14 7.26 ± 0.28 ns p = 0.049 ns
PN10
Male 14.6 ± 0.3 14.1 ± 0.4 14.6 ± 0.5 13.1 ± 0.5 ns p = 0.037 ns
Female 14.2 ± 0.3 13.6 ± 0.6 14.1 ± 0.5 12.7 ± 0.5 ns p = 0.040 ns
PN14
Male 22.1 ± 0.5 21.2 ± 0.6 21.5 ± 0.7 19.6 ± 1.0 ns p = 0.043 ns
Female 21.7 ± 0.4 20.6 ± 0.8 20.6 ± 0.8 19.0 ± 0.9 ns ns ns
PN17
Male 27.4 ± 0.6 26.3 ± 0.6 26.9 ± 0.8 24.5 ± 1.2 ns p = 0.030 ns
Female 26.9 ± 0.5 25.6 ± 0.7 26.0 ± 0.8 24.1 ± 1.1 ns p = 0.047 ns
PN21
Male 34.3 ± 0.6 33.6 ± 1.0 34.7 ± 0.7 31.4 ± 1.1 ns p = 0.020 ns
Female 33.8 ± 0.6 32.8 ± 1.0 33.5 ± 0.9 31.4 ± 1.0 ns ns ns
PN24
Male 43.7 ± 1.1 42.3 ± 0.9 44.3 ± 1.0 39.2 ± 1.4 ns p = 0.004 ns
Female 42.1 ± 0.8 40.4 ± 1.1 42.4 ± 1.1 38.5 ± 1.2 ns p = 0.010 ns
PN28
Male 58.7 ± 1.2 57.4 ± 1.1 59.6 ± 1.2 54.0 ± 1.8 ns p = 0.011 ns
Female 54.9 ± 1.0 54.1 ± 1.4 55.0 ± 1.4 51.3 ± 1.3 ns ns ns
PN35
Male 87.7 ± 1.7 86.6 ± 1.7 87.1 ± 1.3 82.8 ± 2.8 ns ns ns
Female 79.1 ± 1.2 77.8 ± 1.8 77.0 ± 1.4 75.7 ± 1.8 ns ns ns
Data are analysed with a two-way ANOVA reporting differences between Pup (Standard and Reduced litters) and
Dam (Normal and Altered milk quality/composition) groups. Data presented as the mean ± SEM, where ns is
not significant. 1 ns is not significant.
3.2. Mammary Structure and Maternal Plasma Analysis
An interaction between Dam and Pup was identified in mammary weight, where it was decreased
in Reduced litter size pups suckled by Normal milk quality/composition dams compared to Standard
litter size pups suckled by Normal milk quality/composition dams (−40%, Figure 2a; Tukey’s post-hoc).
There was, however, no difference in mammary weight between Standard litter size pups suckled
by Altered or Normal milk quality/composition dams; likely due to an increased alveolar number
(+25%) in Altered milk quality/composition dams, but not area (Table 2). There were no differences in
maternal plasma PTHrP and total calcium between groups (Table 2). An interaction between Dam and
Pup was identified in maternal ionic calcium, whereby it was increased in Reduced litter size pups
suckled by Normal milk quality/composition dams compared to Standard litter size pups suckled
by Normal milk quality/composition dams (+36%) and Reduced litter size pups suckled by Altered
milk quality/composition dams (+97%), but was decreased in Reduced litter size pups suckled by
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Altered milk quality/composition dams compared to Standard litter size pups suckled by Altered
milk quality/composition dams (−40%; Figure 2b; Tukey’s post-hoc). Maternal corticosterone (Table 2)
along with mammary PTHrP (mRNA and protein; Table 2 and Figure 2c) were not affected by litter size
or maternal treatment. A main Dam effect was identified in mammary a-lactalbumin gene abundance,
where it was decreased in Altered milk quality/composition dams (−51%; Figure 2d). An interaction
between Dam and Pup was identified in mammary b-casein, which was lower in Standard litter size
pups suckled by Altered milk quality/composition dams (−65%) and Reduced litter size pups suckled
by Normal milk quality/composition dams (−59%) compared to Standard litter size pups suckled by
Normal milk quality/composition dams (Figure 2e; Tukey’s post-hoc).
3.3. Pup Plasma Analysis and Milk Consumption
Milk PTHrP tended to be increased in dams suckling Reduced litter size pups (Figure 3a; p = 0.060,
two-way ANOVA). Milk Na+/K+, ionic and total calcium, total protein and lactose were not affected
by maternal milk quality/composition or litter size (Table 2). A main Pup effect was identified in pup
plasma PTHrP, where it was increased in Reduced litter size pups (+69%; Figure 3b). This finding
was in conjunction with main Pup effects in pup ionic calcium and total body calcium, where they
were decreased in Reduced litter size pups (−35% and −5%, respectively; Figure 3c,d). Milk intake in
both male and female pups were not affected by maternal milk quality/composition or pup litter size
(Figure 3e,f).













Maternal (n = 4–9 per group)
Plasma PTHrP (pmol/L) 8.2 ± 0.4 9.1 ± 1.2 10.5 ± 0.8 9.6 ± 0.7 ns 1 ns ns
Plasma total calcium (mmol/L) 2.6 ± 0.08 2.6 ± 0.04 2.6 ± 0.05 2.4 ± 0.04 ns ns ns
Plasma corticosterone (ng/mL) 593 ± 59 726 ± 106 551 ± 86 553 ± 80 ns ns ns
Mammary (n = 3–6 per group)
Alveolar number 14.5 ± 1.6 15.9 ± 0.8 11.4 ± 1.2 16.5 ± 1.7 ns p = 0.038 ns
Alveolar area 75.2 ± 3.0 75.1 ± 1.9 79.8 ± 6.5 78.5 ± 3.9 ns ns ns
PTHrP mRNA 1.0 ± 0.1 0.8 ± 0.3 1.1 ± 0.2 1.4 ± 0.3 ns ns ns
Milk (n = 4–8 per group)
Na/K 7.6 ± 1.2 6.5 ± 1.6 9.8 ± 2.5 6.4 ± 0.9 ns ns ns
Ionic calcium (mmol/L) 8.9 ± 0.6 8.7 ± 1.0 7.4 ± 0.9 9.1 ± 0.4 ns ns ns
Total calcium (mmol/L) 64.7 ± 4.0 65.8 ± 3.7 60.4 ± 5.6 57.9 ± 2.8 ns ns ns
Total protein (mg/L) 28.2 ± 4.4 22.0 ± 3.7 25.4 ± 4.5 28.1 ± 3.6 ns ns ns
Lactose (mM) 30.2 ± 7.9 38.4 ± 3.8 29.5 ± 6.0 41.7 ± 10.4 ns ns ns
Data are analysed with a two-way ANOVA reporting differences between Pup (Standard and Reduced litters) and
Dam (Normal and Altered milk quality/composition) groups. Data presented as the mean ± SEM with sex pooled
per litter, where ns is not significant. 1 ns is not significant.
3.4. Milk Fatty Acid Composition
An interaction between Dam and Pup was identified in linoleic acid (LA), arachidonic acid (AA)
and total n-6 fatty acids. Specifically, levels of the individual n-6 PUFAs (LA and AA), and total
n-6 fatty acid content were increased in milk from Standard litter size pups suckled by Altered
milk quality/composition dams (+20% and +21% for LA and total n-6) and Reduced litter size pups
suckled by Normal milk quality/composition(+21%, +48% and +24%, respectively) dams compared
to Standard litter size pups suckled by Normal milk quality/composition dams (Table 3; Tukey’s
post-hoc). There was a main Pup effect in levels of the n-3 LC-PUFA docosahexaenoic acid (DHA)
which was increased in milk from dams suckling Reduced litter size pups (+31%; Table 3), but there
was no difference in total n-3 fatty acid content of the milk between groups. An interaction between
Dam and Pup was identified in long chain saturated fatty acid content, where they were decreased in
the milk of Reduced litter size pups suckled by Normal milk quality/composition dams compared to
Standard litter size pups suckled by Normal milk quality/composition dams (−24%; Table 3, Tukey’s
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post-hoc). A main Pup effect was identified in total LC-MUFA content, where it was increased in
the milk of dams suckling Reduced litter pups (+11%). The ratio of n-6:n-3 fatty acids and medium
saturated fatty acids were not affected by litter size or maternal milk quality/composition (Table 3).











Figure 2. Effect reducing litter size has on maternal and mammary outcomes (n = 5–9 per group).
(a) Mammary weight, (b) maternal ionic calcium concentrations and (c) mammary PTHrP protein
concentration, (d) a-lactalbumin and (e) b-casein mRNA expression. Data are analysed with a two-way
ANOVA reporting differences between Pup (Standard and Reduced litters) and Dam (Normal and
Altered milk quality/composition) groups, with a Tukey’s post-hoc test used to identify where
interactions lie. Data presented as the mean ± SEM, where ns is not significant. Significant differences
between Standard and Reduced litter pups are indicated by an asterisk (* p < 0.05) and differences
between sham operated (Control; Normal milk quality/composition) and uteroplacental insufficiency
surgery (Restricted; altered milk quality/composition) dams are indicated with a double dagger
(‡ p < 0.05). Normal milk quality/composition dams denoted by white open bars and Altered milk
quality/composition dams denoted by black closed bars.
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Figure 3. Effect reducing litter size has on pup calcium handling and milk intake (n = 6–10 litter
averages per group, where appropriate). (a) Milk and (b) pup PTHrP concentrations, (c) pup ionic
calcium concentrations, (d) pup total body calcium and (e,f) pup milk intake. Data are analysed with a
two-way ANOVA reporting differences between Pup (Standard and Reduced litters) and Dam (Normal
and Altered milk quality/composition) groups. Data presented as the mean ± SEM, where ns is not
significant. Normal milk quality/composition dams denoted by white open bars and Altered milk
quality/composition dams denoted by black closed bars.
3.5. Adult Health
Body weight at 6 months was decreased in male (−5%), but not female, offspring from
Reduced litters, which was further exaggerated by Altered milk quality/composition (−5%)
(Table 4). Femur length in both males and females was unaffected by litter size or maternal milk
quality/composition (Table 4). An interaction between Pup and Dam was identified in male and
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female trabecular mineral content, whereby trabecular mineral content was decreased in male (−14%)
and female (−12%) Reduced litter size pups suckled by Altered milk quality/composition dams
compared to Reduced litter size pups suckled by Normal milk quality/composition counterparts
(Figure 4a; Tukey’s post-hoc). A main Dam effect was identified in trabecular density in male offspring,
where it decreased in offspring suckled by Altered milk quality/composition dams (−6%; Figure 4b).
In females, an interaction between Pup and Dam was identified trabecular density, where it was
decreased in Reduced litter size pups suckled by Altered milk quality/composition dams (−8%)
compared to Reduced litter size pups suckled by Normal milk quality/composition dams (Figure 4b;
Tukey’s post-hoc). Cortical mineral content was decreased in male offspring who were suckled by
Altered milk quality/composition dams (−4%), with no change in females (Table 4). Cortical density
was unaffected by litter size or maternal milk quality/composition in both male and female offspring
(Table 4). A main Pup effect was identified in bone bending strength in male, but not female offspring,
where it was decreased in offspring of Reduced litters (−7%; Figure 4c).
Table 3. Fatty acid composition in stomach contents consumed in milk presented as a cumulative
total percentage of fatty acids on postnatal day 6 in the four cross-foster groups (n = 5–7 per group,














Linoleic (18:2n-6) 11.79 ± 0.25 14.12 ± 0.43 ‡1 14.23 ± 0.26 *2 13.85 ± 0.50 p = 0.010 p = 0.019 p = 0.002
Arachidonic (20:4n-6) 1.03 ± 0.06 1.33 ± 0.12 1.52 ± 0.08 * 1.35 ± 0.09 p = 0.014 ns 3 p = 0.023
Total n-6 PUFA 14.4 ± 0.4 17.4 ± 0.7 ‡ 17.9 ± 0.4 * 17.1 ± 0.7 p = 0.009 ns p = 0.003
Omega-3 PUFA
α-linolenic (18:3n-3) 1.40 ± 0.06 1.48 ± 0.09 1.49 ± 0.05 1.46 ± 0.11 ns ns ns
Eicosapentaenoic (20:5n-3) 0.21 ± 0.01 0.17 ± 0.03 0.21 ± 0.02 0.18 ± 0.04 ns ns ns
Docosahexaenoic (22:6n-3) 0.41 ± 0.03 0.45 ± 0.06 0.55 ± 0.04 0.58 ± 0.09 p = 0.047 ns ns
Total n-3 PUFA 2.4 ± 0.09 2.4 ± 0.18 2.7 ± 0.15 2.7 ± 0.21 ns ns ns
n-6:n-3 6.07 ± 0.15 7.11 ± 0.27 6.58 ± 0.28 6.63 ± 0.54 ns ns ns
Total LC-MUFA 22.4 ± 0.9 22.4 ± 1.4 25.8 ± 0.9 23.9 ± 0.8 p = 0.032 ns ns
Saturated Fatty Acids
Medium (6–12) 19.8 ± 1.0 21.1 ± 0.7 21.1 ± 0.7 20.8 ± 0.9 ns ns ns
Long (14–20) 40.4 ± 1.1 35.2 ± 2.1 30.9 ± 1.4 * 34.2 ± 1.9 p = 0.006 ns p = 0.022
Data are analysed with a two-way ANOVA reporting differences between Pup (Standard and Reduced litters)
and Dam (Normal and Altered milk quality/composition) groups, with a Tukey’s post-hoc test used to identify
where interactions lie. Data presented as the mean ± SEM with sex pooled per litter, where ns is not significant.
Significant differences between Standard and Reduced litter pups are indicated by an asterisk (* p < 0.05) and
differences between sham operated (Control; Normal milk quality/composition) and uteroplacental insufficiency
surgery (Restricted; Altered milk quality/composition) dams are indicated with a double dagger (‡ p < 0.05).
Also see Table S1 for individual fatty acids. 1 p < 0.05 Standard-on-Altered vs. Standard-on-Normal; 2 p < 0.05













Figure 4. Effect reducing litter size has on adult offspring bone (n = 9–19 per group, with n = 1
representing 1 male and female per litter) and cardiometabolic health (n = 5–11 per group, with n = 1
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representing 1 male and female per litter). (a,b) Trabecular mineral content and density, (c) bone
bending strength, (d) homeostasis model assessment for insulin resistance (HOMA-IR) and (e) blood
pressure at 6 months. Data are analysed with a two-way ANOVA reporting differences between
Pup (Standard and Reduced litters) and Dam (Normal and Altered milk quality/composition)
groups, with a Tukey’s post-hoc test used to identify where interactions lie. Data presented as the
mean ± SEM, where ns is not significant. Significant differences between sham operated (Control;
Normal milk quality/composition) and uteroplacental insufficiency surgery (Restricted; Altered
milk quality/composition) dams are indicated with a double dagger (‡ p < 0.05). Normal milk
quality/composition dams denoted by white open bars and Altered milk quality/composition dams
denoted by black closed bars, with data from males on the left-hand side and data from females on the
right-hand side.
Fasting glucose at 6 months was not different between groups in either males or females (Table 4).
In male, but not female offspring, a main Dam effect was identified in fasting insulin concentrations
where it was higher in offspring who had been suckled by Altered milk quality/composition dams
and also tended to be lower in Reduced litter size pups (Table 4; p = 0.070). Similarly, glucose AUC
tended to be higher and first phase insulin tended to be lower in male offspring that were suckling
Altered milk quality/composition dams (Table 4; p = 0.080 and p = 0.069, respectively), with no changes
in females. HOMA-IR at 6 months tended to be increased in offspring who had been suckled by
Altered milk quality/composition dams (p = 0.076) and decreased in Reduced litter size offspring
(p = 0.057; Figure 4d). Interestingly, a main Pup and Dam effect were observed in male blood pressure,
where it was increased both in Reduced litter male offspring compared to Standard litter size offspring
(+7%) and in offspring who had been suckled by Altered milk quality/composition dams compared to
Normal milk quality/composition dams (+5%; Figure 4e). HOMA-IR and blood pressure were not
different between groups in female offspring (Figure 4d,e).
Table 4. Adult offspring physiology in the four cross-foster groups at 6 months (n = 9–19 per group for













Body Weight (g) Male 386.1 ± 7.0 368.9 ± 2.3 368.4 ± 7.0 351.8 ± 9.5 p = 0.020 p = 0.023 ns
Female 239.3 ± 4.1 233.1 ± 6.5 238.3 ± 3.7 226.9 ± 4.7 ns 1 ns ns
Bone Parameters
Femur Length (mm) Male 37.01 ± 0.12 36.79 ± 0.23 36.61 ± 0.21 36.01 ± 0.16 ns ns ns
Female 33.09 ± 0.14 32.75 ± 0.19 32.69 ± 0.14 32.42 ± 0.15 ns ns ns
Cortical content (mg·mm−1) Male 10.67 ± 0.15 10.63 ± 0.28 10.74 ± 0.18 9.93 ± 0.13 ns p = 0.005 nsFemale 7.87 ± 0.09 7.79 ± 0.11 7.90 ± 0.12 7.49 ± 0.11 ns ns ns
Cortical density (mg (mm3)−1) Male 1409.4 ± 1.8 1413.3 ± 3.7 1412.6 ± 3.8 1407.9 ± 1.9 ns ns nsFemale 1407.9 ± 2.5 1412.4 ± 1.2 1404.8 ± 1.8 1399.1 ± 2.0 ns ns ns
Metabolic Parameters
Fasting plasma glucose (mmol·L−1) Male 5.77 ± 0.21 5.81 ± 0.19 5.52 ± 0.19 5.64 ± 0.27 ns ns nsFemale 5.15 ± 0.18 5.69 ± 0.18 5.50 ± 0.20 5.64 ± 0.22 ns ns ns
Fasting plasma insulin (ng·ML−1) Male 1.28 ± 0.24 1.82 ± 0.17 0.91 ± 0.12 1.32 ± 0.33 p = 0.070 p = 0.048 nsFemale 1.07 ± 0.24 1.23 ± 0.23 1.09 ± 0.14 1.23 ± 0.21 ns ns ns
Glucose AUC
Male 757.3 ± 87.0 795.6 ± 79.8 742.2 ± 67.1 989.6 ± 62.1 ns p = 0.080 ns
Female 812.9 ± 74.1 701.9 ± 70.1 689.3 ± 52.8 635.2 ± 45.2 ns ns ns
First phase insulin AUC Male 14.25 ± 1.54 10.01 ± 2.08 11.31 ± 1.92 8.53 ± 1.17 ns p = 0.069 ns
Female 13.91 ± 2.02 11.29 ± 2.05 13.81 ± 1.74 14.01 ± 1.84 ns ns ns
Data are analysed with a two-way ANOVA reporting differences between Pup (Standard and Reduced litters) and
Dam (Normal and Altered milk quality/composition) groups. Data presented as the mean ± SEM, where ns is
not significant. 1 ns is not significant.
4. Discussion
Providing offspring with adequate and appropriate nutrition during lactation is essential for
long-term health, with both over- and undernutrition increasing disease susceptibility [14–16]. We have
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previously demonstrated that both the dam and suckling pup can influence maternal milk composition,
and that these effects generally represent an attempt to improve pup growth and development [34].
The current study has demonstrated that reducing litter size at birth, regardless of whether the dam
has normal or altered milk quality/composition impairs pup calcium homeostasis, which may reduce
bone bending strength in male offspring. Additionally, these adult Reduced litter males appear to
have increased cardiovascular disease risk and decreased diabetes risk. Furthermore, altered milk
quality/composition (induced by uteroplacental insufficiency surgery) similarly programs poor bone
health, high blood pressure and impairs glucose tolerance/insulin sensitivity. These finding are likely
due to differential influences of the predetermined litter size at birth [26] and effects on milk quality.
This highlights that caution needs to be taken when interpreting animal studies that focus on early life
nutrition, as the experimental approach may independently modulate milk nutrition and quality.
4.1. Effects of Reducing Litter Size
It is important to note that as all dams underwent a surgical procedure (sham or ligation) and
all litters were cross-fostered the effects reported are as direct consequences of either the maternal
surgery (resulting in altered milk quality/composition) or reduced litter size, thus we have adequately
accounted for all possible confounders, such as stress, across experimental groups. Additionally,
growth restricted pups were not included in the study, only pups born from sham-operated dams that
have intact or reduced litter sizes when cross-fostered, which would limit any changes observed in
pups suckled by dams that underwent uteroplacental insufficiency surgery to the lactation environment
they are exposed to in early postnatal life. Reducing litter size is commonly used in the developmental
programming field, however recent studies demonstrate that this can independently program disease
susceptibility [27–30]. In the current study we report dynamic changes in pup calcium homeostasis and
maternal milk composition as a result of reducing the litter size to 5 pups. Interestingly, despite these
changes in milk composition, no changes in postnatal body weight was observed, which suggests
that other intrinsic hormonal factors may be responsible for maintaining pup growth that requires
further studies. The reduction in mammary gland weight in Normal milk quality/composition
dams suckled by Reduced litter pups may be due to the decreased b-casein gene expression, which is
known to regulate mammary differentiation and is a regulator of milk protein gene expression [49].
However, this likely did not alter alveolar area or number as lactogenic differentiation is completed by
PN6 [49]; although studies at earlier postnatal ages may reveal altered mammary structure. Despite
no changes in maternal PTHrP, dams suckled by Reduced litter pups had increased milk PTHrP.
Previous studies have demonstrated that milk PTHrP is not absorbed by the intestines into the pups
circulation [50], suggesting that the increased pup PTHrP concentrations we report are independent
of milk PTHrP content. This increased pup PTHrP is likely to stimulate bone resorption, and thus
calcium release, in an attempt to increase plasma calcium concentrations, as shown in a previous
study [51], but has also been shown to result in decreased postnatal body calcium content [52].
Interestingly, the increased maternal ionic calcium concentrations in Normal milk quality/composition
dams suckled by Reduced litter pups are likely an attempt to increase milk calcium concentrations
to compensate for this deficit. This, however, did not translate to increased milk calcium content at
the time point investigated in this study, highlighting that milk composition needs to be assessed
at additional postnatal ages. Nevertheless, the increased milk PTHrP in dams suckling Reduced
litter pups would facilitate increased intestinal calcium reabsorption to increase pup plasma calcium
concentrations, preventing any further bone breakdown. These data may highlight why the Reduced
litter size pups suckled by Normal milk quality/quantity dams do not exhibit the same deficits in
adult bone mineral content and density that are observed in the Reduced litter size pups suckled by
Altered milk quality/quantity. Despite this, however, Reduced litter male offspring have decreased
bending strength, indicative of increased fracture risk and thus poor bone health, suggesting that any
compensatory changes in milk composition were not sufficient to fully prevent bone deficits.
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In addition to alterations in pup calcium homeostasis in the Reduced litter group, we also report
changes in milk fatty acid content, highlighting that Reducing litter size has profound effects on
maternal milk quality. Interestingly, milk n-6 fatty acid content was increased in the Reduced litter
size pups suckled by Normal milk quality/quantity dams. This is significant, since increased n-6
fatty acid intakes have been associated with increased fat deposition in early life [11]. High intakes
of n-6 PUFA during lactation also influence lipid tissue status and modulate metabolic pathways
that can lead to diabetes and cardiovascular disease [11]. It is important to note, however, that it
is the balance of omega-6 and omega-3 PUFA in the diet that appears to be the more important
determinant of physiological effects than levels of either PUFA type alone. In the current study,
the n-6:n-3 ratio was not altered, at least at this age, by either litter size or maternal uteroplacental
insufficiency surgery. This suggests that the observed changes in milk PUFA composition may not
be a major factor contributing to the male onset cardiovascular disease we report, but may instead
be due to the decreased post-weaning growth trajectory. Interestingly, reducing litter size increased
milk LC-MUFA and DHA (Reduced litter size pups suckled by Normal milk quality/quantity dams
only) content, which is known to have beneficial effects on metabolic function during critical periods
of development [11]. The improved metabolic health in Reduced litter size pups suckled by Normal
milk quality/quantity dams male offspring may also be attributed to increased milk Pentadecanoic
acid (15:0) and reduced Palmitic acid (16:0) both of which are known to reduce the risk of type 2
diabetes [53]. This may explain why the Reduced litter size male offspring appear to have a decreased
risk of developing diabetes.
4.2. Effects of Altered Milk Quality/Composition
Surprisingly alterations in milk quality/composition, induced by maternal uteroplacental
insufficiency surgery, resulted in very few changes in milk composition compared to the large
number of changes associated with reducing litter size and slowing offspring postnatal growth.
In the current study, we report that dams with altered milk quality/composition have decreased
mammary a-lactalbumin gene abundance. If this translates to decreased milk α-lactalbumin protein
then this may, at least in part, contribute to the poor adult bone health we observed in male offspring
reared by Altered milk quality/composition dams. Specifically, as α-lactalbumin binds calcium [54]
it is possible that decreased milk α-lactalbumin impairs calcium delivery to the pup, compromising
bone mineralization and development. This poor bone health was only apparent in Reduced litter size
pups suckled by Altered milk quality/composition dams, likely because the effect was compounded
by the decreased maternal ionic concentrations that may have compromised calcium delivery at later
lactational ages. Interestingly, a recent study demonstrated that supplementing 6-week old obese
diabetic Zucker rats with α-lactalbumin for 13 weeks improves metabolic function [55]; highlighting
the benefits of α-lactalbumin on metabolic health. If the inverse is also true, and rats are exposed to
decreased α-lactalbumin during development, it is possible that this may contribute to the increased
risk of adult metabolic disease we observed in our rats. In addition, the increased n-6 fatty acid intake
in Standard litter size pups suckled by Altered milk quality/quantity dams during lactation may also
contribute to the increased blood pressure and impaired insulin sensitivity in male offspring [11].
As the female offspring suckled by Altered milk quality/composition dams caught up in body weight
prior to weaning they may be protected against developing cardiometabolic disease, due to the benefits
of early accelerated growth for long-term cardiometabolic health [36,56–58].
4.3. Study Limitations
Despite our study demonstrating that reducing the litter size from 9 pups to 5 pups alters milk
quality/composition and has implications for long-term offspring health, further studies are required
to investigate the effects of the more common practice of reducing litter sizes to 8–10 pups from original
litter sizes of 12–20 pups, since this also has the potential to influence milk quality/quantity and thus
offspring outcomes. Nevertheless, the findings of the current study highlight the potential impact
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reducing litter size, independent of other neonatal factors, has on programming offspring outcomes.
An important factor that was not taken into consideration in the present study is the impact of offspring
sex on milk composition, due to difficulties in controlling for this in our large litter bearing animal
model. Indeed, several epidemiological and experimental (with smaller litter bearing animals) studies
have well demonstrated differences in milk composition between male and female infants [59,60];
demonstrating that infant sex has a significant impact on milk quality. This highlights the need for
well-controlled human and animal studies to identify alterations in milk composition between infant
sexes in several different pregnancy complications.
A limitation of the current study is that maternal behavior was not evaluated throughout lactation.
This is particularly important, as the quality and quantity of maternal care during lactation can
impact on offspring behavioral, endocrine and neural development (see review by Curley and
Champagne [61]). Specifically, a recent study demonstrated that dams whose litters were reduced to
3 pups (to induce postnatal overnutrition) have improved maternal care, characterize by increased
time devoted to arched nursing and licking pups [62]. Not surprisingly the pups had early accelerated
growth and were overweight by PN60, as indicated by increased adiposity, and were hyperglycemic
and hyperleptinemic [62]. These findings are however difficult to compare directly to the results of
the current study where the Reduced litter pups had decreased postnatal growth, which suggests
that the extent of litter size reduction in the current study is unlikely to have resulted in improved
maternal care.
5. Conclusions
This study demonstrates that reducing pup litter size and altered maternal milk
quality/composition differentially program poor adult offspring health, which is likely due to altered
milk quality. Specifically, reducing the litter size alters milk composition, impairs pup calcium
homeostasis and programs poor bone health, which likely contributes to the lower diabetes risk and
poor cardiovascular health. Alterations in maternal milk quality/composition, on the other hand,
programs poor adult bone and cardiovascular health and reduces glucose tolerance/insulin sensitivity.
This study highlights the need for appropriate controls in developmental research to clearly ascertain
phenotypes in the model. Importantly, controls implemented to standardize outcomes across treatment
groups may independently program disease susceptibility, which limit their translatability. Therefore,
care must be taken in interpreting findings from studies that standardize litter size as it may mask
subtle effects on cardiometabolic health.
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Abstract: Maternal nutrition plays a decisive role in developmental programming of many
non-communicable diseases (NCDs). A variety of nutritional insults during gestation can cause
programming and contribute to the development of adult-onset diseases. Nutritional interventions
during pregnancy may serve as reprogramming strategies to reverse programming processes and
prevent NCDs. In this review, firstly we summarize epidemiological evidence for nutritional
programming of human disease. It will also discuss evidence from animal models, for the common
mechanisms underlying nutritional programming, and potential nutritional interventions used as
reprogramming strategies.
Keywords: developmental origins of health and disease (DOHaD); gut microbiota; non-communicable
disease; nutrient-sensing signal; nutrition; oxidative stress; pregnancy; reprogramming
1. Introduction
Maternal nutrition plays an essential role in fetal growth and development. It has long been
known that adverse nutritional conditions during pregnancy may permanently change the structure
and function of specific organs in the offspring, leading to many adult diseases. This concept is now
currently referred to as the Developmental Origins of Health and Disease (DOHaD) [1]. Conversely,
the DOHaD concept provides a strategy to reverse programming processes by shifting the therapeutic
interventions from adulthood to fetal or infantile stage, before clinical phenotype becomes evident [2,3].
Nutritional interventions during pregnancy have started to gain importance as a reprogramming
strategy to prevent DOHaD-associated diseases [4–6].
Nutritional exposure at early life is particularly important, as the plasticity of developing organs
that shape the way in which the body reacts to challenges in later life. This review highlights evidence
for the impact of nutritional programming on offspring health and the role of nutritional interventions
as a reprogramming strategy in the emerging area of DOHaD research.
2. Nutritional Programming of Health and Disease: Good, Bad, or Ugly?
The term nutritional programming describes the process through which exposure to early-life
nutritional stimuli brings about morphological changes or functional adaption of the offspring [7,8].
The long-term consequences of nutritional insults are variable and depend on several factors such as
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the type of nutrient, exposure duration and intensity, species, sex, and the critical time-windows of
development during which it is applied. Nutritional programming is emerging as a critical risk factor
for a number of non-communicable diseases (NCDs), including hypertension, cardiovascular disease,
diabetes, obesity, allergic diseases, kidney disease, neurocognitive impairments, nonalcoholic fatty liver
disease (NAFLD), and metabolic syndrome [3–10]. NCDs constitute the main cause of death all over
the world. Although NCDs are generally preventable, current approaches are obviously insufficient.
Conversely, nutritional programming can also be advantageous. From an evolutionary perspective,
developmental plasticity seems to represent an adaptive process. Developmental plasticity is beneficial
for fitness, despite such benefits may come at a cost to health outcomes. Developmental plasticity can
offer a survival advantage to the offspring based on evolutionary grounding [11]. Also, developmental
plasticity is beneficial when environmental conditions change within generations [11]. Importantly,
several reports suggest, at least in animal models, that developmental programming of adult disease
is potentially reversible by nutritional interventions during the period of developmental plasticity.
In genetic models of hypertension, early-life nutritional interventions can improve cardiovascular
outcomes in adult offspring [12,13]. The identification of critical time-windows and specific nutritional
interventions is thus a promising way to explore in order to offer novel reprogramming strategies.
Considering the good and bad sides of nutritional programming during pregnancy, there is
still an ugly side of it. Currently, little information exists on certain nutrients for women with
pre-existing deficiencies, as the dietary reference intakes are established for healthy individuals.
Almost all dietary reference intake reports lack long-term offspring outcome data to accurately inform
recommendations for women in the pregnancy stage. However, currently in human studies it is
difficult to confirm causation linking maternal nutrition status with phenotypes in offspring. Also,
these cohorts do not identify molecular mechanisms by which the phenotype is generated and aid in
developing specific nutritional interventions for a wide spectrum of adult diseases. As a consequence
of ethical considerations concerning what is achievable or not in human studies, animal models are
essential. It is for this reason that much of our knowledge of the type of nutritional insults driving
the programming process, the critical time-window of vulnerability for nutritional insults, potential
mechanisms underpinning nutritional programming, and reprogramming strategy largely come from
studies in animal models.
On the contrary, there are some limitations of animal models when translating into replications
in human trials. Possible problems include different models with varying similarity to the human
conditions, variability in animals for study, follow-up duration may not correspond to disease latency
in humans, and outcome measures have uncertain relevance to the human conditions [14].
Despite interesting results using nutritional interventions to prevent various adult diseases
have been obtained from animal models, many challenges still lie ahead for successful translation
of promising animal therapies to humans. As nutrients do not drive their programming effect
independently from each other, key questions for future research include what are the nutrient–nutrient
interactions, nutrient–drug interactions, and nutrient–environment interactions that can affect the
programming power on pregnancy and offspring outcomes.
A schematic summarizing the good, the bad, and the ugly sides of nutritional programming
involved in the developmental programming of adult diseases is presented in Figure 1.
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Figure 1. Schematic illustration of the good, the bad, and the ugly sides of nutritional programming
involved in developmental programming of health and disease.
3. Epidemiological Evidence for Nutritional Programming of Human Disease
Excessive or insufficient consumption of a specific nutrient has been linked to developmental
programming of a variety of NCDs [15–27]. Table 1 mainly summarizes cohort studies documenting
adverse offspring outcomes in response to both undernutrition and overnutrition during pregnancy [15–27].
Although low birth weight is considered as a surrogate marker of early-life nutrition and numerous studies
of maternal under- and over-nutrition have revealed its association with offspring health [28], we have
restricted this review only to adverse outcomes starting from childhood.
First, several famine cohort studies consistently showed that offspring exposed to gestational
famine are more vulnerable to metabolic syndrome-related disorders [15–18]. One famous example
is the Dutch famine study, which demonstrated that undernutrition in pregnancy is associated with
increased risk of adult offspring developing coronary heart disease, hyperlipidemia, obesity, obstructive
airways disease, kidney disease, and hypertension [16,18]. The Dutch famine study also showed
that offspring exposed to famine in early gestation are prone to developing coronary heart disease,
hyperlipidemia, and obesity. Exposure in mid gestation is associated with obstructive airways disease
and microalbuminuria. These findings suggest that the timing of undernutrition in pregnancy predicts
which organ system is reprogrammed and leads to the development of adult diseases [16]. However,
no such consequence was observed in the Leningrad siege famine study [29]. The dissimilar effects of
exposure to the two famines suggest the importance of the timing during gestation and the organs and
systems developing during that critical time-window. A recent meta-analysis of 20 studies reported
that fetal famine exposure may increase the risk of overweight and obesity [30].
Overnutrition is a form of malnutrition in which the intake of nutrients or a specific nutrient is
oversupplied, especially in unbalanced proportions. Only a small number of studies have examined
the contribution of excessive intake of a specific macronutrient during pregnancy to the adverse
offspring outcomes [23–27]. It has been demonstrated that high-free-sugar intake in pregnancy is
associated with childhood atopy and asthma [23]. There is also an association between high-protein
intake in pregnancy and the risk for high blood pressure (BP) in adult offspring [24–26]. Additionally,
consumption of a high-fat diet during pregnancy has been reported to increase the risk of overweight
in male adult offspring [27]. It is noteworthy that most studies mainly focused on cardiovascular
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outcomes and metabolic outcomes, rather less attention has been paid to other programming effects,
including neurobehavioral, endocrine, and respiratory outcomes.

































Undernutrition Elevation of bloodpressure 359 59 Netherlands
Dutch famine study
[18]
Low vitamin B12 Insulin resistance 653 6 India PMNS [19]
Low vitamin B12 Impaired cognitionfunction 118 9 India PMNS [20]
Vitamin D deficiency Elevation of bloodpressure 1834 5–6 Netherlands ABCD [21]














pressure 626 30 Scotland Motherwell study [25]
High-protein intake Elevation of bloodpressure 434 20 Denmark DaFO88 [26]
High-fat diet Obesity 965 20 Denmark Aarhus birth cohortstudy [27]
Studies tabulated according to nutritional risk factor and age at measure. ABCD, Amsterdam born children and their
development; ALSPAC, the Avon longitudinal study of parents and children; CHDS, child health and development
studies; CPP, the collaborative perinatal project pregnancy cohort; DaFO88 = Danish fetal origins cohort; MUSP,
Mater University study of pregnancy and its outcomes; PMNS, Pune maternal nutrition study.
Since epidemiological studies do not dissect the physiological and molecular mechanisms by
which the disorder is created, animal models with full control over the dietary manipulations are
essential in the discovery of mechanisms underlying nutritional programming and the development of
ideal nutritional interventions before they are implemented in humans.
4. Insights from Animal Models of Nutritional Programming
4.1. Animal Models for Nutitional Programming
Animal models particularly aid in inferring relevant information for possible translation to clinical
practice in the field of nutritional programming. Using animal model with proven construct validity
can increase the probability of successful translation of preclinical findings to clinical application. The
translatability may further be increased by using a broader spectrum of relevant animal models. The
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choice of one animal model over another mainly depends on its similarity to the human diseases. For
example, rabbits offer a better model of human atherosclerosis than rodents as they are prone to develop
fatty streak lesions in studies of high-fat intake [31]. Although non-human primate is considered as
the gold standard because of their similarity to humans, the most common species used are rodents
in the DOHaD field [32]. Other species such as rabbits, sheep, pigs have been used depending on
the experimental approaches, to study nutritional programming related to offspring outcomes [32].
Mice models provide a low-cost and easy-to-handle option, allowing genetic modification. Rabbits are
suitable for studies on the blastocyst due to their large size. Additionally, their placenta structure and
lipid metabolism are close to those in humans. Sheep are a monotocous species with a long gestational
period as in humans. Pigs are considered as a good model for studying early stages of fertilization
and development. Thus, animal studies play a pivotal role for us to clarify programming effects,
identify critical developmental windows, and develop ideal reprogramming strategies for nutritional
programming. The range of nutritional insults that have been utilized can be grouped into models that
seek to restrict calorie intake, manipulate macronutrient intake, or restrict micronutrient intake.
4.2. Animal Models of Maternal Caloric rRstriction
Rodent studies of calorie restriction ranging from 30–70% to pregnant dams showed hypertension
in the adult offspring [33–35]. Offspring that experienced a 50% calorie restriction during the last
week of gestation showed impairment of beta cell development [36]. In rodents, severe 70% caloric
restriction during pregnancy resulted in obesity, hypertension, hyperleptinemia, and hyperinsulinism
in adult offspring [37]. Similar adverse cardiovascular outcomes have been observed in cows and
sheep [38,39]. Pups exposed to a more severe degree of caloric restriction were likely to develop
hypertension earlier [5]. Additionally, the severity of adverse offspring outcome seems relevant
to the timing of exposure. In a maternal 50% caloric restriction sheep model, no major change in
glucose–insulin homeostasis was observed in adult offspring born of undernourished ewes during early
pregnancy [40]. However, maternal undernutrition during late pregnancy caused glucose intolerance
and insulin resistance in adult offspring. These findings suggest that undernutrition in late pregnancy,
during the period of maximal fetal growth, impacts negatively on the subsequent adult offspring’s
glucose–insulin homeostasis.
4.3. Animal Models of Macronutrients Imbalance
Macronutrients include carbohydrates, proteins, and fats. Sugar consumption, particularly
fructose, has grown over the past several decades and its growth has been paralleled by an increase in
obesity, diabetes, and hypertension [41]. Several rodent studies showed that maternal diets consisting
of 75% simple carbohydrates (dextrose and maltodextrin) led to a significantly higher body weight gain
in offspring [42–44]. Fructose is a monosaccharide naturally present in fruits. However, most of the
increase in fructose consumption now is derived from refined sugars and high-fructose corn syrup [45].
As we reviewed elsewhere [46], consumption of high-fructose alone or as a part of diet by rodent
mothers induces several features of metabolic syndrome in adult offspring, including hypertension,
insulin resistance, obesity, hepatic steatosis, and dyslipidemia.
Of note, adverse effects of fructose feeding depend on the amount and duration of fructose
consumption [47]. Despite being viewed as far in excess of a relevant load, most rodent studies have
been performed using diets containing 50–60% fructose [48,49]. However, a recent study indicated
that maternal consumption of 10% w/v fructose significantly increased BP in mice offspring after 1
year [50]. On the other hand, several studies used fructose as a part of maternal diet along with fat and
salt to induce hypertension in adult offspring [51,52]. As Western diet is characterized by the intake of
high-sugar drinks, high-fat products, and excess salt, it is important to dissect the interplay between
fructose, fat, and salt on the nutritional programming. Indeed, animal studies examining the combined
effects of key components of the Western diet have shown their synergistic effects of fructose, fat, and
salt on the elevation of BP in adult offspring [53,54].
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Protein is another macronutrient. The low-protein model has been extensively used to study the
mechanisms of nutritional programming. In rodents, protein restriction during pregnancy leads to
intrauterine growth retardation (IUGR) with subsequent hyperglycemia, glucose intolerance, insulin
resistance, obesity, and adipocyte hypertrophy [10]. Additionally, rodent studies of protein restriction
ranging from 6–9% to pregnant dams showed hypertension in the adult offspring [55–59]. Similar
to caloric restriction, a greater degree of protein restriction shows a higher propensity to develop
hypertension earlier in offspring [5]. Similar observations in several model species have confirmed the
effects of maternal low-protein diet on the above-mentioned metabolic syndrome-related phenotypes
in mammals [59]. Programming effects of protein restriction occur not only during pregnancy but also
through breastfeeding. Mice offspring born to dams fed with low-protein diet during lactation have
impaired cardiac structure and function that limit exercise/functional capacity [60].
Maternal high-fat diet is a widely used animal model to induce developmental programming of
obesity and related disorders [61]. Adult offspring exposed to a maternal high-fat consumption in
utero developed insulin resistance, increased lipid profile, hepatic steatosis, increased visceral fat mass,
and adipocyte hypertrophy [61–63]. Nevertheless, maternal high-fat-diet-induced responses of BP
include an increase [64,65] or no change [66,67], mainly depending on strain, sex, age, and diverse
fatty acid compositions.
Additionally, alteration of the protein-to-carbohydrate ratio of the maternal diet was related
to an adverse outcome in offspring. Male offspring rats born of dams exposed to a diet
with high-protein/carbohydrate ratio were characterized by elevated BP and a greater degree of
glomerulosclerosis [68]. These data are in agreement with human studies showing that a maternal
high-protein, low-carbohydrate diet is linked to elevated BP in the offspring [24,25].
4.4. Animal Models of Micronutrients Deficiency
There is also evidence to support that deficiencies in micronutrients, including minerals,
trace elements and vitamins, in pregnant mothers are associated with the development of NCDs.
Evidence in rats showed both maternal low- and high-salt diets lead to elevated BP in male adult
offspring [69]. Additionally, maternal calcium-deficient diet increased BP and insulin resistance in
adult rat offspring [70,71]. Furthermore, magnesium-deficient diet in pregnancy caused impaired
kidney function but had no effect on BP in rat offspring [72]. Deficiencies in trace elements and vitamins
in pregnant mothers are associated with the development of hypertension, impaired glucose tolerance,
and insulin resistance in their adult offspring [73–78]. These micronutrients include iron [73,74],
zinc [75,76], and vitamin D [77,78]. Additionally, maternal folate and vitamin B12 restriction increased
visceral adiposity and altered lipid metabolism in rat offspring [79].
The vitamins folic acid, B12, B6, and B2 have a key role as coenzymes in one-carbon metabolism,
serving as methyl-donor nutrients. Because one-carbon metabolism is required for epigenetic regulation
of gene expression, pregnant women are recommended to eat methyl-donor food to reduce adverse
birth outcomes [80]. These foods contain nutrients that directly provide methyl-donors or serve as
cofactors, such as methionine, folic acid, vitamins B2, B6, B12, and choline. Although methyl-donor
supplementation may be of benefit in preventing disease, we recently found that pregnant rats fed
with high-methyl-donor diet led to hypertension in male adult offspring [81]. Thus, additional studies
should be taken to assess the programming effects of these methyl-donor nutrients and to solve the
current conflicting data in regards to maternal methyl-donor diet.
Vitamin C, E, B6, and coenzyme Q-10 have shown beneficial effects on lowering BP [82]. However,
whether deficiencies of these micronutrients on pregnant mothers lead to programmed hypertension in
their offspring remains unclear. So far, no studies have been conducted examining the role of deficient
non-essential nutrients on developmental programming of adult disease.
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5. Common Mechanisms Underlying Nutritional Programming of Disease
In view of the fact that diversely nutritional insults in gestation create very similar outcome in adult
offspring, there might be some common mechanisms contributing to the pathogenesis of nutritional
programming of disease. Currently, possible mechanisms underlying nutritional programming include
nutrient-sensing signals, oxidative stress, tissue remodeling, epigenetic regulation, gut microbiota, and
sex differences [5–10,59]. Each mechanism will be discussed in turn.
5.1. Nutrient-Sensing Signals
Fetal metabolism and development are determined by maternal nutritional status via
nutrient-sensing signals. Sirtuin 1 (SIRT1), cyclic adenosine monophosphate (AMP)-activated protein
kinase (AMPK), mammalian target of rapamycin (mTOR), and peroxisome proliferator-activated
receptors (PPARs) are well-known nutrient-sensing signals [83]. In excessive nutrient conditions, the
mTOR is activated by increases in glucose, amino acid, and insulin levels, while in nutrient-depleted
conditions, AMPK and SIRT1 are activated by increases in intracellular AMP and NAD+ levels,
respectively. Dysregulated nutrient-sensing signals are present in several metabolic diseases [83]. The
interplay between AMPK and SIRT1 driven by maternal nutritional insults was reported to mediate
PPARs and their target genes, thereby generating developmental programming of adult disease [84].
Maternal high-fat diet increased fetal fat mass accompanied by elevated PPARγ but decreased SIRT1
expression [85]. As we mentioned earlier, maternal high-fructose diet induced several phenotypes of
metabolic syndrome in adult offspring [46]. Using the maternal high-fructose rat model, we found
PPAR signaling pathway is significantly regulated in the offspring liver, heart, and kidney using
next-generation RNA sequencing (NGS) analysis [48,86].
On the other hand, pharmacological interventions targeting AMPK or PPARs signaling have
been reported to prevent the development of hypertension and metabolic syndrome in a variety of
fetal programming models [84,87]. Although nutrient-sensing signaling are not likely to be the sole
mechanism that increases susceptibility to disease in later life, it is required to elucidate their interplay
with other mechanisms of nutritional programming in determining its impact on adult diseases of
developmental origins.
5.2. Oxidative Stress
The embryo and fetus have low-antioxidant capacity. An overproduction of reactive oxygen
species (ROS) under suboptimal intrauterine conditions would prevail over antioxidants, leading
to oxidative stress damage and thus compromising fetal development [88]. These damages include
oxidation of biological molecules, like lipids, proteins, and DNA. Excessive pro-oxidant molecules can
overpower the antioxidant defense, resulting in biological damage, namely, oxidative stress. There are
several types of nutritionally mediated oxidative stress sources, including diets high in carbohydrates,
animal-based protein, and saturated fat [89]. Oxidative stress during pregnancy may lead to lifelong
effects on vulnerable organs leading to adverse offspring outcomes in later life [90]. As reviewed
elsewhere [91], several nutritional insults in pregnancy have been linked to oxidative stress in adult
offspring, including maternal caloric restriction [33,35], high-fructose diet [48], low-protein diet [57],
high-fat diet [64,65], zinc-deficiency diet [75], iron-deficiency diet [92,93], and methyl-donor diet [81].
Detailed mechanisms that underlie the interactions between maternal nutrition and oxidative stress
and their roles in the programming process toward adult diseases of developmental origins, however,
remain to be determined.
The major antioxidant nutrients in our body are copper, zinc, manganese, selenium, vitamins
E, C, and A, and the glutathione system. Although some prospective assessment of the effect of
supplemental antioxidants on human health suggests benefit, there are conflicting results in this
area [94]. Although antioxidant nutrients therapy in pregnancy have been shown to prevent adult
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NCDs [33], there is a lack of data on when and how to use antioxidant nutrients to reprogram oxidative
stress-related adult diseases.
5.3. Tissue Remodeling
In the first trimester, there is rapid differentiation and development of organs and systems. The
second trimester is characterized by the development of structures and the start of functional activities.
The third trimester is a period of the most rapid growth during the gestation. Most organ development
lasts to birth, while some others continue to develop after birth, like the liver and nervous system [95].
If nutritional insults in gestation impact on critical periods of rapid growth, then it would be
expected that the organs will mature at a smaller size and with a reduced functional capacity. For
example, maternal low-protein diet caused fewer islets, smaller islets, and reduced islet vascularization
in rat offspring pancreas [96]. The same maternal insult also influenced the thymic growth in a
low-protein diet mice model [97].
Another example is the kidney. Low nephron number plays a key role in the developmental
programming of cardiovascular disease, hypertension, and kidney disease [8]. There is an increasing
body of literature demonstrating the relationship between maternal malnutrition and low nephron
number, as reviewed elsewhere [98,99]. In rodent models, reported nutritional insults include maternal
caloric restriction [35], low-protein diet [56], high-salt diet [69], low-salt diet [69], zinc deficiency [75],
vitamin A restriction [100], and iron restriction [101]. In low-protein diet model, adult male offspring
developed low nephron number and hypertension, which is related to renal hyperfiltration and
activation of the renin–angiotensin system (RAS) [56]. On the other hand, nutritional programming can
also have no effect [102], or even augment nephron number in adult offspring [103]. These observations
highlight that the nutritional programming might be not driven by a single factor (i.e., low nephron
number) and other organ- or phenotype-specific mechanisms remain to be identified.
5.4. Epigenetic Regulation
Persistent epigenetic modification of genes linked to disease is considered as a crucial mechanism
for developmental programming [104]. Epigenetics is defined as alterations in gene expression that are
not explained by changes in the DNA sequence. Epigenetic mechanisms include DNA methylation,
histone modification, and non-coding RNAs, all of which are involved in translating nutritional insults
in pregnancy to the developmental programming of adult diseases [104].
In rats, low-protein diet in pregnancy was shown to alter methylation and expression levels of
PPARα gene and glucocorticoid receptor (GR) genes in the liver of the offspring [105]. Of note is that
such alterations can be reversed by folic acid supplementation. Using DNA microarray technology, a
previous study showed maternal low-protein diet caused a global upregulation of genes implicated
in adipocyte differentiation, as well as in protein, carbohydrate, and lipid metabolism in the visceral
adipose tissue [106]. Additionally, global methylation patterns in the offspring liver and brain have
been studied in two different programming models, low-protein diet model [107], and micronutrient
deficiency model [108], respectively. Several genes belong to the renin–angiotensin system have been
reported to be altered by epigenetic regulation, culminating to the development of hypertension [109].
Using a mouse model, a report showed that maternal low-protein diet caused significant increases
in the mRNA and protein expression of angiotensin converting enzyme-1 (ACE1) in offspring brain,
with changes in DNA methylation and miRNA [110]. Furthermore, maternal undernutrition resulted
in epigenetic changes in hypothalamic genes, GR, neuropeptide Y, and proopiomelanocortin, which
predispose offspring to altered regulation of food intake and glucose homeostasis in later life [111].
Another important point to note is the impact of methyl-donor nutrients involved in the DNA
methylation. It has been reported that maternal serum vitamin B12 levels inversely correlated
with offspring’s global methylation status at birth [112]. Another report showed that folic acid
supplementation directly impacted the methylation status of the IGF2 gene in the infants up to 17
months of age [113]. Moreover, maternal blood concentrations of methyl-donor nutrients measured
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around the time of conception can predict the methylation patterns at metastable epialleles in their
offspring [114].
Overall, these studies support that malnutrition in pregnancy can epigenetically program
development of adult diseases in later life. Nevertheless, the detailed mechanisms underlying
the epigenetic modulation of common genes by different maternal nutritional insults still await for
further study in diverse models of developmental programming.
5.5. Gut Microbiota
There is now growing evidence suggesting the role of early-life gut microbiota in developmental
programming of metabolic syndrome-related disorders [115,116]. Maternal nutritional insults may
cause a microbial imbalance, namely dysbiosis. Dysbiosis of gut microbiota may link early-life
nutritional insults and later risk of adult diseases [117]. The gut microbiota produces a variety of
metabolites detectable in host circulation, including short-chain fatty acids, small organic acids, bile
acids, vitamins, and choline metabolites [118]. During pregnancy, the diet–gut microbiota interactions
can mediate changes in global histone acetylation and methylation not only in mother but also in the fetus
via the contact with their metabolites [119]. Emerging evidence shows that gut microbiota dysbiosis
in early-life might be correlated with adverse offspring outcomes including obesity [120], metabolic
syndrome [120], diabetes [120], hypertension [121], allergy [122], and neurological disorder [123]. On
the other hand, non-essential nutrients are substances within foods that can have a significant impact
on health, for example, dietary fiber. Of note, consumption of dietary fiber has become one dietary
strategy for modulating the gut microbiota. A recent study from our laboratory examined the maternal
high-fructose-induced hypertension model and found that modulation of gut microbiota by inulin
is able to protect adult offspring against programmed hypertension [124]. Although recent studies
demonstrating that microbiota-targeted therapies can be applied to a variety of diseases [125], their
roles on nutritional programming-related disorders, especially the use of prebiotics in pregnancy,
demand further exploration.
5.6. Sex Differences
There is a growing body of evidence that indicates sex differences exist in nutrient intake,
bioavailability, and metabolism [126,127]. Several above-mentioned mechanisms related to
nutritional programming, such as nutrient-sensing signal [128], oxidative stress [129], and epigenetic
regulation [130] have been reported to respond to maternal nutritional insults in a sex-specific manner.
Same maternal nutritional insults, such as caloric restriction [34], high-fructose diet [49], or high-fat
diet [67], can induce different phenotypes on male and female offspring. For example, male offspring
are more prone to hypertension than female offspring [5]. This difference has led many studies to
target their efforts totally to one sex, especially to males [35,56,57,69,75].
Evidence from animal models of maternal overnutrition has suggested that females are more
vulnerable to programming of glucose homeostasis, whereas males are more susceptible to changes
in adiposity and body weight [131–133]. On the other hand, male offspring of pregnant rats with
caloric restriction during early gestation displayed obesity later in life, but female offspring were
unaffected [134].
A few studies have investigated the sex-specific programming response to maternal diet on
transcriptome profiles of the offspring [49,135]. A previous study has shown that more genes in
the placenta were affected in females than in males under different maternal diets [135]. This is
in accord with a report revealing that sex-specific placental adaptations are often associated with
male offspring developing adult disease while females are minimally affected [136]. In a maternal
high-fructose diet model [49], we found a sex-specific alteration of renal transcriptome response to
maternal high-fructose intake and female offspring are more fructose-sensitive. However, whether
higher sensitivity to nutritional insults is beneficial or harmful for programming effects in female
offspring awaits further evaluation. As males and females likely respond differentially to nutritional
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programming, future research is required to clarify whether nutritional interventions also result in
sex-specific reprograming effects.
6. Nutritional Interventions as Reprogramming Strategies
Reprogramming strategies aim to reverse the programmed development and achieve normal
development. These strategies could be nutritional intervention, exercise, lifestyle modification,
or pharmacological therapy. Nutritional programming is theoretically bidirectional. Inadequate
(e.g., folate deficiency) or excessive intake (e.g., excess of macronutrients) of certain nutrients in
pregnancy leads to adult diseases in later life. Conversely, adverse programmed processes during a
compromised pregnancy can be prevented or at least reduced by appropriate nutritional interventions.
It is well known that a balanced, diverse, and nutritious diet is universally recommended to meet
nutritional needs to improve maternal and birth outcomes [137,138]; however, little is known whether
supplementing with certain classes of nutrients in gestation can be beneficial on DOHaD-related
disorders induced by various early-life insults in humans. In the current review, we only restrict to
nutritional interventions during pregnancy and/or lactation periods as reprogramming strategies to
prevent adult diseases of developmental origins in all sorts of animal models, some of which are listed in
Table 2 [33,35,124,139–150]. Rats are the most commonly used species for developmental programming
research. Rats become sexually mature at approximately 5–6 weeks of age. In adulthood, one rat month
is comparable to three human years [151]. Accordingly, Table 2 lists the ages of reprogramming effects
measured in rats ranging from 4 to 14 months, which can be translated to humans of specific age groups,
from childhood to young adulthood. However, limited information is available about the long-term
effects of nutritional interventions on older adult offspring. Additionally, developmental window is
not uniform across different organ systems or species. For example, renal development in rodents,
unlike in humans, continues up to postnatal week 1–2 [99]. Therefore, nutritional interventions during
pregnancy and early lactation period may preserve nephrogenesis and increase nephron numbers to
prevent the developmental programming of kidney disease [35,140].
Table 2. Reprogramming strategies aimed at nutritional interventions to prevent developmental
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Studies tabulated according to types of treatments and age at measure. SD, Sprague–Dawley rat. M, male; F, female.
Most importantly, some nutritional interventions are employed in non-nutritional-insults-induced
programming models [140–142,144]. Nutritional interventions are grouped into macronutrients,
micronutrients, and non-essential nutrients.
6.1. Macronutrieents
Macronutrients used as reprogramming strategies are mainly directed at amino acids. Within the
body, amino acids are used for a wide variety of structural proteins and, hence, they play critical roles
in organogenesis and fetal development. Among them, the most commonly used for reprogramming
is citrulline. Maternal citrulline supplementation has been reported to protect adult offspring against
hypertension and kidney disease in several models of developmental programming, including maternal
caloric restriction [35], streptozotocin-induced diabetes [140], prenatal dexamethasone exposure [141],
and maternal nitric oxide (NO) deficiency [142]. Citrulline is a precursor to arginine, and it is involved in
the generation of NO [152]. Despite post-weaning arginine supplementation being reported to improve
hypertension, insulin sensitivity, and beta cell function in offspring rats [153,154], the reprogramming
effects of arginine supplementation in pregnancy are yet to be examined. Supplemental citrulline is
more efficient than arginine to produce NO as citrulline can bypass hepatic metabolism and allow
renal conversion to arginine. Thus, a better understanding of maternal citrulline supplementation in
the prevention of diverse animal models of developmental programming is warranted before it is
implemented in humans.
Another three amino acids, glycine, branched-chain amino acid, and taurine have also been
used as reprogramming interventions in models of maternal low-protein diet [139], maternal caloric
restriction [143], and streptozotocin-induced diabetes [144], respectively. Glycine is a simple amino
acid not essential to the human diet. Glycine and vitamins (folic acid, vitamin B2, B6, and B12) take
part in one-carbon metabolism and DNA methylation. Thus, glycine supplementation may have
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important implications for fetal programming through epigenetic mechanisms. Additionally, maternal
branched-chain amino acid supplementation protects adult rat offspring against hypertension in a
maternal caloric restriction model [143]. Taurine is an abundant semi-essential, sulfur-containing
amino acid. Taurine supplementation during gestation prevented maternal diabetes-induced
programmed hypertension [144]. Taurine supplementation can lower BP and increase hydrogen
sulfide simultaneously [155]. Cumulative evidence supports hydrogen sulfide as a reprogramming
strategy for long-term protection against programmed hypertension [156]. Additional studies are
required to clarify whether the protective effects of maternal taurine supplementation on programmed
hypertension is related to hydrogen sulfide pathway in other programming models.
So far, three reports showed maternal polyunsaturated fatty acids’ (PUFAs) supplementation has
reprograming effects against hypertension [145,146], cardiac remodeling [146], and liver steatosis [147]
in adult rat offspring. Although PUFAs have been recommended for pregnant and breastfeeding
women [138], a recent meta-analysis that included 3644 children showed maternal supplementation
with omega-3 PUFA during pregnancy does not have a beneficial effect on obesity risk [157]. Thus,
whether there are differential reprogramming effects of individual PUFAs used as dietary supplement
during pregnancy on diverse adult diseases remain to be determined.
6.2. Micronutrients
Micronutrients include vitamins and minerals. Relatively few reports demonstrated
reprogramming effects of maternal micronutrients supplementation on offspring outcome [33,148,149].
One previous report demonstrated that combined micronutrients vitamin C, E, selenium, and folic
acid supplementation in gestation prevented maternal caloric restriction-induced hypertension and
endothelial dysfunction [33]. Vitamin C, E, and selenium have antioxidant properties. These
micronutrients were shown to prevent programmed hypertension by reducing oxidative stress [158].
Folic acid is known to prevent neural tube defects, leading to global recommendations for folic acid
supplementation before and during early pregnancy. Besides, folic acid, combined with other vitamins
B12, B6, and B2, are the source of coenzymes which participate in one-carbon metabolism. In our body,
one-carbon metabolites serve as methyl-donors that are required for DNA methylation. Although
folic-acid supplementation during pregnancy was reported to improve offspring cardiovascular
dysfunction induced by maternal low-protein diet [148], whether its reprogramming effects is related
to epigenetic regulation remains undiscovered. On the other hand, our recent study showed that
pregnant rats fed with high-methyl-donor diet or methyl-deficient diet both resulted in programmed
hypertension in their male adult offspring [81]. Additional studies are required to approve whether
methyl-donor food intake in pregnant women is beneficial to reduce adverse offspring and not just
birth outcomes [80]. In a rabbit model, maternal vitamin E supplementation protected adult offspring
against hypertension and hypercholesterolemia [135]. Many of the physiological functions of vitamin
E, including its antioxidative effects, have been well studied. However, there still exists an ongoing
debate regarding its beneficial effects on human health [159]. Despite recent studies demonstrating that
antioxidant vitamins and minerals can be applied to a variety of diseases [94], their reprogramming
effects on different adult diseases for dietary supplement use during pregnancy remain to be identified.
6.3. Non-Essential Nutrients
Dietary fiber, one of the non-essential nutrients, has been used as reprogramming strategies
to prevent developmental programming of hypertension [124], hepatic steatosis, and insulin
resistance [150]. Maternal supplementation with inulin protected adult rat offspring born to dams fed
with high-fructose diet against the developmental programming of hypertension [124]. Another report
demonstrated that maternal oligofructose supplementation attenuated hepatic steatosis and insulin
resistance in adult rat offspring in a high-fat/-sucrose diet model [150]. Inulin and oligofructose are
the most studied forms of prebiotic foods for beneficial gut microorganisms. As gut microbiota can
influence development of sensitization and allergy, the World Allergy Organization (WAO) experts
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issued their guidelines on the use of prebiotics for all formula-fed infants in allergy prevention [160].
Nevertheless, whether prebiotics can be used in pregnant women for prevention of allergy in their
offspring required further preclinical and clinical evidence.
Additionally, combined supplementations with high-fiber diet and acetate prevented hypertension
in deoxycorticosterone acetate (DOCA)–salt hypertensive mice [161]. Acetate is the most abundant
short-chain fatty acids, the major metabolites of gut microbiota. Considering that the gut microbiota
dysbiosis is a key mechanism underlying nutritional programming, maternal supplementation with
prebiotics or other microbiota-targeting nutritional interventions (e.g., probiotics and postbiotics) might
be used as reprogramming strategies in different adult diseases of developmental origins.
It is noteworthy that reprogramming strategies can be created based on the above-mentioned
mechanisms leading to a variety of adult diseases. For example, maternal inulin supplementation
prevented adult rat offspring against high-fructose diet-induced programmed hypertension associated
with nutrient-sensing signals [124]. The beneficial effects of vitamin C and E, selenium, and folic
acid [33], citrulline [140,142], conjugated linoleic acid [145], and folic acid [148] on developmental
programming of hypertension are relevant to the reduction of oxidative stress. Moreover, low nephron
number was restored by citrulline supplementation in the maternal caloric restriction model [35],
streptozotocin-induced diabetes model [140], and prenatal dexamethasone exposure model [141]. Thus,
nutritional interventions in pregnancy may reprogram common mechanisms of both nutritional and
non-nutritional in utero insults to prevent offspring against adult diseases of developmental origins.
This effect requires more efforts to bridge gaps between basic animal research and clinical practice.
7. Conclusions
Almost all NCDs can originate in early-life. It stressed the importance of taking a DOHaD
approach to prevent and control global burden of NCDs. All nutrients in pregnancy play a pivotal
role in fetal growth and development. Without a doubt, maternal malnutrition is definitely bad for
offspring health as it induces nutritional programming, leading to the developmental programming of
numerous NCDs. Conversely, nutritional programming can also be advantageous. Through animal
models, several nutritional interventions have been proven effective as a reprogramming strategy to
prevent the development of various NCDs. Although there is a great opportunity that reprogramming
strategy is good for offspring health, there is also an ugly side to it.
Given that the complexities of nutritional programming in pregnancy lead to both beneficial
and deleterious effects in mother and offspring health, there remains a long road ahead to determine
the “right” nutritional intervention for the “right” person (mother or offspring) at the “right” time,
to prevent the DOHaD-related diseases. It is clear that better understanding of the type of nutrient,
dose of supplement, and therapeutic duration for nutritional interventions are needed before patients
could benefit from this reprogramming strategy. We expect that studies utilizing animal models of
nutritional programming will provide the much-needed scientific basis for the development of ideal
reprogramming strategies for clinical practice that will improve pregnancy and offspring outcomes
in humans.
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